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Abstract 
Insects initiate innate immune responses after microbial infection. Extracellular 
proteolytic cascades lead to melanization of pathogens and parasites present in the hemocoel, as 
well as production of antimicrobial peptides to combat foreign microbes. Serpins are a 
superfamily of serine protease inhibitors, which regulate the proteolytic cascades by blocking 
activity of proteases. An antifungal peptide, diapausin, is among the induced antimicrobial 
peptides in M. sexta hemolymph, helping to protect this insect from fungal infection. 
Thirty-two serpin genes identified from M. sexta genome were characterized. The 
number of exons in serpin genes varies from 1 to 10, with some conserved intron positions 
providing evidence of patterns of serpin gene evolution. MsSerpin-15 and 28 encode 2 and 3 
splicing isoforms respectively, with different reactive center loop sequences. Twenty-seven 
serpin gene products were predicted to be secretory, with amino-terminal signal peptides. An 
analysis of conserved amino acid residues in the gate, shutter and breach regions of serpins and 
the pattern of residues in the reactive center loop hinge region suggested that approximately three 
quarters of M. sexta serpin proteins (including splicing isoforms) are functional protease 
inhibitors. This work benefits the future investigation regarding the evolution, structure, and 
function of serpins in M. sexta and other insects. 
Synthetic peptides with the sequences derived from part of the M. sexta serpin-3 reactive 
center loop (RCL) were used to test the hypothesis that they may inactivate serpin-3 by 
mimicking the insertion of the RCL that occurs during the protease inhibition reaction. Among 
four RCL-derived peptides with sizes of 5-9 amino acid residues, the shortest peptide, Ac-
SVAFS-NH2, demonstrated the greatest effect on blocking the inhibitory activity of recombinant 
serpin-3 by enhancing the conversion of serpin-3 from inhibitor to substrate for 
prophenoloxidase-activating protease-3. Ac-SVAFS-COO- with improved solubility showed the 
same effects on serpin-3 as Ac-SVAFS-NH2. Addition of Ac-SVAFS-COO
--treated recombinant 
serpin-3 to plasma led to elevated levels of prophenoloxidase activation, suggesting that the 
serpin in complex with the peptide could not regulate prophenoloxidase-activating proteases. 
Similar results were observed when the RCL-derived peptide was mixed with plasma, to allow it 
to interact with endogenous serpin-3. Circular dichroism analysis showed that serpin-3 
complexed with Ac-SVAFS-COO- has a deeper trough at 215 nm compared with the free serpin-
3, consistent with a slight difference in secondary structure upon interaction with Ac-SVAFS-
  
COO-. Furthermore, the complex of serpin-3 and Ac-SVAFS-COO- displayed greater heat 
stability than free serpin-3, which is consistent with the predicted peptide insertion into -sheet 
A. 
Recombinant diapausin-1 and diapausin-2 blocked growth of Saccharomyces cerevisiae, 
with IC50 of 30 M and 60 M, respectively. Observation of the cell morphology revealed the 
disruption of daughter cell separation after cell division, resulting in cell clusters in the presence 
of diapausin. Morphological analysis revealed that diapausin-1 causes appearance of an 
elongated mother cell with a small, flattened bud and wider neck, as well as less elliptical shape. 
The growth of Candida albicans and Candida krusei was inhibited by diapausin-1, with IC50 of 
60 M and 20 M respectively. Furthermore, diapausin-1 impaired the germination of conidia 
and hyphal growth of Beauveria bassiana, an insect pathogenic fungus. FITC-labeled diapausin-
1 bound to the surface of S. cerevisiae, and pull-down experiments showed that diapausin-1 
binds to -1,3-glucan, a primary component of fungal cell walls. This study advances our 
understanding of an insect immune response to fungal infections and may contribute to the 
identification of new targets for the development of antifungal drugs. 
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Abstract 
Insects initiate innate immune responses after microbial infection. Extracellular 
proteolytic cascades lead to melanization of pathogens and parasites present in the hemocoel, as 
well as production of antimicrobial peptides to combat foreign microbes. Serpins are a 
superfamily of serine protease inhibitors, which regulate the proteolytic cascades by blocking 
activity of proteases. An antifungal peptide, diapausin, is among the induced antimicrobial 
peptides in M. sexta hemolymph, helping to protect this insect from fungal infection. 
Thirty-two serpin genes identified from M. sexta genome were characterized. The 
number of exons in serpin genes varies from 1 to 10, with some conserved intron positions 
providing evidence of patterns of serpin gene evolution. MsSerpin-15 and 28 encode 2 and 3 
splicing isoforms respectively, with different reactive center loop sequences. Twenty-seven 
serpin gene products were predicted to be secretory, with amino-terminal signal peptides. An 
analysis of conserved amino acid residues in the gate, shutter and breach regions of serpins and 
the pattern of residues in the reactive center loop hinge region suggested that approximately three 
quarters of M. sexta serpin proteins (including splicing isoforms) are functional protease 
inhibitors. This work benefits the future investigation regarding the evolution, structure, and 
function of serpins in M. sexta and other insects. 
Synthetic peptides with the sequences derived from part of the M. sexta serpin-3 reactive 
center loop (RCL) were used to test the hypothesis that they may inactivate serpin-3 by 
mimicking the insertion of the RCL that occurs during the protease inhibition reaction. Among 
four RCL-derived peptides with sizes of 5-9 amino acid residues, the shortest peptide, Ac-
SVAFS-NH2, demonstrated the greatest effect on blocking the inhibitory activity of recombinant 
serpin-3 by enhancing the conversion of serpin-3 from inhibitor to substrate for 
prophenoloxidase-activating protease-3. Ac-SVAFS-COO- with improved solubility showed the 
same effects on serpin-3 as Ac-SVAFS-NH2. Addition of Ac-SVAFS-COO
--treated recombinant 
serpin-3 to plasma led to elevated levels of prophenoloxidase activation, suggesting that the 
serpin in complex with the peptide could not regulate prophenoloxidase-activating proteases. 
Similar results were observed when the RCL-derived peptide was mixed with plasma, to allow it 
to interact with endogenous serpin-3. Circular dichroism analysis showed that serpin-3 
complexed with Ac-SVAFS-COO- has a deeper trough at 215 nm compared with the free serpin-
3, consistent with a slight difference in secondary structure upon interaction with Ac-SVAFS-
  
COO-. Furthermore, the complex of serpin-3 and Ac-SVAFS-COO- displayed greater heat 
stability than free serpin-3, which is consistent with the predicted peptide insertion into -sheet 
A. 
Recombinant diapausin-1 and diapausin-2 blocked growth of Saccharomyces cerevisiae, 
with IC50 of 30 M and 60 M, respectively. Observation of the cell morphology revealed the 
disruption of daughter cell separation after cell division, resulting in cell clusters in the presence 
of diapausin. Morphological analysis revealed that diapausin-1 causes appearance of an 
elongated mother cell with a small, flattened bud and wider neck, as well as less elliptical shape. 
The growth of Candida albicans and Candida krusei was inhibited by diapausin-1, with IC50 of 
60 M and 20 M respectively. Furthermore, diapausin-1 impaired the germination of conidia 
and hyphal growth of Beauveria bassiana, an insect pathogenic fungus. FITC-labeled diapausin-
1 bound to the surface of S. cerevisiae, and pull-down experiments showed that diapausin-1 
binds to -1,3-glucan, a primary component of fungal cell walls. This study advances our 
understanding of an insect immune response to fungal infections and may contribute to the 
identification of new targets for the development of antifungal drugs. 
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Chapter 1 - Literature Review 
 Innate Immune Responses in Insect 
In order to survive different kinds of invading pathogens, organisms have evolved 
efficient and robust defense mechanisms to protect themselves by suppressing or killing 
infectious microbes (Buchmann, 2014). The innate immune system uses natural barriers, 
phagocytes, and soluble mediators to take immediate effect upon invasion of foreign 
microorganisms. In contrast, the adaptive immune system tailors the response towards specific 
antigens and produces corresponding antibodies to attack foreign invaders (Delves et al., 2017; 
Coico and Sunshine, 2015). Innate immune responses are extensively relied on by invertebrates 
which lack adaptive immunity. Vertebrates, with powerful and specific adaptive elements, still 
retain the innate immune functions, which prompt self-defense immediately upon infection. 
Potentially constituting 90% of the animal life forms on earth, insects have adapted to most 
environments on land (Erwin, 1997), which, to some extent, must benefit from the vital role that 
innate immune responses play throughout the insect lifetime. 
Recognition of foreign bacteria, fungi or parasites in the hemolymph is carried out by 
various pattern recognition receptors (Hoffmann et al., 1999). Downstream protective responses 
are triggered by the binding of pattern recognition receptors to pathogen associated molecular 
patterns absent in insects, such as lipopolysaccharide on Gram-negative bacteria, peptidoglycan 
on most bacteria, and -1,3-glucan on fungi (Kanost et al., 2004). Fat body and humoral 
effectors in the hemocoel coordinately mediate a series of defense actions, including 
phagocytosis, encapsulation and nodulation, melanization and synthesis of antimicrobial 
peptides/proteins (Horohov and Dunn, 1983; Hughes et al., 1983; Zhu et al., 2003a).  
Prophenoloxidase activation, a proteolytic cascade leading to melanization of pathogens 
and parasites, is one of the most important defensive components in insects (Ashida, 1998; 
Kanost and Gorman, 2008). In M. sexta, it was discovered that binding of -1,3-glucan to -1,3-
glucan recognition protein induces autoactivation of hemolymph protease14 (HP14), followed by 
activation of hemolymph protease 21 (HP21) and hemolymph protease 2 (HP2) by HP14 (Wang 
and Jiang, 2006; Wang and Jiang, 2010; Takahashi et al., 2015; Wang and Jiang, 2007; He et al., 
2018; Gorman et al., 2007). Prophenoloxidase-activating protease 2 and 3 (PAP2, PAP3) are 
then activated by HP21 and/or HP2. The PAPs then cleave and activate prophenoloxidase 
2 
(proPO), the enzyme responsible for initiating melanin production (Wang and Jiang, 2007; 
Gorman et al., 2007; He et al., 2018; Gupta, et al., 2005; Wang et al., 2014; Jiang et al., 1998).  
Another hemolymph protease cascade induced by microbes leads to activation of the 
cytokine Spätzle and expression of antimicrobial genes via activation of Toll pathway or Imd 
pathway (An et al., 2009; An et al., 2010; Myllymaki et al., 2014). Genomic annotation in many 
insects, such as D. melanogaster, M. sexta, Bombyx mori, Anopheles gambiae, and Apis 
mellifera, leads to the expectation that more serine proteases and serine protease homologs are 
likely to be involved in the activation of immune cascades (Cao et al., 2015b; Kanost and Jiang 
2015; Cao et al., 2017; Zhao et al., 2010; Veillard et al., 2016; Zou et al., 2006). Serine protease 
cascades must be regulated to prevent damage caused by immune factors in tissues. A 
superfamily of serine protease inhibitors, serpins, is well characterized to be critical in the 
regulation of extracellular proteolytic cascades in insects (Jiang et al., 2003; Jiang et al., 2009; 
Park et al., 2011; Levashina et al., 1999; Ahmad et al., 2009; Zou and Jiang, 2005; An and 
Kanost, 2010; An et al., 2011c; Zou et al., 2010; Abraham et al., 2005; Michel et al., 2006; An et 
al., 2011a; Ligoxygakis et al., 2002; De Gregorio et al., 2002; Scherfer et al., 2008; Tong et al., 
2005; Tong and Kanost, 2005; Tang et al., 2008; Zhu et al., 2003b; Wang and Jiang, 2004; Wang 
and Jiang, 2006; He et al., 2017b; Yang et al., 2018).  
Toll and Imd signaling pathways, which transduce extracellular messages of foreign 
invasion into the nuclei of cells, trigger the transcriptional activation of immune-related genes 
(Gillespie et al., 1997; Cao et al., 2015a; Buchon et al., 2014). In D. melanogaster, the Toll 
signaling pathway is active in fat body and induces expression of antimicrobial peptides, such as 
drosomycin, through translocation to the nucleus of NF-B transcription factor Dif, while the 
Imd signaling pathway is active particularly in gut and induces the expression of antimicrobial 
peptides, such as diptericin, through the NF-B transcription factor Relish (Buchon et al., 2014). 
More antimicrobial peptides and proteins from diverse insect species have been discovered and 
characterized, such as defensins from Diptera, Hymenoptera, Coleoptera, Lepidoptera, 
Hemiptera, Isoptera, and Odonata, cecropins from Diptera, Coleoptera, Lepidoptera, and 
Isoptera, proline-rich antimicrobial peptides from Hemiptera, Hymenoptera, Lepidoptera, and 
Diptera, and moricins and gloverins from Lepidoptera (Yi et al., 2014). 
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 Serpins 
Serpins are a superfamily of proteins with conserved tertiary structure, containing three 
-sheets, 8-9 -helices and a solvent-exposed reactive center loop (RCL) (Silverman et al., 
2001). The distribution of serpins is broad, present in viruses, unicellular prokaryotes, unicellular 
eukaryotes, archaea, plants, invertebrates, and vertebrates (Turner et al., 2007; Irving et al., 2002; 
Gettins, 2002; Roberts and Hejgaard, 2008; Meekins et al., 2017; Gettins and Olson, 2016). Most 
serpins act as serine protease inhibitors, whereas some are non-inhibitory serpins with various 
physiological functions, including acting as storage proteins, hormone transporters and molecular 
chaperones (Gettins and Olson, 2016; Huntington and Stein, 2001; Carrell and Read, 2017; 
Widmer et al., 2012). Mammalian serpins regulate proteases in vital physiological processes, 
such as hemostasis, fibrinolysis, blood clotting and inflammation (Rau et al., 2007). 
More novel functions of serpins were investigated in the past decades. For example, some 
serpins expressed by orthopox viruses were discovered to be caspase inhibitors, regulating the 
apoptotic response (Pickup, 1994; Dobbelstein and Shenk, 1996). Human maspin is a well-
known tumor suppressor and a potential prognostic indicator for various types of cancers (Zhou 
et al., 1994; Berardi et al., 2013). High abundance of human 1-antichymotrypsin and its direct 
interaction with A in Alzheimer’s plaques imply certain functions in Alzheimer’s pathogenesis 
(Baker et al., 2007). Some mutations can lead to the polymerization of serpin molecules, 
resulting from aberrant conformational changes by misplacing the RCL in an adjacent serpin 
molecule (Gooptu and Lomas, 2009). Serpinopathy was designated to describe the diseases 
caused by serpin polymerization. 
 Serpin conformations  
Many crystal structures of serpins are available with various conformational forms in 
PDB (http://www.rcsb.org). Slight folding differences, especially the status and relative positions 
of the RCL, define several serpin forms with particular properties. The native form features a 
complete solvent-exposed RCL with potential inhibitory activity against serine proteases. The 
RCL in this state is usually not structurally characterized due to its flexibility. Two residues 
flanking the scissile bond cut by a protease in the inhibition reaction are designated as P1 and 
P1’. Residues on the amino-terminal side of scissile bond are numbered in a direction of C- to N-
terminus: P2, P3, P4…and so on. Residues on the carboxyl-terminal side of the scissile bond are 
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numbered in a direction of N- to C- terminus: P2’, P3’, P4’…and so on. A determined native 
structure of M. sexta serpin-1K is shown in Figure 1-1A (Li et al., 1999). The native form of 
serpins is quite vulnerable and least stable among all forms, with average melting temperature of 
58C (Kaslik et al., 1997). 
The cleaved form of serpin is the product of proteolysis at the scissile bond of the native 
form. The N-terminal part of the RCL is inserted into -sheet A as the 4th strand (Fig. 1-1B). The 
cleaved form is the most stable serpin conformation, with melting temperature >110C (Bruch et 
al., 1988; Hervé and Ghélis, 1990).   
The latent serpin form is recognized by the insertion of the intact RCL into -sheet A as 
the 4th strand (Fig. 1-1C). The difference between the latent and cleaved forms is the stretch of -
sheet C 1st strand following RCL due to relocalization of the entire RCL (Stout et al., 2000). The 
resulting absence of exposed RCL as a bait deprives the inhibitory function of the serpin, while 
significantly stabilizing the conformation, with a melting temperature of 85-90C (Onda et al., 
2005). 
The delta form of serpin is only characterized in 1-antichymotrypsin as one naturally 
occurring variant (Gooptu et al., 2000). As shown in Figure 1-1D, partial incorporation of the 
intact RCL occurs up to P12 into -sheet A, while the last turn of helix F and the loop connecting 
s3A unwind and are recruited to -sheet A as well. This inactive form is believed to be an 
intermediate conformation during folding or misfolding (Gooptu et al., 2000).   
The “polymer” form of serpin results from insertion of the RCL into -sheet A of another 
serpin molecule, known also as the “loop-sheet” model or “domain-swapping” model (Fig 1-1E) 
(Ekeowa et al., 2010; Santangelo et al., 2012; Yamasaki et al., 2010; Yamasaki et al., 2011; 
Huntington and Whisstock, 2010). Serpinopathies refer to those diseases that arise from serpin 
aberrant polymerization, as a consequence of point mutation in a serpin gene that favors the 
polymeric form. For example, the Z-variant of 1-antitrypsin has a substitution of glutamate 342 
to lysine, which results in accumulation of polymerized 1-antitrypsin within hepatocytes and 
lung (Lomas et al., 1992; Elliott et al., 1998). Pathogenesis of cirrhosis, hepatocellular 
carcinoma, neonatal hepatitis and emphysema are associated with Z-variant polymerization 
(Gooptu et al., 2014). 
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 Mechanism of serpin inhibition 
Unlike canonical serine protease inhibitors, such as Kazal, Kunitz and Bowman-Birk 
inhibitors, serpins adopt a so-called “suicide” mechanism to inhibit serine proteases (Bode and 
Huber, 1992). The inhibition of a protease by a serpin includes cleavage by the protease of a 
specific “scissile” bond between residues designated P1-P1’ in the serpin RCL (Loebermann et 
al., 1984). A noncovalent complex between the protease and serpin is formed though interaction 
of the protease active site and the serpin RCL (Ye et al., 2001). After the P1 residue is correctly 
positioned in the primary specificity pocket of the protease, the serine in the active site attacks 
and cleaves the scissile bond, leading to the formation of a covalent acyl complex of protease 
and serpin. This cleavage triggers a dramatic conformational change, in which the RCL is 
incorporated into -sheet A as a new strand (s4A) (Stratikos and Gettins, 1999; Huntington et al., 
2000). Translocation of the protease is accompanied by permanent distortion of the protease 
active site, such that the second half of the hydrolysis reaction does not occur. The protease is 
trapped in a covalent complex with the serpin (Gettins and Olson, 2016). 
Formation of the non-covalent Michaelis complex is the first step for irreversible 
inhibition of a protease by a serpin. Structures of 11 serpin-protease Michaelis complexes have 
been investigated by NMR or X-ray crystallography so far (Peterson et al., 2000; Ye et al., 2001; 
Baglin et al., 2002; Dementiev et al., 2003; Dementiev et al., 2004; Li et al., 2004; Johnson et al., 
2006; Li et al., 2008; Lin et al., 2011; Gong et al., 2015). It was revealed from the determined 
structures that the non-covalent Michaelis complex formation does not cause the tertiary 
structure change to either protease or serpin main body. The conformation of the serpin RCL in 
the Michaelis complex resembles that of small canonical inhibitors (Pearce et al., 2007). The P1 
residue of the serpin RCL fits in the active site of the protease, with the aid from contacts of 
subsites on protease and residues flanking the RCL scissile bond (Peterson et al., 2000; Ye et al., 
2001; Baglin et al., 2002; Dementiev et al., 2003; Dementiev et al., 2004; Li et al., 2004; 
Johnson et al., 2006; Li et al., 2008; Lin et al., 2011; Gong et al., 2015). 
Through formation of the acyl intermediate between protease and serpin, hydrolysis of 
the scissile bond on a serpin RCL occurs, immediately followed by RCL insertion into -sheet A 
as a new strand between s3A and s5A, resulting in the translocation of protease by over 70 Å 
(Stratikos and Gettins, 1998; Stratikos and Gettins, 1999; Fa et al., 2000). Rapid insertion of the 
cleaved RCL is critical for efficient inhibition. A serpin acts as predominately a substrate rather 
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than inhibitor if the overall rate of proteolysis and subsequent release of cleaved serpin is greater 
than that of loop insertion and subsequent distortion of the protease active site (Gettins, 2002).  
Rapid loop insertion requires the coordination of several flexible regions in the serpin, 
named the hinge, shutter, breach, and gate (Stein and Carrell, 1995; Whisstock et al., 2000). The 
breach, at the entrance where cleaved RCL begins to insert, has highly conserved residues 
allowing a hydrophobic core to accept a new strand. The shutter region, the main part on -sheet 
A that opens and accepts the cleaved RCL, is essential for promoting the inhibition reaction. The 
gate region is responsible for accommodating the dramatic translocation of the protease. The 
hinge region (P17-P9) of inhibitory serpins is typically composed of residues with small side 
chains, which contribute to the mobility for conformational change of the RCL (Hopkins et al., 
1993). A consensus pattern in the hinge region is conserved in inhibitory serpins. P17 is usually 
glutamate, P16 is glutamate/lysine/arginine, P15 is glycine, P14 is threonine/serine, and P12-P9 
are alanine/glycine/serine (Irving et al., 2000). Additionally, studies showed that mutations to 
place a proline in the proximal RCL prior to P2 residue disrupts the formation of a new  strand, 
blocking RCL incorporation (Hopkins et al., 1993; Hopkins and Stone, 1995; Gettins, 2002). 
Sufficient length of RCL is necessary to assist the full insertion into -sheet A (Huntington, 
2011). Determination of crystal structures of cleaved human antitrypsin (AT), serpin protein Z-
dependent proteinase inhibitor (ZPI), protein C inhibitor (PCI) and plasminogen activator 
inhibitor-1 (PAI-1) demonstrated a requirement for at least 16 residues in the RCL prior to the 
scissile bond in RCL for full insertion (Schreuder et al., 1994; Huang et al., 2010; Li and 
Huntington, 2008; Jensen and Gettins, 2008).        
Specificity of serpins as inhibitors against proteases is a topic more complicated than 
serine protease specificity against substrates. Though serpin specificity largely relies on the P1 
residue, recent studies discovered more determinants that can provide a more complete 
explanation for specificity exceptions. For example, residues flanking the scissile bond 
contribute to complementary interactions with subsites on the target protease, which affect the 
selection of protease to be inhibited. Furthermore, RCL dynamics and the local electrostatics also 
contribute to the specificity (Gettins, 2002; Marijanovic et al., 2019). 
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 Arthropod serpins 
Sequences of serpin proteins across species may have only 20% identity in spite of 
common tertiary structures (Irving et al., 2000). Arthropod serpins lack orthology with 
mammalian serpins and there has been much less research regarding their structures and 
functions. Arthropod serpins, mostly with inhibitory activity, regulate a wide range of 
physiological processes, such as proPO activation, Toll pathway activation, development, 
reproduction, and host-pathogen interactions (Meekins et al., 2017). With the completion of 
many insect genome projects, identification of novel serpin genes and further studies regarding 
the evolution, structure and function are starting to thrive. There are at least 36 species from 7 
insect orders with publications to describe serpins from either genome or transcriptome 
sequencing (Table 1-1). The total number of serpin genes in insect genomes varies from 7 (Apis 
mellifera) to 34 (Bombyx mori) (Zou et al., 2006; Zou et al., 2009). Eighteen anopheline 
mosquitoes throughout the world contain 12-23 serpin genes, implying gene expansion events 
after the divergence of those species (Neafsey et al., 2015). 
Besides gene duplication to diversify serpin variants in a genome, mutually exclusive 
alternate splicing also occurs in arthropods to expand serpin protein functions. M. sexta serpin-1 
has 14 different versions of exon 9, each encoding a different RCL, with distinct inhibitory 
spectra against proteases (Jiang and Kanost, 1997; Li et al., 2018; Jiang et al.,1994). Alternative 
exon splicing was also adopted by lepidopteran orthologs of M. sexta serpin-1 at the same 
position. Bombyx mori, diverged 84 million years ago from M. sexta (Wahlberg et al., 2013), has 
only 3 exon 9 duplicates in its serpin-1 gene, encoding 3 isoforms by using exon 9a, 9b or 9c 
(Liu et al., 2011). Serpin-1 from Choristoneura fumiferana generates 4 isoforms via alternative 
exons encoding the RCL (Zheng et al., 2009). The Mamestra configurata serpin-1 gene encodes 
9 variants through alternative exon 9 usage (Hegedus et al., 2008). Additionally, by using 
alternative splicing exons, Pteromalus puparum serpin-1, Anopheles gambiae SRPN10 and 
Drosophila melanogaster Spn4 are able to express RCL variants (Yan et al., 2017; Danielli et al., 
2003; Börner and Ragg 2008). 
There are 14 serpin structures from 6 arthropod species that have been solved by X-ray 
crystallography (Table 1-2). Most structures are in native form with exposed RCL, while D. 
melanogaster Spn42Da and Ixodes ricinus IRS-2 were in cleaved form with proximal RCL 
incorporated as a strand in -sheet A (Ellisdon et al., 2014; Kovarova et al., 2010). M. sexta 
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serpin-1B was crystalized in Michaelis complex with rat trypsin, showing the interaction of P3-
P3’ residues of the RCL with the trypsin active site (Ye et al., 2001). A. gambiae SRPN2 and T. 
molitor serpin-48 have a partial insertion of the hinge RCL into -sheet A, which also occurs in 
human antithrombin III (An et al., 2011b; Park et al., 2011; Zhang et al., 2015b). However, the 
partial insertion in SRPN2 did not show the allosteric activation that is associated with partial 
insertion of hinge RCL in antithrombin (Zhang et al., 2015b). Thus, the function of the short 
inserted hinge observed in some insect serpins still remains intriguing. Latent form has not been 
reported in arthropod serpins yet, perhaps because they still remain undiscovered or they are 
absent in arthropods. 
One of the most studied functions of arthropod serpins is regulating proteolytic cascades 
in the hemolymph. Upon the invasion of foreign organisms, pattern recognition proteins present 
in hemolymph initiate immune responses by amplifying the infection signal through proteolytic 
cascades such as the proPO activation pathway. D. melanogaster deficient for spn27A was 
reported to exhibit spontaneous melanization associated with elevated activity of PO, indicating 
unregulated proPO activation in the absence of spn27A (De Gregorio et al., 2002; Ligoxygakis et 
al., 2002). A characterized target protease of spn27A in D. melanogaster proPO activation 
cascade is MP2 (Tang et al., 2006). Comparably, knockdown of A. gambiae SRPN2 also resulted 
in appearance of melanotic pseudotumors on internal tissues (Michel et al., 2005). Biochemical 
results revealed that activation of proPO was suppressed by SRPN2 via inactivating CLIPB9, a 
proPO-activating protease (An et al., 2011a). In Ostrinia furnacalis, serpin-3 blocks the 
activation of proPO by irreversibly forming an inhibitory complex with proPO-activating 
enzyme, SP13 (Chu et al., 2015). In Tenebrio molitor, three pairs of serpin-protease were 
characterized to play important roles in melanization triggered by immune challenge (Jiang et al., 
2009). 
Serpins are involved in the regulation of Toll pathway as well. The recognition of 
invading organisms stimulates a proteolytic cascade, which leads to the proteolytic processing of 
proSpätzle and binding of cytokine Spätzle to the Toll receptor. Extracellular signaling is thus 
transduced into cells to initiate expression of antimicrobial effectors. Regulation of Toll pathway 
by serpins was studied in T. molitor. A protease MSP, activated by microbial infection, could be 
inhibited by SPN40, while SAE, proteolytically activated by MSP, is inhibited by SPN55 (Jiang 
et al., 2009). SPE, which processes proSpätzle, is inhibited by SPN48 (Jiang et al., 2009; Park et 
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al., 2011). M. sexta serpin-1J was found to suppress activation of Toll pathway by inactivating 
HP8, a Spätzle-processing protease (An et al., 2011c). Mass spectrometry was used to detect M. 
sexta serpin-1A, serpin-1E, serpin-3, serpin-6 and serpin-9 in complex with HP8 in the plasma as 
well, suggesting their possible roles in regulating HP8 in vivo (Ragan et al., 2010; Christen et al., 
2012; Zou and Jiang, 2005; He et al., 2017b). HP6, upstream of HP8 in the Toll pathway, formed 
complexes in M. sexta plasma with serpin-4, 5, 9 and 13, which might be HP6 regulatory factors 
in vivo (An and Kanost, 2010; He et al., 2017b). In D. melanogaster, Spn1 (Spn42Dd) regulates 
the Toll pathway induced by GNBP3 over-expression (Fullaondo et al., 2011).     
Besides the well-studied functions of serpins in regulating innate immune responses, 
serpins are also engaged in other physiological processes identified in D. melanogaster. D. 
melanogaster Spn27A regulates activation of the Toll pathway to control embryonic dorsal-
ventral axis formation (Ligoxygakis et al., 2003; Hashimoto et al., 2003). Repression of Spn5 
(Spn88Ea) expression resulted in defective wing expansion during eclosion (Charron et al., 
2008). Spn76A, a non-inhibitory serpin, is accumulated in the female Drosophila genital tract 
during mating, while Spn28B and Spn28F with putative inhibitory activity, are highly expressed 
in the male accessory gland (Reichhart et al., 2011; Coleman et al., 1995). But the specific 
functions of those serpins still remain elusive. 
Secretory serpins found in insect venom or saliva are likely to mediate the interactions 
between parasites and hosts. Parasitoid wasps contained several serpins in the venom and one of 
them, LbSPNy was discovered to suppress melanization in host hemolymph, possibly by 
interacting with serine proteases within the activation cascade (Colinet et al., 2009). Blood-
feeding arthropods, such as mosquitoes and ticks, use proteins in saliva to interfere with host 
hemostasis and anti-inflammatory actions (Rau et al., 2007). Recombinant serpin IRS-2 from a 
tick, I. Ricinus inhibited human cathepsin G and mast cell chymase, which are proinflammatory 
proteases in host blood (Chmelar et al., 2011). Alboserpin from saliva of a mosquito, Aedes 
albopictus, not only tightly binds to Factor Xa in a reversible manner to inhibit its activity, but 
also binds to heparin and phospholipids, which might help to localize and concentrate alboserpin 
at proper sites to prevent clotting during mosquito feeding. The injection of recombinant 
alboserpin into mice significantly delayed thrombosis at the site of vascular injury (Calvo et al., 
2011). 
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 Manduca sexta serpins 
Manduca sexta, commonly known as the tobacco hornworm, is a model insect for 
biochemical studies because of its large size, ease of rearing and short life cycle (Kanost et al., 
2004). Extensive research was conducted in M. sexta to understand the mechanisms of insect 
development, reproduction, and immune responses. 
Since the first serpin (serpin-1B) from M. sexta was isolated and characterized in 1989 
(Kanost et al., 1989), biochemical studies and genetic analyses were implemented for 
understanding M. sexta serpins’ roles in physiological processes, especially in humoral defensive 
responses. A variety of serpins were identified in M. sexta hemolymph and linked to roles in 
regulation of the proPO activation cascade and Toll pathway activation (Meekins et al., 2017). 
The accomplishment of M. sexta whole genome sequencing makes it possible to discover 
additional serpin genes which have not been revealed by cDNA and transcriptome sequencing 
(Kanost et al., 2016).   
Various commercially available serine proteases have been utilized to characterize the 
inhibitory selectivity of M. sexta serpins (Kanost et al., 1989; Jiang and Kanost, 1997; Gan et al., 
2001; Tong and Kanost, 2005; He et al., 2017b; Yang et al., 2018). Unfortunately, RNA 
interference technique for suppressing expression of plasma proteins has not been successful in 
our lab with M. sexta larvae (Terenius et al., 2011), which adds difficulties to the discovery of 
interactive proteases in vivo and roles that serpins play in particular biological processes. 
Therefore, generally two methods were developed, aiming at finding potential proteases 
inhibited by M. sexta serpins in vivo: (1) Inhibitory assays in vitro by using purified recombinant 
Manduca serine proteases, such as PAP1 and PAP3. (2) Immunoaffinity approach in plasma 
followed by mass spectrometry for identifying serpin-bound proteases. The following paragraphs 
will summarize the Manduca serpins which were hypothesized to regulate immune responses by 
blocking particular proteases in proPO activation and Toll pathways (Fig. 1-2, Table 1-3). 
Investigation of the M. sexta serpins started in 1989 with serpin-1B isoform, which is 
inhibitory against porcine pancreatic elastase and bovine chymotrypsin (Kanost et al., 1989). 
Later research with other serpin-1 isoforms demonstrated the variety of inhibition selectivity 
caused by alternatively spliced exon 9-encoding RCL sequences (Jiang et al., 1994; Jiang and 
Kanost, 1997). A study taking advantage of qPCR, 2D-PAGE and mass spectrometry provided 
in-depth insights into 12 serpin-1 isoforms (Ragan et al., 2010). The transcripts of serpin-1 
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isoforms were not abundant in naïve hemocytes, and challenge of M. luteus did not significantly 
induce the expression of any isoform. In contrast, fat body was shown to highly express serpin-1 
isoforms, especially serpin-1B, with significantly higher levels than the other isoforms. Serpin-
1A, 1E and 1J were detected in complex with HP8 in the naïve hemolymph, and recombinant 
serpin-1J formed a complex with HP8 in vitro, indicating their putative functions in the Toll 
pathway by inhibiting HP8, which is a proSpätzle-activating enzyme (Ragan et al., 2010; An et 
al., 2011c). Serpin-1J can also inhibit PAP3 (Jiang et al., 2003). An inhibitory complex was 
reported to form between recombinant serpin-1I and HP14 in vitro, and addition of serpin-1I to 
plasma significantly suppressed activation of proPO (Wang and Jiang, 2006). An unknown 
variant of serpin-1 was found in acyl-complex with proHP1, an active conformation without 
proteolytic activation (He et al., 2017a). 
Serpin-2 is an intracellular inhibitor present in M. sexta hemocytes. The mRNA level of 
serpin-2 was highly induced in larvae after injection with bacteria. Purified serpin-2 from 
hemocytes was only inhibitory against human cathepsin G among tested proteases, which is 
consistent with the sequence analysis of serpin-2 protein with less similarity to the consensus 
pattern for inhibitory serpins (Gan et al., 2001). The presence of serpin-2 in hemocytes and 
induced expression in response to bacterial challenge point to its participation in immune 
responses, but its physiological function of it still remains unclear. 
Serpin-3 is the most studied serpin in M. sexta. Serpin-3 is constitutively expressed in 
hemolymph and can be induced by injection of bacteria or fungi. Recombinant serpin-3 was 
quite active against PAP1 and PAP3 with complete inhibition at 1.6:1 and 1.9:1 molar ratio 
(serpin:protease) respectively. PO activation in plasma was suppressed by recombinant serpin-3 
in a dose-dependent manner (Zhu et al., 2003b). Immunoaffinity chromatography using serpin-3 
antibody pulled down serpin-3 in plasma complexed with PAP1, PAP2, PAP3, and HP8, while 
another immunoaffinity column using HP1 antibody captured proHP1-serpin-3 complex 
(Christen et al., 2012). Serpin-3 is likely to modulate both proPO activation and Toll pathway by 
targeting distinct proteases.  
Expression of serpin-4 and serpin-5 is highly induced in fat body upon injection of 
bacteria, but inhibitory activity of recombinant serpin-4 or serpin-5 against PAP1 or PAP3 was 
not as potent as that of serpin-3. Recombinant serpin-4 and serpin-5 purified from Sf9 cells 
blocked 50% amidase activity of PAP-1 at 25:1 and 13:1 molar ratio respectively, and PAP-3 at 
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40:1 and 17:1 molar ratio respectively. However, recombinant serpin-4 could completely inhibit 
the PO activation of bacteria-triggered plasma at 0.4 g/l, while addition of serpin-5 did not 
completely block proPO activation (Tong and Kanost, 2005). HP1 and HP6 were covalently 
complexed with serpin-4 and serpin-5 in plasma activated by Gram-positive or Gram-negative 
bacteria, but serpin-4 formed a complex with HP21 in plasma induced only by Gram-positive 
bacteria (Tong et al., 2005). Those results suggested multiple putative target proteases of serpin-
4 in both proPO activation and Toll pathway, while serpin-5 might regulate the Toll pathway. 
Serpin-6 is constitutively expressed at a low level but highly induced in hemocytes and 
fat body after bacterial challenge. Recombinant PAP3 was completely inhibited by recombinant 
serpin-6 at molar ratio of 2:1 (serpin:protease). Ninety percent inhibition of PO activation 
occurred when 140 g/ml recombinant serpin-6 was added to induced plasma. Immunoaffinity 
chromatography using serpin-6 antibody uncovered PAP3 and HP8 in covalent complex with 
serpin-6 in plasma (Zou and Jiang, 2005). The presence of serpin-6 bound to proHP1 suggested 
one more putative protease target for serpin-6 in vivo (He et al., 2017a). Expression of serpin-7 is 
constitutive in both hemocytes and fat body, but can be significantly induced in fat body by 
bacterial challenge. Recombinant serpin-7 exhibited inhibitory activity against recombinant 
PAP3. Addition of recombinant serpin-7 to plasma resulted in the suppression of PO activation 
(Suwanchaichinda et al., 2013).    
Transcripts of serpin-9 and serpin-13 are abundant in fat body and relatively low in 
hemocytes. They are the only two M. sexta serpins whose expression is downregulated after 
injection of bacteria. In fat body, serpin-9 mRNA level did not change, while serpin-13 mRNA 
level significantly decreased. In hemocytes, transcription of both serpin-9 and serpin-13 
decreased after bacterial infection. Addition of recombinant serpin-9 or serpin-13 to plasma 
decreased proPO activation. ProHP1, HP6 and HP8 were discovered to form inhibitory 
complexes with serpin-9 in plasma, whereas serpin-13 complexes formed with ProHP1, HP2 and 
HP6 (He et al., 2017b). 
Transcription level of serpin-12 remains low in both hemocytes and fat body, but can be 
significantly up-regulated by injection of bacteria. Recombinant serpin-12 added to plasma 
reduced the PO activation elicited by E. coli or M. luteus, as well as the proteolytic activation of 
several hemolymph protease precursors. Antibodies to serpin-12 pulled down an HP14-serpin-12 
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complex from plasma, suggesting that HP14 is a putative protease target for serpin-12 in vivo 
(Yang et al., 2018). 
In summary, ten M. sexta serpins have been studied by biochemical approaches. Nine of 
them are extracellular proteins circulating in the hemolymph, and seven can be up-regulated in 
response to bacterial challenge. Their inhibitory activities potentially contribute to the regulation 
of proteolytic cascades that lead to melanization and antimicrobial peptide synthesis during 
defensive reactions. Putative target proteases of those Manduca serpins have been identified 
from plasma through immunoaffinity chromatography. However, the full picture of the serpin-
protease system in immune responses requires more work in the future. 
 Serpin RCL-derived Peptides 
Serine protease inhibition by serpins relies on rapid insertion of the proximal RCL after 
formation of the acyl complex with a protease (Loebermann et al., 1984; Carrell and Travis 
1985). Therefore, reducing the overall rate of loop insertion can switch an inhibitory serpin to a 
protease substrate (Gettins, 2002). One approach to block serpin function is to pre-occupy the 
spot where the RCL will translocate. Synthetic peptides with sequences copied from serpin RCL 
hinge regions were discovered to be inhibitors of serpins by forming a stable complex with them 
and subsequently preventing RCL incorporation (Jendrny and Beck-Sickinger, 2015). 
Nomenclature of RCL-derived peptides simply follows the numbering rules for the RCL. For 
example, peptide P14-P10 stands for the sequence mimicking the P14-P10 residues of the 
original serpin RCL. 
 Structure of serpinRCL-derived peptide binary complexes 
There are several structures of serpin:RCL-derived peptide complex characterized by X-
ray crystallography: PAI-12P14-P10, PAI-2P14-P1, antithrombinP14-P3, antithrombinP14-
P8WMDF and antithrombinP14-P9MLF (Fig. 1-3) (Xue et al., 1998; Jankova et al., 2001; 
Skinner et al., 1998; Zhou et al., 2004). Crystal structures demonstrate that RCL-derived peptides 
are positioned as a new strand between s3A and s5A, with hydrogen bonds formed to stabilize 
the structure, which considerably resembles the corresponding endogenous RCL in an inhibitory 
complex, latent serpin form, and cleaved serpin form. 
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 In antithrombin the hinge region is partially inserted into -sheet A in the native state, 
which is associated with heparin-mediated activation of antithrombin (McCoy et al., 2003; 
Schreuder et al., 1994). This short insertion is believed to restrict the flexibility of the RCL and 
reduce its accessibility to target proteases. Conformational changes of antithrombin can be 
triggered by binding of heparin to helix D, leading to the extension of the hinge insertion and full 
expansion of the RCL. As a result, fully stretched RCL becomes more vulnerable to protease 
factor Xa, with rate of proteolysis increased by 265-fold (Olson et al., 1992). Once complexed 
with peptide P14-P3, native antithrombin extends the inserted hinge region, and the rate of factor 
Xa proteolysis increased by 36-fold (Skinner et al., 1998), converting antithrombin from an 
inhibitor to a substrate of factor Xa. The antithrombinP14-P3 structure provides the insights of 
the molecular mechanism for an RCL-derived peptide acting as serpin inhibitor.  
A structure of PAI-1 with two molecules of peptide P14-P10 annealing between s3A and 
s5A was different from the other 1:1 complexes of serpins with RCL-derived peptides (Xue et 
al., 1998). One of the peptides was positioned as predicted in the space where P14-P10 residues 
on RCL are meant to be when incorporation occurs, whereas the other peptide was found 
unexpectedly to be placed where P6-P2 residues are meant to be after RCL incorporation (Xue et 
al., 1998). It still remains unclear whether the binding of these two identical peptides is 
cooperative or sequential, and whether there is a significant difference in binding affinity of 
these two sites. 
Two other serpinRCL-derived peptide structures were formed with non-serpin derived 
peptides. Synthetic peptides, WMDF and formyl-MLF were found to be localized with P14-P8 
and P14-P9 respectively within -sheet A (Zhou et al., 2004). WMDF and formyl-MLF fit into 
the place where P6-P4 residues on RCL would anneal. The concurrence of one RCL-derived 
peptide and one exogenous peptide in s4A position might enlighten the design of therapeutic 
peptides intended to interrupt serpin functions. 
 Inhibitory effects of RCL-derived peptides on serpins 
Structures of serpinRCL-derived peptide complexes confirmed the insertion of synthetic 
peptides within -sheet A, which abolishes the incorporation of the RCL and increases the 
vulnerability of the RCL to proteolysis. In agreement with structures, biochemical assays of 
RCL-peptide bound serpins demonstrated the transition from inhibitors to substrates (Table 1-4). 
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Investigations of RCL-derived peptides are performed frequently with human serpins, including 
1-antitrypsin, antithrombin, PAI-1 and PAI-2. The length of those serpin-blocking peptides 
varies from 15 to 5 amino acid residues, with mostly mimicking the hinge RCL, which tends to 
have small, hydrophobic residues, allowing this flexible sequence to drive the incorporation of 
the N-terminal RCL into -sheet A during protease inhibition (Irving et al., 2000).  
Synthetic peptides with sequences spanning P15 or P14 to P1 of the RCL were the first to 
be described as a counterpart of the incorporated strand A4. Specifically, P15-P1 from 1-
antitrypsin, P14-P1 from antithrombin, P14-P1 from PAI-1 and P14-P1 from PAI-2 were shown 
to convert corresponding serpins from an inhibitor to a substrate (Mast et al., 1992; Schulze et 
al., 1990; Björk et al., 1992; Eitzman et al., 1995; Jankova et al., 2001). Furthermore, research 
with human α1-antitrypsin revealed that peptides representing the proximal RCL (P14-P4 and 
P14-P8) are sufficient to substantially inhibit antitrypsin activity, while those peptides 
representing the distal part of the RCL (P10-P1, P9-P1 and P8-P1) were much less efficient in 
blocking α1-antitrypsin (Schulze et al., 1992). Similar results were observed in PAI-1 as well. 
PAI-1 complexed with P14-P9, lost nearly all of its inhibitory activity against uPA, whereas P8-
P3 resulted in 60% reduction of inhibitory activity against uPA (D'Amico et al., 2012). 
Evidence of conformational changes caused by the insertion of RCL-derived peptides 
was observed in α1-antitrypsin and antithrombin by circular dichroism (CD) at 220nm (Schulze 
et al., 1990; Schulze et al., 1992; Carrell et al., 1991; Björk et al., 1992). Strands 3A and 5A are 
parallel in the native serpin before incorporation of the RCL as strand 4A, in a new antiparallel 
relationship with strands 3A and 5A, which increases the stability of the overall structure 
(Gettins and Olson, 2016). Native serpins are relatively unstable, with average melting 
temperature of around 58C, while the other forms that contain strand 4A have a much higher 
melting temperature, such as cleaved serpins with >110C melting temperature (Pearce et al., 
2007). Significant increase of melting temperature of antithrombin from 58C to 85C after 
forming complex with peptide P14-P1 is consistent with the contribution of the peptide as strand 
4A to thermostability of antithrombin (Björk et al., 1992).  
The effect of RCL-derived peptides on serpins may not be very specific. It was reported 
that P15-P1 RCL peptide derived from α1-antitrypsin had off-target activity on antichymotrypsin 
and antithrombin (Mast et al., 1992). P14-P3 peptide from antithrombin was able to inactivate 
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α1-antitrypsin (Chang et al., 1996). This may be because inhibitory serpins share a sequence rich 
in small hydrophobic residues in the hinge region, which is used to design RCL-derived peptides. 
This significantly impedes the application of RCL-derived peptides in therapies for serpin related 
diseases. Furthermore, a few cases claimed the induction of antithrombin polymerization in the 
presence of P14-P8 and P14-P9, but attenuation of polymerization in the presence of longer 
RCL-derived peptides (Fitton et al., 1997; Chang et al., 1997). The mechanism of this 
discrepancy is not fully elaborated yet, but may be explained by the exposure of the lower half of 
the cleft caused by the insertion of a short peptide in the upper half of the cleft. The vacant site in 
the lower cleft between s3A and s5A becomes vulnerable to the corresponding part in another 
serpin RCL in proximity and easily leads to formation of linear polymers (Fitton et al., 1997; 
Chang et al., 1997). Modifying RCL-derived peptides and introducing assistant small molecules 
are being developed to optimize specificity and efficacy (Chang et al., 2009). 
RCL peptides from plasminogen activator inhibitor-1 (PAI-1) suppress activity of this 
serpin and result in decreased blood clot lysis in vitro (Eitzman et al., 1995; D'Amico et al., 
2012; Van De Craen et al., 2012). A series of RCL-derived peptides from mammalian 
neuroserpin and a myxomavirus serpin displayed anti-inflammatory, anti-atherogenic and pro-
thrombotic functions in mice, indicating that RCL peptides can have biological activity in vivo 
(Ambadapadi et al., 2016). Another application of RCL-derived peptides is to depolymerize or 
deaccelerate aberrant polymerization of serpin monomers, as a potential treatment for human 
serpinopathies (Fitton et al., 1997).    
 Antifungal Peptides 
Present widely in multicellular organisms, antimicrobial peptides (AMPs) are a group of 
principle effectors in innate immune systems. AMPs are diverse in size and structure, but a 
majority of them cause damage to pathogens by disrupting the cell membrane (Rautenbach et 
al., 2016). Cell wall and cytosolic molecules can also be the target for AMPs. Most of the 
reported AMPs found in insects are antibacterial, with only a few described as active against 
fungi (He et al., 2015). Those demonstrated with fungistatic or fungicidal activity are designated 
antifungal peptides. The number of identified antifungal peptides from diverse organisms is 
growing rapidly with 1127 deposited in the  Antimicrobial Peptide Database 
(http://aps.unmc.edu/AP/main.php). 
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 Modes of action 
The fungal cell membrane is a target for most antifungal peptides (Rautenbach et al., 
2016). Cell wall synthesis-related enzymes are localized at the membrane, including -1,3-
glucan synthase, 1,6-glucan synthase, and chitin synthase, which generate polymers for cell wall 
construction and maintenance (Lesage and Bussey, 2006). Various lipids, including 
glycerophospholipids, sphingolipids and sterols are components of cell membrane and also 
critical for cell communication and functioning (Baxter et al., 2015a). Some antifungal peptides 
can be against both bacteria and fungi by targeting the common lipid components of the 
membrane (Nguyen et al., 2011). However, fungi-specific peptides either inhibit membrane 
compounds only present in fungi, or use the cell wall components as target, such as 
mannoproteins and chitin (Rautenbach et al., 2016). 
The cell wall of fungi is a cross-linked complex composed primarily of polysaccharide 
but also containing minor proteins (Lesage and Bussey, 2006). Chitin is a -1,4-N-
acetylglucosamine polymer anchored to a glucan network in the cell wall (Cabib, 2009). Several 
chitin-interacting antifungal peptides have been reported, such as defensin NP-1 from rabbit, Pp-
AMP1/2 from Japanese bamboo, and Tu-AMP1/2 from bulbs of tulip (Levitz et al., 1986; 
Fujimura et al., 2005; Fujimura et al., 2004). Also linked to -1,3-glucan on fungal cell wall, 
mannoproteins are diversely N-glycosylated or O-mannosylated and they act as structural 
proteins or cell adhesion proteins (Dean, 1999; Dempski and Imperiali, 2002; Ragni et al., 2007; 
Dranginis et al., 2007; Cappellaro et al., 1994). NaD1, a defensin from Nicotiana alata appears 
to interact with mannoproteins on the cell wall of Fusarium oxysporum prior to subsequent cell 
penetration (et al., 2010). Human histatin binds to cell wall protein Ssa1/2, and its fungicidal 
activity was significantly compromised in the absence of Ssa1/2 (Li et al., 2003). The above 
studies revealed that cell wall components, including mannoproteins and chitin, can potentially 
be cell receptors for anchoring antifungal peptides, which resembles the mechanism of yeast 
killer toxins (Breinig et al., 2004; Luksa et al., 2015).  
Cell wall biogenesis enzymes, which are responsible for producing the polysaccharide 
network, span the fungal cell membrane, include -1,3-glucan synthase, -1,6-glucan synthase 
and chitin synthase (Lesage and Bussey, 2006). Only -1,3-glucan synthase was found to be a 
target for an antifungal peptide, echinocandin (Cappelletty and Eiselstein-McKitrick, 2007). 
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Echinocandin is a cyclic lipopeptide that blocks the synthesis of -1,3-glucan by non-
competitively inhibiting -1,3-glucan synthase (Sawistowskaschroder et al., 1984). Potent 
antifungal activity and no off-target effect has led to successful commercialization of 
echinocandin and its derivatives as pharmaceutical products (Sucher et al., 2009).  
Neutral or negatively charged glycerophospholipids make up 55-75% of fungal 
membrane lipids and tend to have electrostatic interactions with cationic antifungal peptides 
(Daum et al., 1998; Ejsing et al., 2009; Singh and Prasad, 2011). Therefore, binding to fungal 
membrane and subsequently interrupting the integrity of the membrane is believed to be the most 
common mode of action for cationic AMPs, including the majority of antifungal peptides 
(Yeaman and Yount, 2003). A group of antifungal/antimicrobial peptides with single linear -
helical structure, such as cecropin A/B from Hyalophora cecropia and LL-37 from vertebrates, 
were observed to have broad spectrum antifungal/antimicrobial activities by binding to 
glycerophospholipids in the target membrane (DeLucca et al., 1997; De Lucca et al., 1998a; den 
Hertog et al., 2005). Certain cationic antifungal peptides display preference for specific lipids on 
the membrane. NaD1 from tobacco and TPP3 from tomato specifically bind to 
phosphatidylinositol(4,5)-bisphosphate (PIP2) mediated by a binding motif (Payne et al., 2016; 
Baxter et al., 2015b). 
 Antifungal peptides in insects 
Expression of diverse AMPs in response to invading bacteria and fungi apparently benefit 
the thriving of insects (Yi et al., 2014). Insect AMPs are typically synthesized in fat body and 
secreted to hemolymph upon microbial infection (Kanost et al., 2004). Most insect AMPs were 
isolated after injection of Gram-positive or Gram-negative bacteria, leading to the extensive 
discovery of antibacterial peptides rather than antifungal peptides. But some antibacterial 
peptides were observed to have antifungal activity because of the common modes of action on 
cell membrane (Faruck et al., 2016). Because modes of action for majority of insect antifungal 
peptides remain elusive, representative antifungal peptides from insects with proposed 
mechanisms are discussed below. 
Cecropins, with single -helical structure, were first isolated from Hyalophora cecropia 
(cecropia moth) and demonstrated to have inhibitory activity against a variety of fungi, including 
Saccharomyces cerevisiae, Phytophthora infestans, Fusarium oxysporum, and Fusarium 
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verticillioides (Cavallarin et al., 1998; De Lucca et al., 1998a; De Lucca et al., 1998b; Ekengren 
and Hultmark 1999; Vizioli et al., 2000). The mode of action for cecropins is believed to be 
disrupting the fungal membrane by binding to glycerophospholipids, which also explains the 
presence of antibacterial activity (De Lucca et al., 1998a; De Lucca et al., 1998b). 
Drosomycin from D. melanogaster did not show any antibacterial activity, but was quite 
active against phytopathogenic fungi (Terras et al., 1993; Fehlbaum et al., 1994). Drosomycin is 
composed of one -helix and three -strands with four pairs of disulfide bonds to stabilize the 
structure (Landon et al., 1997). Potent antifungal activity of drosomycin was observed in various 
fungi with IC50 from 0.9-12 M (Fehlbaum et al., 1994; Tian et al., 2008). Hyphal lysis caused 
by drosomycin was reported in susceptible fungi Botrytis cinerea and Neurospora crassa 
(Fehlbaum et al., 1994; Gao and Zhu 2008). The target of drosomycin on the fungal membrane 
remains to be identified, with possibly sphingolipids due to the similarity with plant defensin 
(Gao and Zhu, 2008). The recognized -patch and -patch on the molecular surface of 
drosomycin was expected to mediate the membrane binding and permeability respectively (Tian 
et al., 2008). 
Gloverin from M. sexta is a protein 177 amino acid long, rich with glycine (Xu et al., 
2012). Inhibitory activity of gloverin was detected against S. cerevisiae, Bacillus cereus and 
Cryptococcus neoformans, but not E. coli or S. aureus. However, recombinant M. sexta gloverin 
was shown to bind O-specific antigen and outer core carbohydrate moieties of 
lipopolysaccharide, which are present in Gram-negative bacteria. Gloverin also binds to Gram-
positive lipoteichoic acid and peptidoglycan and fungal laminarin (Xu et al., 2012).  
A recently discovered family of antifungal peptides in M. sexta, designated diapausin, 
was active against S. cerevisiae but not bacteria (Al Souhail et al., 2016). Recombinant 
diapausin-1 caused curled germination tubes in Magnaporthe oryzae and reduced hyphal growth 
of Fusarium culmorum and F. graminearum. Diapausin-1 binds to the surface of yeast, which 
requires further investigation as a target for its mode of action (Al Souhail et al., 2016).  
 Goals of Current Research 
With the completion of the M. sexta genome project, discovering all potential serpin 
genes in M. sexta became possible (Kanost et al., 2016). Ten M. sexta serpins have been 
identified and characterized by cDNA cloning and biochemical approaches, demonstrating the 
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important roles they play in regulation of innate immune responses, including proPO activation 
and the Toll pathway (Fig. 1-2). Having a general picture and dataset of complete serpin genes in 
M. sexta would benefit the future study on serpins regarding evolution, structure and 
physiological functions. Using both the genome database and transcription dataset, as well as the 
i5K database (https://i5k.nal.usda.gov), discovering and characterizing M. sexta serpin genes and 
protein products was the first goal of my research. To address this goal, I followed several 
specific aims: 
(1) Present basic information on M. sexta serpin genes and proteins, such as complete 
sequences, the absence or presence of signal peptide, number of exons and introns of each serpin 
gene, location on the scaffold and so on. 
(2) Look for any serpin genes with alternative splicing  
(3) Characterize evolution of M. sexta serpins 
(4) Predict inhibitory properties of serpins based on analysis of RCL sequences 
 
Several publications reported that RCL-mimicking small peptides were able to block the 
inhibitory activity of human serpins, including PAI-1, PAI-2, 1-antitrypsin and antithrombin. 
Crystal structures confirmed that the RCL-derived peptides insert into -sheet A of the serpin, 
leading to the hindrance of endogenous RCL incorporation, which is critical for a serpin to 
inhibit a protease. The research on mammalian serpins stimulated my investigation to test the use 
of RCL-derived peptides in insects. This research would lay a foundation for future study of 
using small peptides to manipulate serpin actions in vivo. Serpin-3 is one of the well-studied 
serpins in M. sexta, so I decided to start with serpin-3 and its RCL-derived peptides. I aimed to 
investigate the function of serpin-3 RCL-derived peptides following the specific aims: 
(1) Design and synthesize small peptides based on M. sexta serpin-3 RCL sequence 
(2) Express and purify serpin-3 target protease PAP3 and obtain active form 
(3) Determine whether the RCL-derived peptides block serpin-3 in vitro 
(4) Test the activity of the peptides in hemolymph 
(5) Verify the incorporation of peptide in serpin-3 by using circular dichroism 
 
Diapausin-1 was isolated from M. sexta hemolymph, demonstrating antifungal activity 
against S. cerevisiae, M. oryzae, F. culmorum and F. graminearum in previous research. I 
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wanted to explore the potential use of diapausin on clinic and pest control by testing its 
antifungal activity against human pathogenic fungus Candida and entomopathogenic fungus 
Beauveria. Additionally, elucidating the specific target and mode of action of diapausin-1 would 
be instructive to understand the defensive mechanisms of insects against fungal infection. My 
specific aims regarding diapausin were: 
(1) Express and purify recombinant diapausins in active form 
(2) Test inhibitory activity of diapausin against pathogenic fungi, such as Candida 
albicans and Beauveria bassiana 
(3) Reveal the potential mechanisms of diapausin-1 by morphological analysis 
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Figure 1-1. Representatives of serpin conformations. 
Crystal structures of serpin proteins were from PDB and colored with PyMOL. -helices are in red, -sheets are in yellow, loops are 
in green, and RCL regions are in cyan. (A) Native serpin-1K from M. sexta, PDB ID: 1SEK. (B) Cleaved Spn42Da from D. 
melanogaster, PDB ID: 4P0O. (C) Latent PAI-1 from H. sapiens, PDB ID: 1DVN. (D) Delta antichymotrypsin from H. sapiens, PDB 
ID: 1QMN. (E) Dimer antithrombin from H. sapiens, PDB ID: 2ZNH. 
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Figure 1-2. Manduca sexta serpins and their putative target proteases in innate immune responses. 
Pattern recognition proteins are in blue, activated/active serine proteases are in red, serine protease homologs are in orange, and 
serpins are in green. Activation process is indicated with solid arrow, possible self-activation is indicated with dotted arrow and 
inhibition process is indicated with a blue bar and an arrow. Antimicrobial peptides induced are in an orange box. An asterisk 
indicates active serine protease without proteolytic activation. 
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Figure 1-3. Representatives of serpinRCL-derived peptide complex. 
Structures are from PDB and colored with PyMOL. -sheet A is in yellow, RCL is in cyan, 
RCL-derived peptide is in magenta and non-serpin derived peptide is in orange. (A) PAI-
12P14-P10, PDB ID: 1A7C. (B) PAI-2P14-P1, PDB ID: 1JRR. (C) antithrombinP14-P3, 
PDB ID: 1BR8. (D) antithrombinP14-P8WMDF, PDB ID: 1JVQ 
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Figure 1-4. Scheme of fungal cell wall and cell membrane with examples of antifungal peptides. 
Antifungal peptides are in orange boxes with arrow indicating the target in cell wall or cell membrane. This figure was modified from 
Marina Rautenbach et al.(Rautenbach et al., 2016).  
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 Tables 
Table 1-1. Arthropod serpinomes. 
Class Order Species Common name Source Number of 
serpin genes 
Reference 
Arachnida Ixodida Ixodes scapularis deer tick genome 45 (Mulenga et al., 2009) 
Rhipicephalus microplus cattle tick transcriptome 18, 22 (Tirloni et al., 2014; Rodriguez-Valle et al., 2015) 
Amblyomma americanum lone star tick transcriptome 30a (Porter et al., 2015) 
Sarcoptiformes Sarcoptes scabiei itch mite genome 10 (Rider et al., 2015) 
Insecta Orthoptera Locusta migratoria migratory locust transcriptome 36 (Zhang et al., 2015a) 
Coleoptera Tribolium castaneum red flour beetle genome 31 (Zou et al., 2007) 
Tenebrio molitor flour beetle transcriptome 87b (Zhu et al., 2013) 
Hymenoptera Apis mellifera honeybee genome 7 (Zou et al., 2006) 
Pteromalus puparum endoparasitic wasp genome 10 (Yang et al., 2017) 
Diptera Anopheles gambiae African malaria mosquito genome+transcriptome 19 (Suwanchaichinda and Kanost, 2009; Neafsey et al., 2015) 
A. merus  genome 17 (Neafsey et al., 2015) 
A. arabiensis  genome 13 
A. quadriannulatus  genome 13 
A. melas  genome 19 
A. christyi  genome 12 
A. epiroticus  genome 15 
A. stephensi (Indian)  genome 16 
A. stephensi (SDA-500)  genome 17 
A. maculatus  genome 20 
A. culicifacies  genome 16 
A. minimus  genome 13 
A. funestus  genome 15 
A. dirus  genome 15 
A. farauti  genome 17 
A. atroparvus  genome 23 
A. sinensis  genome 20 
A. albimanus  genome 19 
A. darlingi  genome 19 
29 
Aedes aegypti yellow fever mosquito genome 23 (Gulley et al., 2013) 
Culex quinquefasciatus southern house mosquito genome 31 
Drosophila melanogaster fruit fly genome 29 (Reichhart, 2005; Garrett et al., 2009) 
Glossina morsitans tsetse fly transcriptome 10 (Mwangi et al., 2011) 
Lepidoptera Chilo suppressalis striped rice stem borer transcriptome 12c (Ge et al., 2013) 
Bombyx mori silkworm genome 34 (Zou et al., 2009) 
Ostrinia furnacalis Asian corn borer transcriptome 14 (Shen et al., 2014) 
Manduca sexta tobacco hornworm genome 32 (Li et al., 2018) 
 
a This number might not be accurate because alleles and very similar genes can be distinguished in transcriptome. 
b 57 found in male, 33 found in female and 30 found in both. 
c 9 out of 12 with full-length sequences. 
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Table 1-2. Arthropod serpins with solved structures. 
Species Serpin Form PDB ID Reference 
M. sexta Serpin-1K native 1SEK (Li et al., 1999) 
Serpin-1B Michaelis complex with rat trypsin 1K9O (Ye et al., 2001) 
Serpin-12 native 6CJ7 (Yang et al., 2018) 
D. melanogaster Serpin-42Da cleaved 4P0O 
(Ellisdon et al., 2014) 
Serpin-42Da cleaved 4P0F 
A. gambiae SRPN2 native 3PZF (An et al., 2011b) 
SRPN2 (S358E) native 4RO9 
(Zhang et al., 2015b) 
SRPN2 (S358W) native 4ROA 
SRPN2 (K198C) native 4ROB 
SRPN2 (K198C/E359C) native 4RSQ 
SRPN18 native 5C98 (Meekins et al., 2016) 
B. mori Serpin-18 native 4R9I (Guo et al., 2015) 
T. molitor Serpin-48 native 3OZQ (Park et al., 2011) 
I. ricinus IRS-2 cleaved 3NDA (Kovarova et al., 2010) 
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Table 1-3. Characterized serpins from M. sexta. 
 
Constitutive/ 
induced 
concentration 
in 
hemolymph 
(𝛍g/ml) 
Protease inhibited 
non-Manduca target protease 
inhibited 
References immunoblotting 
or protease 
activity assay 
immunoaffinity 
serpin-1A 
400 
 HP8 Tryp, Plas, PR2 (Jiang and Kanost, 1997; Ragan et al., 2010) 
serpin-1B   CatG, PPE&HNE, PtK, Sub, PR1,  (Kanost et al., 1989; Jiang and Kanost, 1997) 
serpin-1C   PtK, PR1 (Jiang and Kanost, 1997) 
serpin-1D    (Jiang and Kanost, 1997) 
serpin-1E  HP8 PR2 (Jiang and Kanost, 1997; Ragan et al., 2010) 
serpin-1F   PPE&HNE, Sub (Jiang and Kanost, 1997) 
serpin-1G   Sub,  (Jiang and Kanost, 1997) 
serpin-1H   Chy, CatG, PtK,  (Jiang and Kanost, 1997) 
serpin-1I HP14  Chy, CatG, PPE&HNE (Jiang and Kanost, 1997; Wang and Jiang, 2006) 
serpin-1J PAP3 HP8 PR2 (Jiang and Kanost, 1997; Jiang et al., 2003; Ragan et al., 2010; An et al., 2011c) 
serpin-1K   Chy, CatG, PtK (Jiang and Kanost, 1997) 
serpin-1Z   Chy, CatG (Jiang and Kanost, 1997) 
serpin-2    CatG,  (Gan et al., 2001) 
serpin-3 5-12/30-75 PAP1, PAP3 PAP1, PAP2, PAP3, HP8, proHP1 Chyd (Zhu et al., 2003b; Christen et al., 2012; He et al., 2017a) 
serpin-4 3/7 PAP1, PAP3, HP6 proHP1, HP6, HP21  Tryp (He et al., 2017a; Tong et al., 2005; Tong and Kanost, 2005) 
serpin-5 1/3-8 PAP1, PAP3, HP6 proHP1, HP6 Tryp (He et al., 2017a; Tong et al., 2005; Tong and Kanost, 2005; An and Kanost, 2010) 
serpin-6 15/30 PAP3 PAP3, HP8  (Wang and Jiang, 2004; Zou and Jiang, 2005; He et al., 2017a) 
serpin-7  PAP3   (Suwanchaichinda et al., 2013) 
serpin-9   proHP1, HP6, HP8 Tryp, Chy, PPE&HNE, CatG (He et al., 2017b; He et al., 2017a) 
serpin-12   HP14 Chy, PPE, CatG (Yang et al., 2018) 
serpin-13   proHP1, HP2, HP6 Tryp, HNE, CatG (He et al., 2017b; He et al., 2017a) 
Abbreviations: Tryp, trypsin; Plas, plasmin; CatG, cathepsin G; PPE, porcine pancreatic elastase; HNE, human neutraphil elastase; PtK, protease K; Sub, subtilisin; Chy, chymotrypsin.
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Table 1-4. RCL-derived peptides as serpin inhibitors. 
Sequences of the RCL from the conserved glycine residue at the N-terminus to P1 on the C-terminus of each serpin are in bold. 
Sequences of RCL-derived peptides are aligned with the original RCL. Mutants of residues on peptides are in blue. Ac: acetyl. 
Original serpin Peptides Sequence Target serpin References 
⍺1-antitrypsin   N-GTEAAGAMFLEAIPM-C  
 P15-P1    GTEAAGAMFLEAIPMY ⍺1-antitrypsin 
(Mast et al., 1992)    ⍺1-antichymotrypsin 
   antithrombin 
 P15-P3 Ac-GTEAAGAMFLEAI ⍺1-antitrypsin 
(Chang et al., 1996) 
   antithrombin 
 P14-P1  Ac-TEAAGAMFLEAIVM ⍺1-antitrypsin (Schulze et al., 1990) 
 P14-P4  Ac-TEAAGAMFLEA ⍺1-antitrypsin 
(Schulze et al., 1992)  P14-P8  Ac-TEAAGAM ⍺1-antitrypsin 
 P12-P1    Ac-AAGAMFLEAIVM ⍺1-antitrypsin 
antithrombin  N-GSEAAASTAVVIAGR-C   
 P14-P1 Ac-SEAAASTAVVIAGR antithrombin (Björk et al., 1992) 
 P14-P2 Ac-SEAAASTAVVIAG antithrombin (Carrell et al., 1991) 
 P14-P3 Ac-SEAAASTAVVIA antithrombin (Chang et al., 1996) 
   ⍺1-antitrypsin (Skinner et al., 1998) 
 P14-P9 Ac-SEAAAS antithrombin (Carrell et al., 1991) 
PAI-1  N-GTVASSSTAVIVSAR-C   
 P14-P1 Ac-TVASSSTAVIVSAR PAI-1 (Eitzman et al., 1995) 
 P14-P7 Ac-TVASSSTA PAI-1 (Kvassman et al., 1995) 
 P14-P9    TVASSS PAI-1 (D'Amico et al., 2012) 
 P14-P10 Ac-TVASS-NH2 PAI-1 (Xue et al., 1998) 
 P8-P3          TAVIVS PAI-1 (D'Amico et al., 2012) 
PAI-2  N-GTEAAAGTGGVMTGR-C   
 P14-P1 Ac-TEAAAGTGGVMTGR PAI-2 (Jankova et al., 2001) 
 P14-P1(TP8D) Ac-TEAAAGDGGVMTGR PAI-2 
(Di Giusto et al., 2005) 
 P14-P1(TP8M) Ac-TEAAAGMGGVMTGR PAI-2 
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Chapter 2 - Analysis of Serpin Genes and Proteins in Manduca sexta 
Part of this chapter has been published as a journal article: 
Li, M., Christen, J. M., Dittmer, N. T., Cao, X., Zhang, X., Jiang, H., Kanost, M. R. 
(2018). The Manduca sexta serpinome: Analysis of serpin genes and proteins in the tobacco 
hornworm. Insect biochemistry and molecular biology, 102, 21-30. 
 Introduction 
Serpins are a superfamily of proteins, many of which inhibit serine proteinases. They 
share a conserved tertiary structure composed of three β-sheets, 8-9 α-helices, and an exposed 
reactive center loop (RCL) (Silverman et al., 2001). The mechanism for proteinase inhibition by 
serpins includes cleavage by the proteinase of a specific peptide bond (the scissile bond) between 
residues designated P1-P1’ in the serpin RCL. The inhibition reaction begins with the formation 
of a noncovalent complex between the proteinase and serpin through interaction of the proteinase 
active site with the serpin RCL (Ye et al., 2001). Once the P1 side chain is correctly positioned 
in the primary specificity pocket of the proteinase, the active site serine of the proteinase attacks 
and cleaves the scissile bond, resulting in formation of a covalent acyl complex of the serpin and 
proteinase. The serpin undergoes a large conformational change, in which the RCL inserts as the 
fourth strand in its β-sheet A. The proteinase is translocated by about 70 Å, and its active site 
catalytic triad becomes distorted, resulting in proteinase inactivation (Gettins and Olson, 2016). 
Serpins have been identified in animals, plants, bacteria, archaea, and some viruses 
(Gettins, 2002). Insect serpins have been a subject of significant research efforts in the last three 
decades (Meekins et al., 2017). Biochemical studies and genetic analyses have shown that some 
insect serpins regulate extracellular proteinase cascades in the hemolymph, which stimulate 
innate immune responses, including the Toll pathway and prophenoloxidase activation (Shin et 
al., 2006; Jiang et al., 2009; Park et al., 2011; Levashina et al., 1999; Ahmad et al., 2009; Zou 
and Jiang, 2005; An and Kanost, 2010; An et al., 2011; Zou et al., 2010; Abraham et al., 2005; 
Michel et al., 2006; Ligoxygakis et al., 2002; De Gregorio et al., 2002; Scherfer et al., 2008; 
Tang et al., 2008; Jiang et al., 2003; Zhu et al., 2003; Wang and Jiang, 2004; Tong and Kanost, 
2005; Tong et al., 2005; Wang and Jiang, 2006; He et al., 2017; Yang et al., 2018). 
Completion of insect genome projects has revealed the presence of many previously 
unknown serpin genes. Thirty-four serpin genes have been identified in Bombyx mori (Zou et al., 
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2009), thirty-one in Culex quinquefasciatus (Gulley et al., 2013), thirty-one in Tribolium 
castaneum (Zou et al., 2007), twenty-nine in Drosophila melanogaster (Reichhart, 2005; 
Reichhart et al., 2011), twenty-three in Aedes aegypti (Gulley et al., 2013), eighteen in Anopheles 
gambiae (Christophides et al., 2002; Suwanchaichinda and Kanost, 2009), ten in Pteromalus 
puparum (Yang et al., 2017), and at least seven serpin genes in Apis mellifera (Zou et al., 2006). 
However, physiological functions of most insect serpins are unknown. 
The first insect serpin (serpin-1B) with a known sequence was isolated from hemolymph 
of the tobacco hornworm, M. sexta (Kanost et al., 1989). Since then, nine additional serpins from 
M. sexta have been identified and investigated through biochemical studies (Jiang et al., 1994; 
Gan et al., 2001; Zhu et al., 2003; Tong and Kanost, 2005; Zou and Jiang, 2005; 
Suwanchaichinda et al., 2013; He et al., 2017; Yang et al., 2018). In this chapter, I described the 
properties of serpin genes identified in the M. sexta genome (Kanost et al., 2016). Thirty-one 
genes encoding serpin proteins and one likely serpin pseudogene were characterized. 
Alternatively spliced isoforms were detected and demonstrated. Sequence alignment and 
conserved residue comparison were performed and used to make structure-function predictions. 
 Materials and Methods 
 Basic parameters of serpin genes and proteins 
Searching for novel serpin genes in M. sexta OGS2.0 
(https://i5k.nal.usda.gov/Manduca_sexta) were performed by Dr. Jayne Christen, and Dr. 
Michael Kanost corrected the coding sequences and protein sequences. Conversion of scaffold 
ID and NCBI accession number is available on 
ftp://ftp.ncbi.nlm.nih.gov/genomes/all/GCA/000/262/585/GCA_000262585.1_Msex_1.0/GCA_0
00262585.1_Msex_1.0_assembly_report.txt. Gene structure information, including alternative 
splicing, exons and introns was obtained from M. sexta JBrowse/Apollo 
(https://i5k.nal.usda.gov/available-genome-browsers) (Poelchau et al., 2015). Theoretical 
molecular weight and pI of mature serpins were calculated using ProtParam 
(http://us.expasy.org/) (Gasteiger et al., 2005). Signal peptides were predicted using SignalP 4.1 
(http://www.cbs.dtu.dk/services/SignalP/) (Petersen et al., 2011). Multiple sequence alignments 
were performed using ClustalW2 (http://www.ebi.ac.uk/Tools/msa/clustalw2/) (Larkin et al., 
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2007). Prediction of secondary structures in the aligned sequences was based on the crystal 
structure of M. sexta serpin-1K (Li et al., 1999) and human α1-antitrypsin (Irving et al., 2000). 
Conserved residues in the shutter, breach, hinge, gate and other regions were identified as 
described previously (Irving et al., 2000).  
 Cloning of MsSerpin-7 gene 
The MsSerpin-7 gene was found with parts in two scaffolds, 12474 and 15728. 
Phylogenetic analysis showed that MsSerpin-7 was grouped with serpins that only have a single 
exon, so MsSerpin-7 was suspected to have single exon as well. To test this hypothesis, the full 
length of MsSerpin-7 gene from genomic DNA of M. sexta was amplified by PCR, using a 
forward primer (5’-AAC ACC CGT CCC ATG AGA ATG TGG ACT-3’) that contains the start 
codon (underlined) and a reverse primer (5’-AAA CGT TAG CTC TCA CAC AAC TGA AGG-
3’) that contains the stop codon (underlined). PCR was performed using Taq DNA polymerase 
(Invitrogen) as follows: initial denaturation at 95 C for 3 min followed by 30 cycles of 
denaturing at 95 C for 30 seconds, annealing at 58 C for 30 seconds, extension at 68 C for 90 
seconds, and a final extension at 68 C for 10 min. Products were gel purified, cloned into pCR4-
TOPO vector using TOPO TA Cloning Kit (Invitrogen), and used to transform competent 
Escherichia coli strain TOP10 (Invitrogen). Recombinant plasmids were extracted and subjected 
to EcoRI-HF digestion, and the inserted MsSerpin-7 gene was sequenced at GENWIZ. 
 Analysis of serpin transcript abundance upon immune challenge 
Protein sequences of M. sexta serpins were used as TBLASTN queries with default 
settings to search against RNAseq CIFH09contigs 
(http://darwin.biochem.okstate.edu/blast/blast.html) (Zhang et al., 2011). Hits were filtered by 
the following criteria: score > 100 bits, E value < 0.01, identities > 90. Reads of control 
hemocytes, control fat body, bacteria-induced hemocytes and bacteria-induced fat body were 
retrieved from previous work and normalized accordingly (Zhang et al., 2011).  
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 Results and Discussion 
 Overview of serpin genes 
Thirty-two serpin genes were identified in the M. sexta genome by Dr. Michael Kanost 
and Dr. Jayne Christen (Table 2-1). Complete CDS and protein sequences of 31/32 were 
revealed, while MsSerpin-29 lacks a significant part of the typically conserved amino-terminal 
region, perhaps due to incomplete genome assembly. Most of the serpin genes are located on a 
single genomic scaffold, but MsSerpin-3 and MsSerpin-7 were fragmented, with exons on more 
than one scaffold. MsSerpin-3 sequence was confirmed by the published cDNA sequences. 
Cloning of MsSerpin-7 from genomic DNA by PCR showed single band of ~1.2 kilobases which 
implied no intron present (Fig. 2-1). Sequencing further confirmed the single exon structure of 
MsSerpin-7 gene. MsSerpin-22 had two apparent haplotypes on different scaffolds 00144 and 
00153. Several genomic scaffolds contain multiple serpin genes within a relatively small region 
(Fig. 2-2, Table B-1), including 8 serpin genes located within a 20 kb segment on scaffold 
00379. The M. sexta serpin genes vary from one exon to ten (Table 2-1 and Fig. 2-3), with most 
composed of 8-10 exons. MsSerpins-4, 5, 7, 9, and 14 contain a single exon (Table 2-1). 
 Alternative splicing of MsSerpin-15 and MsSerpin-28 
Besides MsSerpin-1 reported before, two additional M. sexta serpin genes, MsSerpin-15 
and MsSerpin-28 have alternative exons encoding the carboxyl terminal ∼45 residues, including 
the RCL (Fig. 2-4, Table B-2). MsSerpin-15, encodes two serpin splicing isoforms with different 
exon 9 sequences encoding the RCL. A closely related B. mori gene, BmSerpin2, has a similar 
gene structure and also encodes two splicing isoforms with different RCL sequences (Zou et al., 
2009). The MsSerpin-28 gene contains three versions of exon 7, each encoding a different RCL 
sequence. 
MsSerpin-17 was originally thought to encode two splicing isoforms based on the 
OGS2.0 assembly. Isoform A contained putative consecutive exon 6A, 7A and 8A, and isoform 
B contained putative consecutive exon 6B, 7B and 8B. Between tentative exon 8A and 6B there 
are 7007 bp, which contains a 3107 bp gap. However, I found that predicted alternative splicing 
of MsSerpin-17 was likely caused by assembly errors. Tentative exon 6A of MsSerpin-17 
probably missed 105 bp at the 5’ end. If this 105 bp “intron” is considered as the 5’ end of exon 
6A, sequences of 6A and 6B would be identical. Besides, tentative exon 7A has identical 
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sequence with tentative exon 7B, so do tentative exon 8A with 8B. The corresponding intron 
sequence alignments demonstrated high similarity between tentative splicing regions. Therefore, 
I suspect exon 6, 7 and 8 with introns of MsSerpin-17 were incorrectly duplicated during genome 
assembly, and the evidence for presence of MsSerpin-17 splicing isoforms currently is not 
convincing.   
 Analysis and comparison of serpin amino acid sequences 
A majority of the M. sexta serpin gene products are predicted to be secreted, with amino-
terminal secretion signal peptides varying from 15 to 24 residues (Table 2-1). MsSerpin-2 was 
reported to by cytoplasmic without signal peptide (Gan et al., 2001). MsSerpin-15, 16, and 17 
lack a detected signal peptide and thus may be cytoplasmic proteins. Alignment of the amino 
acid sequences (Fig. B-1) indicates that although overall sequence identity between some serpins 
is fairly low (∼35%), there are regions of identity between all of the sequences that correspond 
with secondary structures conserved in insect and mammalian serpin three-dimensional 
structures. The length of the mature serpins varies from 332 to 502 residues with a theoretical 
mass of 37.8-57.1 kDa (excluding MsSerpin-29, 284 residues). Notably, MsSerpin-10 has a 
nearly 100-amino acid insertion between helix-F and strand-3A (Fig. B-1), resulting in its greater 
than average length of 502 residues. The B. mori ortholog, BmSerpin10, has an insertion of a 
similar length at the same position (Zou et al., 2009). The structure and potential function of this 
region is not yet known, but perhaps could be a site for interaction with other proteins. The 
calculated isoelectric point of most of the M. sexta serpins varies from 4.4 to 7.3. However, 
MsSerpin-12, 14, 20, 21, 22, 26, 29, and 31 are more basic, with a calculated pI of approximately 
8-9 (Table 2-1). 
 RCL region of M. sexta serpins 
The RCL in serpins is a solvent-exposed region between strand-4A and strand-1C, 
consisting of 16-25 amino acid residues (Meekins et al., 2016). In the inhibition of a proteinase 
by a serpin, the proteinase cleaves the RCL at a specific position called the scissile bond, 
between two residues designated P1 and P1’ (Loebermann et al., 1984). As a result, the amino-
terminal segment of the RCL inserts into β-sheet A, forming a new strand between strand-3A and 
strand-5A, with formation of an irreversible serpin-proteinase complex (Stratikos and Gettins, 
1999; Huntington et al., 2000; Dunstone and Whisstock, 2011). Some members of the serpin 
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superfamily, such as ovalbumin, Hsp47/SERPINH1, maspin and MENT, lack the capability for 
protease inhibition (Huntington and Stein, 2001; Nagata, 1996; Zhou et al., 1994; Grigoryev et 
al., 1999). The sequence and length of the RCL of such non-inhibitory serpins are factors that 
distinguish them from inhibitory serpins (Irving et al., 2000). In non-inhibitory serpins, either the 
length of the RCL limits the complete translocation of the protease, or the critical residues in the 
hinge region are not favorable for rapid loop insertion (Widmer et al., 2012; Al-Ayyoubi et al., 
2004; Stein et al., 1991; McGowan et al., 2006). 
In order to predict inhibitory or non-inhibitory M. sexta serpins, I analyzed their RCL 
sequences (Fig. 2-5). The hinge region (P15-P9) of inhibitory serpins is typically composed of 
two charged residues, followed by a series of residues with small hydrophobic side chains, which 
contribute to mobility for the conformational change accompanying RCL insertion into β-sheet A 
(Hopkins et al., 1993). A consensus pattern in the hinge region can be used as a theoretical 
guideline to recognize inhibitory serpins. P17 is usually glutamate, P16 is glutamate/lysine/ 
arginine, P15 is glycine, P14 is threonine/serine/alanine, and P12-P9 are alanine/glycine/serine 
(Irving et al., 2000). Additionally, the presence of proline in the proximal RCL prior to the P2 
residue disrupts the formation of a new β strand, leading to failure of RCL incorporation 
(Hopkins et al., 1993; Hopkins and Stone, 1995; Gettins, 2002). Furthermore, conserved residues 
in the breach and shutter regions, which facilitate sheet opening to accept the RCL as a new 
strand in the β-sheet should also be considered (Whisstock et al., 2000b; Whisstock et al., 
2000a). Guided by the above criteria, 16 of the 48 serpin gene products (MsSerpin-1D, 8, 10, 18-
20, 22-27, 29-32) are predicted to encode non-inhibitory serpins. They lack the consensus pattern 
of inhibitory serpins in the hinge region, and these putative non-inhibitors are relatively rich in 
proline in the proximal RCL and less conserved in the breach and shutter regions (Fig. B-1). The 
other 32 genes encode proteins more likely to have a mobile hinge region, few proline residues 
in the proximal RCL, and highly conserved residues in the breach and shutter regions and thus 
are more likely to function as proteinase inhibitors. 
The scissile bond position for some inhibitory M. sexta serpins were previously 
determined experimentally (Jiang and Kanost, 1997; Zou and Jiang, 2005; He et al., 2017; Yang 
et al., 2018). For the remaining serpins likely to be inhibitory, the position of their RCL scissile 
bond was predicted based on the distance from the hinge and previously confirmed cleavage sites 
of studied serpins (Gettins, 2002; Jiang and Kanost, 1997; Zou and Jiang, 2005; Reichhart et al., 
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2011). Based on putative P1 residues, M. sexta serpins can be categorized into three groups: 1) 
serpins with K or R at P1, including MsSerpin-1A, 1E, 1J, 1N, 1Y, 3, 4, 5, 6, 7, 9, 13, 15B, 16, 
17, and 28B; 2) serpins with Y or F at P1, including MsSerpin-1C, 1H, 1K, 1Z, 15A, and 21; and 
3) serpins with small hydrophobic residues at P1, including MsSerpin-1B, 1F, 1G, 1I, 2, 11, 12, 
28A, and 28C. Distinguishing inhibitory and non-inhibitory serpins and characterizing inhibitory 
selectivity will require future biochemical experiments using purified serpins. 
 Intron positions of M. sexta serpin genes 
Intron positions are often conserved in closely related genes, including serpin genes (Roy 
et al., 2003; Kaiserman and Bird, 2005). Based on the number of exons and intron positions, M. 
sexta serpins can be categorized into the following groups (Fig. 2-3): I) serpin genes with a 
single exon (MsSerpin-4, 5, 7, 9 and 14); II) serpin genes with 2-3 coding exons and one intron 
position that is conserved (MsSerpin-8, 23, 20, 32 and 24); III) serpin genes with 6-8 coding 
exons and 2-3 intron positions conserved (MsSerpin-3, 10, 11, 12); IV) serpins genes with 7-10 
coding exons and most intron positions are conserved (MsSerpin-16, 29, 22, 21, 26, 31, 30, 18, 
19, 25, 27, 28, 1, 2, 17, 15). Serpin genes 6 and 13 contain multiple introns but none at conserved 
positions. Genes in groups I and II may be derived from a single retrotransposition event 
followed by several rounds of gene duplication. One series of duplications may have led to 
MsSerpin-4, 5, 7, 9, and 14, while a second series of duplications occurring after gaining an 
intron led to group II genes MsSerpin-8, 20, 23, 24, and 32. A similar process of serpin gene 
evolution was also described in B. mori (Zou et al., 2009). Phylogenetic analysis indicated 17 
orthologous gene pairs between M. sexta and B. mori serpins (Li et al., 2018). It is interesting to 
note that 13 of the 16 genes in groups I, II, and III have orthologs in B. mori, thus these genes 
evolved before the divergence of these two lineages. In contrast, 12 of the 16 genes in group IV 
do not have an ortholog in B. mori, indicating that either those genes arose after the divergence 
or that they were lost in B. mori. It is intriguing that of the 13 serpin genes that appear to have 
evolved in M. sexta after its divergence from the common ancestor with B. mori, 10 encode 
proteins that are predicted to be non-inhibitory. Of the 17 orthologous gene pairs between M. 
sexta and B. mori, 14 are predicted to encode protease inhibitors, while only three are non-
inhibitory. Thus, it appears that most of the serpin proteins present in M. sexta but not in B. mori 
have a function other than protease inhibition. 
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 Differential expression of M. sexta serpins in response to immune challenge 
Previous studies on changes of transcription level in response to immune challenge were 
performed in M. sexta day-1 fifth instar larvae, providing reference information on immune-
related genes (Zhang et al., 2011; Gunaratna and Jiang, 2013). The fold change of mRNA 
abundance 24 h after injection of bacteria in fat body and hemocytes of MsSerpin1-7, 9, 11-15, 
17-19, and 22 were derived from CIFH (Control/Induced Fat body/Hemocyte) libraries (Zhang et 
al., 2011) (Table B-3). The unavailability of data for other M. sexta serpins probably resulted 
from low level of transcription in chosen life stage and tissue. MsSerpin-1 and 17 exhibited >2 
fold increase in mRNA level in hemocytes, but remained the same level or showed slight up-
regulation in fat body. In contrast, MsSerpin-4, 7, 14, 18 and 22 displayed a significant up-
regulation of transcript level in fat body but not in hemocytes. mRNA levels of MsSerpin-2, 3, 5, 
6, 11, 12, 15 and 17 increased more than 2-fold in both fat body and hemocytes (Table B-3). The 
data of MsSerpin-3, 4, 5, 6 and 7 are consistent with RT-PCR results in published literature (Zhu 
et al., 2003; Tong and Kanost, 2005; Zou and Jiang, 2005; Suwanchaichinda et al., 2013; Yang et 
al., 2018). The only discrepancy occurs to MsSerpin-2, which did not show any presence of 
mRNA in fat body even after bacterial challenge in immunoblot analysis (Gan et al., 2001), but 
2.8-fold increase by RNAseq was observed in CIFH libraries (Gunaratna and Jiang, 2013). 
Surprisingly, MsSerpin-19 is the only gene on the list, whose transcript level decreased after 
injection of a mixture of Escherichia coli, Micrococcus luteus and curdlan. A similar effect has 
been reported in multiple lepidopterans in response to parasitoid wasps, which interfere with 
serpin levels by targeting transcripts with miRNA, such as miR-8 (Beckage and Kanost, 1993; 
Song et al., 2008; Etebari and Asgari, 2014; Lee and Hyun, 2014).  
Furthermore, proteomics data and immunoblotting analysis regarding the changes in 
expression of several M. sexta serpins in hemolymph after infection of bacteria are available in 
previous work (He et al., 2016; Zhu et al., 2003; Tong and Kanost, 2005; Zou and Jiang, 2005). 
Intact protein abundance of MsSerpin-3, 4, 5, 11 and 12 significantly increased in hemolymph 
after infection (Zhu et al., 2003; Tong and Kanost, 2005; He et al., 2016), while intact MsSerpin-
1A, 1E, 1K, 1Z, 6 and 13 remained the similar level (Zou and Jiang, 2005; He et al., 2016). 
However, MsSerpin-3, 4 and 12 started to prevail in the high Mr bands once hemolymph was 
induced, suggesting a complex formation with serine proteases was triggered by immune 
challenge. MsSerpin-1A, 1K, 1Z, 6, 11, 13, 15 and 30 were not present in high Mr bands after 
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infection, indicating an absence or degradation of serpin-protease complex. Surprisingly, unique 
spectral counts of total MsSerpin-9 decreased from 38 to 3 after immune challenge (He et al., 
2016). What contributes to the degradation of MsSerpin-9 in induced hemolymph might be an 
appealing question to be answered. 
 Future Directions 
Identification and characterization of M. sexta serpin genes provided a general picture 
and data set for future study regarding evolution, structure and physiological functions of serpins 
in M. sexta and other insects.     
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 Figures 
 
 
Figure 2-1. Cloning of MsSerpin-7 gene. 
(A) MsSerpin-7 was amplified from M. sexta genomic DNA by PCR, followed by 1% agarose 
gel electrophoresis. (B) After MsSerpin-7 fragment was cloned into pCR4-TOPO vector, the 
recombinant construct was verified by restriction enzyme EcoRI-HF digestion.  
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Figure 2-2. M. sexta serpin gene clusters.  
Seven clusters of serpin genes identified on individual genomic scaffolds are shown, with length 
and orientations identified by red arrows. An overlapping region of oppositely directed 
MsSerpin-24 and MsSerpin-8 is indicated by brown color. 
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Figure 2-3. Intron positions of M. sexta serpin genes.  
Intron positions are marked on linear maps of the serpin polypeptides, based on alignment of 
their amino acid sequences (Fig. B-3). Arrowheads of the same color indicate identical intron 
position. Unconserved intron positions are shown with black arrowheads. Serpins are organized 
based on the topology of a phylogenetic tree based on their amino acid sequence alignment. 
Serpins lacking an intron are in group I, those with one conserved intron position are in group II, 
with 2-3 conserved intron positions are in group III, with four or more conserved intron positions 
are in group IV. MsSerpins-6 and 13 contain multiple introns, but the intron positions are not 
shared with other serpin genes.  
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Figure 2-4. Simplified splicing variant diagrams of M. sexta serpin-15 and 28. 
(A) Alternative exon 9 of MsSerpin-15 has two variants, 9A and 9B. (B) Alternate splicing to 
include exon 7A, 7B or 7C leads to the expression of MsSerpin-28A, 28B and 28C respectively. 
Alternative exons are in color, exons which are always expressed are in grey, and untranslated 
regions of the last exon of each gene are in white. 
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Figure 2-5. Alignment of the RCL region of M. sexta serpins. 
The consensus sequence observed in the hinge region of inhibitory serpins is indicated above the 
alignment. Predicted and known P1 residues are in red. Serpins whose scissile bond has been 
experimentally determined are marked with an asterisk. Predicted non-inhibitory serpins are 
underlined. ClustalX2 was used to color amino acids based on percentage of consensus by 
default parameters.  
*serpin-1A EEGAEAAAANAFFITRQARLDIRY----------FVANKPF
 serpin-1N EEGAEAAAANAIIVINKSGDDDFK----------FDVNRPF
*serpin-1J EEGAEAAAANAFILTDRCCSDYDDNIE-------FDVNRPF
*serpin-1F EEGAEAAAANAFIAVVDSIDIFERTIE-------FHADRPF
*serpin-1H EEGAEAAAANAFITYVESIDNFVPTIE-------FDVNRPF
 serpin-1G EEGAEAAAANAFFIVGITSIQFEPPVIE------FHVNRPF
*serpin-1I EEGAEAAAANVFTIVGLSLDFSLNEIK-------FVVNKPF
*serpin-1K EEGAEAAAANAFKITFYSFHFVPK----------VEINKPF
 serpin-1C EEGAEAAAANAFFIIESYSSYEPVVPV-------FDIDKPF
 serpin-1E EEGAEAAAANVIRVVKKKFRVIPPVLK-------FHVDRPF
*serpin-1Z EEGAEAAAANAFGIAYLSAVIRSPV---------FNADHPF
*serpin-1B EEGAEAAAANAFGIVPASLILYPE----------VHIDRPF
 serpin-1Y EEGAEAAAANDVSIGLRSGFISSAV---------MVIDRPF
 serpin-15A EEGAEAAAATAMSFAFCSAIIGEETVPY------FTADHPF
 serpin-15B EEGAEAAAATGMVMMLRCAPMPSPH---------FRADHPF
 serpin-17 EEGTEAAASTGITLDPKSAEIVMTTSY-------FRADHPF
*serpin-6 EEGTVAAAATALFGFRSSRPAEPTR---------FIANFPF
 serpin-7 EEGTVAAAATIAGLEDRILGPR------------FEANREF
*serpin-9 EEGTVAAAATEAMFEPRMMPEQ------------FVANKPF
 serpin-11 EEGTVAAAASSAMVVPLINDGVD-----------LRADRPF
 serpin-16 EEGAIAGAFTAFVTCRTTSVYIPPPPVK------FTVDRPF
 serpin-4 EEGTVASGVTIAEFSNRIGIIR------------YEVNRPF
 serpin-5 EAGTVASAATTASFADRISTPS------------FHANRPF
 serpin-21 EKGTEAAASSAISIGFVTLNMR------------FIADHPF
*serpin-13 EYGTEAVAATSGILARSAEQ--------------FYADSPF
 serpin-28B ENGTLAAVATGIIVSTRSAIRPQPVIKI------FDADHPH
 serpin-28A ENGTLAAVATAIIAMTMSLPISPPETQI------FDADHPH
 serpin-28C ENGTLAAVATVFFGVGATAAVAPPKIYE------FNANHGH
*serpin-12 ERGGSAAAATSFAAVALSYDEPSLY---------FRANKPF
 serpin-3 ELGSVAFSATQIGIQNKFGEDSDINYE-------VVANKPF
 serpin-14 ERGVRARSGIPDTLINDKGAVE------------FIANKPF
 serpin-2 ETGGEGGDGSGIDIRSISFMADAETRESAY----FRADHPF
 serpin-22 EMGVARHDRHLPDQEYMQRIMMGPGINILE----FAADRPF
 serpin-25 EGLQQCDADSKEDSEESHFPN-------------HVIDGPF
 serpin-27 EGLKQCDPDSQEDSEEYDLPN-------------HVIDGPF
 serpin-26 EVKPQSPYPSSHLQGRNKCRTK------------FIINSAV
 serpin-31 EIQQRASIHSPMCPIGKCLPK-------------VRLNKPM
 serpin-30 REVRKGQLNSKWCPSKNLPF--------------VKMNHAC
 serpin-18 GLGQNAITSDCGENAKE-----------------VVIDSGF
 serpin-19 GLGASENPYALENLEPKHT---------------VNIDSAF
 serpin-29 NTGVHLEVVTSIYSALSKTTSINEG---------SKVENPF
 serpin-23 SHGIDSYNPEFIEFTEYSTGLDPKLGHE------MIANRPF
 serpin-24 RAGVHPNTEELPSFLSGTNSCDSETGLDPILGREFIANKPF
 serpin-32 RTGLNPYEHEITPAQDTGETGLHAEIGKD-----FIADRTF
 serpin-20 RPGLKPCPHEVIAPTKGTDKETGLEPELGKE---FIANKPF
 serpin-8 PPPADTQGNLLTGLLHAATSLTAKTASLVGRE--FIANKPF
 serpin-10 NAESSASELSVANPAIEMSKNMPISEVKQPRR--FSADHPF
 serpin-1D EEGAEAAAANVVRGIRPRPSVRPPTPK-------FEADRPF
                         
 R S SSSS
EKGT GGGG
 E   AAAA
Hinge consensus
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Table 2-1. Summary of M. sexta serpins. 
Gene 
name 
Gene ID in 
OGS2.0 
Scaffold 
number 
NCBI accession 
number 
Exon 
numbera 
B. mori 
serpin 
ortholog 
protein 
product 
GenBank 
ID 
Protein 
length 
(residues)b 
Signal 
peptidec 
MW 
(kDa)d 
pId Scissile bond 
determined 
experimentally  
inhibitorye 
serpin-1 Msex2.12851 00761 JH669038.1 10 BmSpn1 serpin-1A AAC47342.1 375 1-16 (A*G) 41.9 5.46 + + 
serpin-1B AAC47343.1 376 1-16 (A*G) 41.9 5.01 + + 
serpin-1C AAC47339.1 376 1-16 (A*G) 42.3 4.95   + 
serpin-1D AAC47341.1 379 1-16 (A*G) 42.3 5.36   - 
serpin-1E AAC47335.1 379 1-16 (A*G) 42.4 5.70   + 
serpin-1F AAC47333.1 381 1-16 (A*G) 42.4 5.01 + + 
serpin-1G AAC47336.1 380 1-16 (A*G) 42.3 5.11   + 
serpin-1H AAC47332.1 382 1-16 (A*G) 42.7 4.96 + + 
serpin-1I AAC47337.1 379 1-16 (A*G) 42.3 5.11 + + 
serpin-1J AAC47340.1 381 1-16 (A*G) 42.7 4.88 + + 
serpin-1K AAC47334.1 376 1-16 (A*G) 42.1 5.44 + + 
serpin-1N MG753799.1 378 1-16 (A*G) 42.2 5.01   (+) 
serpin-1Y MG753798.1 376 1-16 (A*G) 41.8 5.18   (+) 
serpin-1Z AAC47338.1 376 1-16 (A*G) 41.8 5.17 + + 
serpin-2 Msex2.04874  00101 JH668379.1 9   serpin-2 AAB58491.1 381 none 42.2 4.99   + 
serpin-3 Msex2.11872, 
Msex2.15169, 
Msex2.15173 
00559, 
08663, 
08596  
JH668837.1 
AIXA01026169.1 
AIXA01026102.1 
7 BmSpn3 serpin-3 AAO21505.1 435 1-20 (A*D) 48.9 5.27   + 
serpin-4 Msex2.04237 00077 JH668355.1 1 BmSpn4 serpin-4 AAS68503.1 391 1-16 (C*D) 44.7 5.90   + 
serpin-5 Msex2.12952 00791 JH669068.1 1 BmSpn4 serpin-5 AAS68507.1 379 1-17 (C*D) 42.7 6.12   + 
serpin-6 Msex2.06874 00170 JH668448.1 9 BmSpn6 serpin-6 AAV91026.1 395 1-17 (S*Q) 45.0 5.57 + + 
serpin-7 Msex2.15425, 
Msex2.15342 
12474, 
15728 
AIXA01029976.1 
AIXA01033229.1 
1 BmSpn32 serpin-7 ADM86478.1 385 1-15 (G*A) 42.8 5.29   + 
serpin-8 Msex2.01482 00024 JH668302.1 3 BmSpn8 serpin-8   401 1-21 (A*Q) 44.2 4.45   (-) 
serpin-9 Msex2.09571 00304 JH668582.1 1 BmSpn7 serpin-9 MG732912.1 382 1-20 (A*Q) 43.3 4.89 + + 
serpin-10 Msex2.11870 00559 JH668837.1 8 BmSpn10 serpin-10   502 1-17 (A*R) 57.1 5.11   (-) 
68 
serpin-11 Msex2.11871 00559 JH668837.1 9 BmSpn11 serpin-11   391 1-18 (C*I) 44.5 6.23   (+) 
serpin-12 Msex2.11869 00559 JH668837.1 6 BmSpn12 serpin-12 MG732913.1 467 1-18 (S*Q) 51.4 8.52 + + 
serpin-13 Msex2.06711 00158 JH668436.1 10 BmSpn13 serpin-13 MG732911.1 423 1-21 (A*I) 48.3 5.27 + + 
serpin-14 Msex2.09570 00304 JH668582.1 1 BmSpn14 serpin-14   386 1-17 (A*H) 45.0 9.52   (+) 
serpin-15 Msex2.06848 00170 JH668448.1 9 BmSpn2 serpin-15A   377 none 41.3 4.60   (+) 
serpin-15B 373 none 41.0 4.92   (+) 
serpin-16 Msex2.09066 00258 JH668536.1 9 BmSpn9 serpin-16   389 none  43.2 5.80   (+) 
serpin-17 Msex2.15518 00101 JH668379.1 8   serpin-17   381 none 42.5 4.93   (+) 
serpin-18 Msex2.10821 00379 JH668657.1 10   serpin-18   408 1-19 (A*E) 45.5 4.86   (-) 
serpin-19 Msex2.10820 00379 JH668657.1 9   serpin-19   390 1-19 (G*T) 44.2 4.87   (-) 
serpin-20 Msex2.15520  00125 JH668403.1 2   serpin-20   404 1-16 (S*E) 45.7 8.80   (-) 
serpin-21 Msex2.09937 00316 JH668594.1 9   serpin-21   386 1-19 (A*K) 43.1 9.64   (+) 
serpin-2f Msex2.06154, 
Msex2.06167 
00144, 
00153 
JH668422.1 
JH668431.1 
9 BmSpn33 serpin-22   387 1-22 (S*D) 46.8 9.27   (-) 
serpin-23 Msex2.01480 00024 JH668302.1 3   serpin-23   375 1-16 (Q*E) 42.1 4.86   (-) 
serpin-24 Msex2.01481 00024 JH668302.1 3   serpin-24   411 1-22 (A*S) 46.7 5.63   (-) 
serpin-25 Msex2.10827 00379 JH668657.1 10   serpin-25   382 1-22 (G*Y) 43.9 5.96   (-) 
serpin-26 Msex2.10822 00379 JH668657.1 10   serpin-26   381 1-20 (A*Y) 43.8 9.53   (-) 
serpin-27 Msex2.10826 00379 JH668657.1 10   serpin-27   386 1-19 (A*F) 44.2 7.26   (-) 
serpin-28 Msex2.10818 00379 JH668657.1 8 BmSpn28 serpin-28A   332 1-24 (L*L) 38.0 5.04   (+) 
serpin-28B 332 1-24 (L*L) 37.9 6.06   (+) 
serpin-28C 333 1-24 (L*L) 37.8 5.59   (+) 
serpin-29g Msex2.09069 00258 JH668536.1 7   serpin-29   284 none 31.8 8.22   (-) 
serpin-30 Msex2.10824 00379 JH668657.1 9   serpin-30   379 1-23 (S*K) 44.0 6.29   (-) 
serpin-31 Msex2.10823 00379 JH668657.1 10   serpin-31   382 1-20 (A*Y) 43.8 9.05   (-) 
serpin-32 Msex2.05826 00125 JH668403.1 2   serpin-32   406 1-17 (A*K) 46.5 6.84   (-) 
 
a Number of exons included in the mRNA after splicing 
b Length of mature serpin was calculated after removing the putative signal peptide 
c SignalP 4.1 was used for signal peptides prediction 
d Theoretical molecular weight and isoelectric point were calculated by ProParam tool on the ExPASy website 
e Confirmed inhibitory activity is indicated by + or -, predicted inhibitory activity was in brackets 
f Serpin-22 has a haplotype without signal peptide 
g Serpin-29 gene may be a pseudogene or an incomplete assembly 
69 
 References 
Abraham, E. G., S. B. Pinto, A. Ghosh, D. L. Vanlandingham, A. Budd, S. Higgs, F. C. Kafatos, 
M. Jacobs-Lorena & K. Michel (2005) An immune-responsive serpin, SRPN6, mediates 
mosquito defense against malaria parasites. Proceedings of the National Academy of Sciences of 
the United States of America, 102, 16327-16332. 
Ahmad, S. T., S. T. Sweeney, J.-A. Lee, N. T. Sweeney & F.-B. Gao (2009) Genetic screen 
identifies serpin5 as a regulator of the toll pathway and CHMP2B toxicity associated with 
frontotemporal dementia. Proceedings of the National Academy of Sciences of the United States 
of America, 106, 12168-12173. 
Al-Ayyoubi, M., P. G. Gettins & K. Volz (2004) Crystal structure of human maspin, a serpin 
with antitumor properties: reactive center loop of maspin is exposed but constrained. The Journal 
of Biological Chemistry, 279, 55540-55544. 
An, C. & M. R. Kanost (2010) Manduca sexta serpin-5 regulates prophenoloxidase activation 
and the Toll signaling pathway by inhibiting hemolymph proteinase HP6. Insect biochemistry 
and molecular biology, 40, 683-689. 
An, C., E. J. Ragan & M. R. Kanost (2011) Serpin-1 splicing isoform J inhibits the proSpätzle-
activating proteinase HP8 to regulate expression of antimicrobial hemolymph proteins in 
Manduca sexta. Developmental and comparative immunology, 35, 135-141. 
Beckage, N. E. & M. R. Kanost (1993) Effects of parasitism by the braconid wasp Cotesia 
congregata on host hemolymph proteins of the tobacco hornworm, Manduca sexta. Insect 
biochemistry and molecular biology, 23, 643-653. 
Christophides, G. K., E. Zdobnov, C. Barillas-Mury, E. Birney, S. Blandin, C. Blass, P. T. Brey, 
F. H. Collins, A. Danielli, G. Dimopoulos, C. Hetru, N. T. Hoa, J. A. Hoffmann, S. M. Kanzok, 
I. Letunic, E. A. Levashina, T. G. Loukeris, G. Lycett, S. Meister, K. Michel, L. F. Moita, H. M. 
Muller, M. A. Osta, S. M. Paskewitz, J. M. Reichhart, A. Rzhetsky, L. Troxler, K. D. Vernick, 
D. Vlachou, J. Volz, C. von Mering, J. Xu, L. Zheng, P. Bork & F. C. Kafatos (2002) Immunity-
related genes and gene families in Anopheles gambiae. Science (New York, N.Y.), 298, 159-165. 
De Gregorio, E., S.-J. Han, W.-J. Lee, M.-J. Baek, T. Osaki, S.-I. Kawabata, B.-L. Lee, S. 
Iwanaga, B. Lemaitre & P. T. Brey (2002) An immune-responsive Serpin regulates the 
melanization cascade in Drosophila. Developmental cell, 3, 581-592. 
Dunstone, M. A. & J. C. Whisstock (2011) Crystallography of serpins and serpin complexes. 
Methods in Enzymology, Vol 501: Serpin Structure and Evolution, 501, 63-87. 
Etebari, K. & S. Asgari (2014) Accuracy of microRNA discovery pipelines in non-model 
organisms using closely related species genomes. PLoS One, 9, e84747. 
70 
Gan, H., Y. Wang, H. Jiang, K. Mita & M. R. Kanost (2001) A bacteria-induced, intracellular 
serpin in granular hemocytes of Manduca sexta. Insect biochemistry and molecular biology, 31, 
887-898. 
Gasteiger, E., C. Hoogland, A. Gattiker, M. R. Wilkins, R. D. Appel & A. Bairoch. 2005. Protein 
identification and analysis tools on the ExPASy server. In The proteomics protocols handbook, 
571-607. Springer. 
Gettins, P. G. & S. T. Olson (2016) Inhibitory serpins. New insights into their folding, 
polymerization, regulation and clearance. The Biochemical journal, 473, 2273-2293. 
Gettins, P. G. W. (2002) Serpin structure, mechanism, and function. Chemical reviews, 102, 
4751-4804. 
Grigoryev, S. A., J. Bednar & C. L. Woodcock (1999) MENT, a heterochromatin protein that 
mediates higher order chromatin folding, is a new serpin family member. The Journal of 
Biological Chemistry, 274, 5626-5636. 
Gulley, M. M., X. Zhang & K. Michel (2013) The roles of serpins in mosquito immunology and 
physiology. Journal of insect physiology, 59, 138-147. 
Gunaratna, R. T. & H. Jiang (2013) A comprehensive analysis of the Manduca sexta 
immunotranscriptome. Developmental and comparative immunology, 39, 388-398. 
He, Y., X. Cao, S. Zhang, J. Rogers, S. Hartson & H. Jiang (2016) Changes in the plasma 
proteome of Manduca sexta larvae in relation to the transcriptome variations after an immune 
challenge: evidence for high molecular weight immune complex formation. Molecular & 
Cellular Proteomics, 15, 1176-1187. 
He, Y., Y. Wang, P. Zhao, S. Rayaprolu, X. Wang, X. Cao & H. Jiang (2017) Serpin-9 and-13 
regulate hemolymph proteases during immune responses of Manduca sexta. Insect biochemistry 
and molecular biology, 90, 71-81. 
Hopkins, P. C. R., R. W. Carrell & S. R. Stone (1993) Effects of mutations in the hinge region of 
serpins. Biochemistry, 32, 7650-7657. 
Hopkins, P. C. R. & S. R. Stone (1995) The contribution of the conserved hinge region residues 
of α1-antitrypsin to its reaction with elastase. Biochemistry, 34, 15872-15879. 
Huntington, J. A., A. McCoy, K. J. Belzar, X. Y. Pei, P. G. Gettins & R. W. Carrell (2000) The 
conformational activation of antithrombin. A 2.85-Å structure of a fluorescein derivative reveals 
an electrostatic link between the hinge and heparin binding regions. The Journal of Biological 
Chemistry, 275, 15377-15383. 
Huntington, J. A. & P. E. Stein (2001) Structure and properties of ovalbumin. Journal of 
Chromatography B: Biomedical Sciences and Applications, 756, 189-198. 
71 
Irving, J. A., R. N. Pike, A. M. Lesk & J. C. Whisstock (2000) Phylogeny of the serpin 
superfamily: implications of patterns of amino acid conservation for structure and function. 
Genome research, 10, 1845-1864. 
Jiang, H. & M. R. Kanost (1997) Characterization and functional analysis of 12 naturally 
occurring reactive site variants of serpin-1 from Manduca sexta. Journal of Biological 
Chemistry, 272, 1082-1087. 
Jiang, H., Y. Wang & M. R. Kanost (1994) Mutually exclusive exon use and reactive center 
diversity in insect serpins. The Journal of Biological Chemistry, 269, 55-58. 
Jiang, H., Y. Wang, X. Q. Yu, Y. Zhu & M. Kanost (2003) Prophenoloxidase-activating 
proteinase-3 (PAP-3) from Manduca sexta hemolymph: a clip-domain serine proteinase 
regulated by serpin-1J and serine proteinase homologs. Insect biochemistry and molecular 
biology, 33, 1049-1060. 
Jiang, R., E. H. Kim, J. H. Gong, H. M. Kwon, C. H. Kim, K. H. Ryu, J. W. Park, K. Kurokawa, 
J. Zhang, D. Gubb & B. L. Lee (2009) Three pairs of protease-serpin complexes cooperatively 
regulate the insect innate immune responses. Journal of Biological Chemistry, 284, 35652-
35658. 
Kaiserman, D. & P. I. Bird (2005) Analysis of vertebrate genomes suggests a new model for 
clade B serpin evolution. BMC genomics, 6, 167. 
Kanost, M., E. Arrese, X. Cao, Y. Chen, S. Chellapilla, M. Goldsmith, E. Grosse-Wilde, D. 
Heckel, N. Herndon, H. Jiang, A. Papanicolaou, J. Qu, J. Soulages, H. Vogel, J. Walters, R. 
Waterhouse, S. Ahn, F. Almeida, C. An, P. Aqrawi, A. Bretschneider, W. Bryant, S. Bucks, H. 
Chao, G. Chevignon, J. Christen, D. Clarke, N. Dittmer, L. Ferguson, S. Garavelou, K. Gordon, 
R. Gunaratna, Y. Han, F. Hauser, Y. He, H. Heidel-Fischer, A. Hirsh, Y. Hu, D. Kalra, C. 
Klinner, C. Konig, C. Kovar, A. Kroll, S. Kuwar, S. Lee, R. Lehman, K. Li, Z. Li, H. Liang, S. 
Lovelace, Z. Lu, J. Mansfield, K. McCulloch, T. Mathew, B. Morton, D. MuznyJ, D. Muzny, D. 
Neunemann, F. Ongeri, Y. Pauchet, L. Pu, I. Pyrousis, X. Rao, A. Redding, C. Roesel, A. 
Sanchez-Gracia, S. Schaack, A. Shukla, G. Tetreau, Y. Wang, G. Xiong, W. Traut, T. Walsh, K. 
Worley, D. Wu, W. Wu, Y. Wu, X. Zhang, Z. Zou, H. Zucker, A. Briscoe, T. Burmester, R. 
Clem, R. Feyereisen, C. Grimmelikhuijzen, S. Hamodrakas, B. Hansson, E. Huguet, L. Jermiin, 
Q. Lan, H. Lehman, M. Lorenzen, H. Merzendorfer, I. Michalopoulos, D. Morton, S. 
Muthukrishnan, J. Oakeshott, W. Palmer, Y. Park, A. Passarelli, et al., (2016) Multifaceted 
biological insights from a draft genome sequence of the tobacco hornworm moth, Manduca 
sexta. Insect biochemistry and molecular biology, 76, 118-147. 
Kanost, M. R., S. V. Prasad & M. A. Wells (1989) Primary structure of a member of the serpin 
superfamily of proteinase inhibitors from an insect, Manduca sexta. The Journal of Biological 
Chemistry, 264, 965-972. 
Larkin, M. A., G. Blackshields, N. P. Brown, R. Chenna, P. A. McGettigan, H. McWilliam, F. 
Valentin, I. M. Wallace, A. Wilm, R. Lopez, J. D. Thompson, T. J. Gibson & D. G. Higgins 
(2007) Clustal W and Clustal X version 2.0. Bioinformatics, 23, 2947-2948. 
72 
Lee, G. J. & S. Hyun (2014) Multiple targets of the microRNA miR-8 contribute to immune 
homeostasis in Drosophila. Developmental and comparative immunology, 45, 245-251. 
Levashina, E. A., E. Langley, C. Green, D. Gubb, M. Ashburner, J. A. Hoffmann & J. M. 
Reichhart (1999) Constitutive activation of toll-mediated antifungal defense in serpin-deficient 
Drosophila. Science (New York, N.Y.), 285, 1917-1919. 
Li, J., Z. Wang, B. Canagarajah, H. Jiang, M. Kanost & E. J. Goldsmith (1999) The structure of 
active serpin 1K from Manduca sexta. Structure, 7, 103-109. 
Li, M., J. M. Christen, N. T. Dittmer, X. Cao, X. Zhang, H. Jiang & M. R. Kanost (2018) The 
Manduca sexta serpinome: analysis of serpin genes and proteins in the tobacco hornworm. Insect 
biochemistry and molecular biology, 102, 21-30. 
Ligoxygakis, P., N. Pelte, C. Ji, V. Leclerc, B. Duvic, M. Belvin, H. Jiang, J. A. Hoffmann & J. 
M. Reichhart (2002) A serpin mutant links Toll activation to melanization in the host defence of 
Drosophila. The EMBO journal, 21, 6330-6337. 
Loebermann, H., R. Tokuoka, J. Deisenhofer & R. Huber (1984) Human α1-proteinase inhibitor: 
crystal structure analysis of two crystal modifications, molecular model and preliminary analysis 
of the implications for function. Journal of Molecular Biology, 177, 531-557. 
McGowan, S., A. M. Buckle, J. A. Irving, P. C. Ong, T. A. Bashtannyk-Puhalovich, W.-T. Kan, 
K. N. Henderson, Y. A. Bulynko, E. Y. Popova, A. I. Smith, S. P. Bottomley, J. Rossjohn, S. A. 
Grigoryev, R. N. Pike & J. C. Whisstock (2006) X-ray crystal structure of MENT: evidence for 
functional loop-sheet polymers in chromatin condensation. EMBO Journal, 25, 3144-3155. 
Meekins, D., X. Zhang, K. Battaile, S. Lovell & K. Michel (2016) 1.45 angstrom resolution 
structure of SRPN18 from the malaria vector Anopheles gambiae. Acta Crystallographica 
Section F-Structural Biology Communications, 72, 853-862. 
Meekins, D. A., M. R. Kanost & K. Michel. 2017. Serpins in arthropod biology. In Seminars in 
cell & developmental biology, 105-119. Elsevier. 
Michel, K., C. Suwanchaichinda, I. Morlais, L. Lambrechts, A. Cohuet, P. H. Awono-Ambene, 
F. Simard, D. Fontenille, M. R. Kanost & F. C. Kafatos (2006) Increased melanizing activity in 
Anopheles gambiae does not affect development of Plasmodium falciparum. Proceedings of the 
National Academy of Sciences of the United States of America, 103, 16858-16863. 
Nagata, K. (1996) Hsp47: a collagen-specific molecular chaperone. Trends in biochemical 
sciences, 21, 23-26. 
Park, S. H., R. Jiang, S. Piao, B. Zhang, E.-H. Kim, H.-M. Kwon, X. L. Jin, B. L. Lee & N.-C. 
Ha (2011) Structural and functional characterization of a highly specific serpin in the insect 
innate immunity. Journal of Biological Chemistry, 286, 1567-1575. 
Petersen, T. N., S. Brunak, G. von Heijne & H. Nielsen (2011) SignalP 4.0: discriminating signal 
peptides from transmembrane regions. Nature Methods, 8, 785. 
73 
Poelchau, M., C. Childers, G. Moore, V. Tsavatapalli, J. Evans, C. Y. Lee, H. Lin, J. W. Lin & 
K. Hackett (2015) The i5k Workspace@NAL-enabling genomic data access, visualization and 
curation of arthropod genomes. Nucleic Acids Research, 43, D714-D719. 
Reichhart, J. M. (2005) Tip of another iceberg: Drosophila serpins. Trends in cell biology, 15, 
659-665. 
Reichhart, J. M., D. Gubb & V. Leclerc (2011) The Drosophila serpins: multiple functions in 
immunity and morphogenesis. Methods in Enzymology: Biology of Serpins, 499, 205-225. 
Roy, S. W., A. Fedorov & W. Gilbert (2003) Large-scale comparison of intron positions in 
mammalian genes shows intron loss but no gain. Proceedings of the National Academy of 
Sciences of the United States of America, 100, 7158-7162. 
Scherfer, C., H. Tang, Z. Kambris, N. Lhocine, C. Hashimoto & B. Lemaitre (2008) Drosophila 
Serpin-28D regulates hemolymph phenoloxidase activity and adult pigmentation. Developmental 
biology, 323, 189-196. 
Shin, S. W., G. Bian & A. S. Raikhel (2006) A toll receptor and a cytokine, Toll5A and Spz1C, 
are involved in toll antifungal immune signaling in the mosquito Aedes aegypti. Journal of 
Biological Chemistry, 281, 39388-39395. 
Silverman, G. A., P. I. Bird, R. W. Carrell, F. C. Church, P. B. Coughlin, P. G. Gettins, J. A. 
Irving, D. A. Lomas, C. J. Luke, R. W. Moyer, P. A. Pemberton, E. Remold-O'Donnell, G. S. 
Salvesen, J. Travis & J. C. Whisstock (2001) The serpins are an expanding superfamily of 
structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel 
functions, and a revised nomenclature. The Journal of Biological Chemistry, 276, 33293-33296. 
Song, K. H., M. K. Jung, J. H. Eum, I. C. Hwang & S. S. Han (2008) Proteomic analysis of 
parasitized Plutella xylostella larvae plasma. Journal of insect physiology, 54, 1271-1280. 
Stein, P. E., A. G. W. Leslie, J. T. Finch & R. W. Carrell (1991) Crystal structure of uncleaved 
ovalbumin at 1.95 Å resolution. Journal of Molecular Biology, 221, 941-959. 
Stratikos, E. & P. G. Gettins (1999) Formation of the covalent serpin-proteinase complex 
involves translocation of the proteinase by more than 70 Å and full insertion of the reactive 
center loop into beta-sheet A. Proceedings of the National Academy of Sciences of the United 
States of America, 96, 4808-4813. 
Suwanchaichinda, C. & M. R. Kanost (2009) The serpin gene family in Anopheles gambiae. 
Gene, 442, 47-54. 
Suwanchaichinda, C., R. Ochieng, S. Zhuang & M. R. Kanost (2013) Manduca sexta serpin-7, a 
putative regulator of hemolymph prophenoloxidase activation. Insect biochemistry and 
molecular biology, 43, 555-561. 
Tang, H., Z. Kambris, B. Lemaitre & C. Hashimoto (2008) A serpin that regulates immune 
melanization in the respiratory system of Drosophila. Developmental Cell, 15, 617-626. 
74 
Tong, Y., H. Jiang & M. R. Kanost (2005) Identification of plasma proteases inhibited by 
Manduca sexta serpin-4 and serpin-5 and their association with components of the prophenol 
oxidase activation pathway. The Journal of Biological Chemistry, 280, 14932-14942. 
Tong, Y. & M. R. Kanost (2005) Manduca sexta serpin-4 and serpin-5 inhibit the prophenol 
oxidase activation pathway: cDNA cloning, protein expression, and characterization. The 
Journal of Biological Chemistry, 280, 14923-14931. 
Wang, Y. & H. Jiang (2004) Purification and characterization of Manduca sexta serpin-6: a 
serine proteinase inhibitor that selectively inhibits prophenoloxidase-activating proteinase-3. 
Insect biochemistry and molecular biology, 34, 387-395. 
Wang, Y., & Jiang, H. (2006) Interaction of β-1, 3-glucan with its recognition protein activates 
hemolymph proteinase 14, an initiation enzyme of the prophenoloxidase activation system in 
Manduca sexta. Journal of Biological Chemistry, 281(14), 9271-9278. 
Whisstock, J. C., R. Skinner, R. W. Carrell & A. M. Lesk (2000a) Conformational changes in 
serpins: I. the native and cleaved conformations of α 1-antitrypsin. Journal of Molecular Biology, 
296, 685-699. 
Whisstock, J. C., Skinner, R., Carrell, R. W., & Lesk, A. M. (2000). Conformational changes in 
serpins: I. The native and cleaved conformations of α1-antitrypsin. Journal of molecular biology, 
295(3), 651-665. 
Widmer, C., J. M. Gebauer, E. Brunstein, S. Rosenbaum, F. Zaucke, C. Droegemueller, T. Leeb 
& U. Baumann (2012) Molecular basis for the action of the collagen-specific chaperone 
Hsp47/SERPINH1 and its structure-specific client recognition. Proceedings of the National 
Academy of Sciences of the United States of America, 109, 13243-13247. 
Yang, F., Y. Wang, N. Sumathipala, X. Cao, M. R. Kanost & H. Jiang (2018) Manduca sexta 
serpin-12 controls the prophenoloxidase activation system in larval hemolymph. Insect 
biochemistry and molecular biology. 
Yang, L., Y. Mei, Q. Fang, J. Wang, Z. Yan, Q. Song, Z. Lin & G. Ye (2017) Identification and 
characterization of serine protease inhibitors in a parasitic wasp, Pteromalus puparum. Scientific 
Reports, 7(1), 15755. 
Ye, S., A. L. Cech, R. Belmares, R. C. Bergstrom, Y. Tong, D. R. Corey, M. R. Kanost & E. J. 
Goldsmith (2001) The structure of a Michaelis serpin-protease complex. Nature Structural & 
Molecular Biology, 8, 979-983. 
Zhang, S., R. T. Gunaratna, X. Zhang, F. Najar, Y. Wang, B. Roe & H. Jiang (2011) 
Pyrosequencing-based expression profiling and identification of differentially regulated genes 
from Manduca sexta, a lepidopteran model insect. Insect biochemistry and molecular biology, 
41, 733-746. 
75 
Zhou, Z., A. Anisowicz, M. J. H. Hendrix, A. Thor, M. Neveu, S. Sheng, K. Rafidi, E. Seftor & 
R. Sager (1994) Maspin, a serpin with tumor-suppressing activity in human mammary epithelial 
cells. Science, 263, 526-529. 
Zhu, Y., Y. Wang, M. J. Gorman, H. Jiang & M. R. Kanost (2003) Manduca sexta serpin-3 
regulates prophenoloxidase activation in response to infection by inhibiting prophenoloxidase-
activating proteinases. The Journal of Biological Chemistry, 278, 46556-46564. 
Zou, Z., J. D. Evans, Z. Lu, P. Zhao, M. Williams, N. Sumathipala, C. Hetru, D. Hultmark & H. 
Jiang (2007) Comparative genomic analysis of the Tribolium immune system. Genome biology, 
8, R177. 
Zou, Z. & H. Jiang (2005) Manduca sexta serpin-6 regulates immune serine proteinases PAP-3 
and HP8. cDNA cloning, protein expression, inhibition kinetics, and function elucidation. The 
Journal of Biological Chemistry, 280, 14341-14348. 
Zou, Z., D. L. Lopez, M. R. Kanost, J. D. Evans & H. Jiang (2006) Comparative analysis of 
serine protease-related genes in the honey bee genome: possible involvement in embryonic 
development and innate immunity. Insect molecular biology, 15, 603-614. 
Zou, Z., Z. Picheng, H. Weng, K. Mita & H. Jiang (2009) A comparative analysis of serpin genes 
in the silkworm genome. Genomics, 93, 367-375. 
Zou, Z., S. W. Shin, K. S. Alvarez, V. Kokoza & A. S. Raikhell (2010) Distinct melanization 
pathways in the mosquito Aedes aegypti. Immunity, 32, 41-53. 
76 
Chapter 3 - Peptides Based on RCL of Manduca sexta Serpin-3 
Block Its Protease Inhibitory Function 
 Introduction 
Serpins have been extensively studied since the name was coined in 1985 to define a 
family of serine protease inhibitors with conserved tertiary structure (Carrell and Travis, 1985). 
Broadly distributed throughout vertebrates, invertebrates, plants, unicellular organisms and even 
some viruses, most serpins act as serine protease inhibitors, although some have other functions, 
including acting as hormone transporters and molecular chaperones (Silverman et al., 2001; 
Meekins et al., 2017; Roberts and Hejgaard, 2008; Irving et al., 2002; Turner et al., 2007; Gettins 
and Olson, 2016). The tertiary structure of serpins is comprised of three β-sheets, 8-9 α-helices, 
and a solvent-exposed reactive center loop (RCL) that is near the carboxyl-terminal end of the 
serpin sequence (Silverman et al., 2001). When a serpin encounters a target protease, the 
protease cleaves a specific peptide bond of the RCL (designated P1-P1’, the “scissile bond”) but 
the second half of the hydrolysis reaction does not occur, leaving the protease and serpin in an 
acyl-intermediate state. The amino-terminal end of the RCL rapidly inserts into serpin β-sheet A 
as a new strand (strand 4A), and the protease is translocated to the other side of serpin molecule, 
resulting in formation of an irreversible inhibitory complex, with the active site of the protease 
distorted (Gettins and Olson, 2016). Alternatively, the cleavage of the scissile bond can proceed 
as a typical protease hydrolysis reaction, producing a shortened and disabled serpin protein, with 
no inhibition of the protease. The balance of these two types of serpin-protease interactions 
determines the efficiency of a serpin as an inhibitor of a given protease (Shin and Yu, 2002). 
Rapidly expanding sequence data from insect genomes and transcriptomes has resulted in 
discovery of thousands of insect serpins, but the physiological functions of only a few have been 
investigated experimentally through biochemical or genetic studies. Many insect serpins are 
secreted into the circulating hemolymph and regulate extracellular protease cascades, which 
activate innate immune responses (Meekins et al., 2017). By inactivating specific proteases, 
serpins suppress the immune reactions to avoid excessive production of harmful molecules, 
which may cause damage to host insects (Kanost and Gorman, 2008).  
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Immune responses mediated by hemolymph serine proteases and their regulation by 
serpins have been studied intensively in a model species, M. sexta, the tobacco hornworm 
(Kanost and Jiang, 2015). The M. sexta genome contains 32 serpin genes, and only 10 of these 
have been studied with regard to their function (Li et al., 2018; Yang et al., 2018). M. sexta 
serpin-3 expression increases during immune challenge, and it inhibits key proteases in two 
immune cascades. Serpin-3 inhibits prophenoloxidase activating proteases (PAPs), the terminal 
enzymes in prophenoloxidase activation leading to melanin synthesis, and it inhibits hemolymph 
protease 8, which cleaves proSpätzle to stimulate the toll pathway (Zhu et al., 2003; Christen et 
al., 2012). M. sexta serpin-3 is orthologous to Drosophila melanogaster serpin-27a and 
Anopheles gambiae SRPN2, which are also significant regulators of innate immune protease 
cascades (Michel et al., 2005; Michel et al., 2006). 
Studies of mammalian serpins have shown that peptides with sequences derived from the 
RCL can modulate serpin function. A synthetic peptide with sequence of the P14-P1 residues of 
the human α1-antitrypsin RCL integrated into α1-antitrypsin, and this modified serpin exhibited 
properties similar to cleaved α1-antitrypsin, including lack of inhibitory activity (Schulze et al., 
1990). This finding was followed by studies investigating peptides with sequences derived from 
the RCL of other human serpins, such as antithrombin, antichymotrypsin, plasminogen activator 
inhibitor-1, and plasminogen activator inhibitor-2 (PAI-1 and PAI-2) (Carrell et al., 1991; Mast 
et al., 1992; Eitzman et al., 1995; Jankova et al., 2001). Characterization of crystal structures of 
the binary complex of serpin with RCL-derived peptide verified the insertion of the RCL-derived 
peptide as strand 4A in the serpins in antithrombin, PAI-1, and PAI-2 (Skinner et al., 1998; Zhou 
et al., 2004; Xue et al., 1998; Jankova et al., 2001). In most cases, the principle consequence of 
RCL-derived peptide incorporation was loss of protease inhibitory activity of the serpin, which 
acted instead as a substrate of the target protease (Jendrny and Beck-Sickinger, 2015; Björk et 
al., 1992; D'Amico et al., 2012). Research in this area has focused on interactions of human 
serpins and their RCL-derived peptides, because of relevance to serpinopathies, a class of 
conformational disorders featuring a polymer of serpins in which the RCL of one serpin is 
inserted into the β-sheet A of an adjacent serpin monomer (Gooptu and Lomas, 2009). There is 
evidence for potential therapeutic use of RCL-derived peptides to treat serpinopathies, by 
blocking aberrant polymerization both in vitro and in vivo (Mahadeva et al., 2002; Ambadapadi 
et al., 2016).  
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These results on mammalian serpins stimulated this investigation to test the use of RCL-
derived peptides to manipulate serpin actions in insects, as reagents for experiments to provide a 
better understanding of serpin physiological functions, particularly for serpins with unknown 
roles. To test this idea, I hypothesized that serpin-3 from M sexta would be inactivated by 
synthetic peptides designed based on its RCL sequence, due to binding and insertion of the 
peptides between -sheet strands A3 and A5 in place of its own RCL, thus blocking inhibition.  I 
studied a series of peptides with sequences from the serpin-3 RCL and identified an optimum 
short sequence that blocked inhibition of prophenoloxidase-activating protease 3 (PAP3) by 
serpin-3 and also significantly diminished regulation of proPO activation in hemolymph plasma.  
 Materials and Methods 
 Insects 
M. sexta eggs originally obtained from Carolina Biological Supply were used to establish 
a laboratory colony, which has been maintained by feeding on a wheat germ-based artificial diet, 
with a photoperiod of 16 h of light and 8 h of darkness at 26°C. 
 Synthesis of peptides 
Peptides were synthesized in the KSU Biotechnology/Proteomics Core Laboratory using 
solid phase peptide synthesis on an ABI 431 automated peptide synthesizer (Applied 
Biosystems, Waltham, MA) with N-Fmoc protected amino acids (P3 Biosystems, Louisville, KY 
and AnaSpec, Fremont, CA). CLEAR amide resin (Peptides International, Louisville, KY) was 
used for synthesis of Ac-SVAFSATQ-NH2, Ac-SVAFSAT-NH2, Ac-SVAFSA-NH2, and Ac-
SVAFS-NH2, while Wang resin pre-loaded with the initial amino acid (AnaSpec, Fremont, CA) 
was used to synthesize Ac-SVAFS-COO-. The amino termini were acetylated using acetic 
anhydride. The peptides were cleaved from the resin using a solution of 98% trifluoroacetic acid 
(TFA) and 2% deionized water. This was mixed at room temperature for 90 min. The slurry was 
filtered, and the liquid was poured into ice-cold diethyl ether to precipitate peptides. The peptides 
were then washed with diethyl ether three times and lyophilized. Once dried, the peptides were 
analyzed using reverse phase HPLC using a C18 column. Solvent A was 99.9% water and 0.1% 
TFA and Solvent B was 90% acetonitrile, 9.9% water, and 0.1% TFA. A 10% to 90% Solvent B 
gradient over 30 min was used to elute the peptides. Purity was shown to be over 80%. MALDI-
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TOF MS was also used for confirmation of the correct mass on a Bruker Ultraflex II instrument 
(Billerica, MA). Lyophilized peptides were dissolved in 2, 2, 2-trifluoroethanol (TFE) before 
use.  
 Expression and purification of recombinant PAP3 
A recombinant baculovirus stock for proPAP3 expression was obtained from Dr. Haobo 
Jiang (Wang et al., 2001) and amplified in Sf9 cells in suspension culture in Sf-900 II SFM 
(Thermo Fisher Scientific) medium. One liter of Sf9 cells (2×106/ml) was infected with the 
recombinant baculovirus at a multiplicity of infection of 2 and cultured at 27°C with shaking at 
140 rpm for 72 h. The medium containing secreted proPAP was harvested by centrifugation at 
4°C, 300 × g for 10 min. Ammonium sulfate (537 grams) was added to the medium, followed by 
incubation at 4°C for 2 days without disturbing. A brown precipitate was carefully collected 
from the surface of medium and then dialyzed against 5 L of 15 mM sodium phosphate, pH 8.0 
three times at 4°C. Immunoblot analysis of this sample using PAP3 polyclonal antiserum 
(described below) indicated that proPAP3 was cleaved at a position consistent with its 
proteolytically activated form (Jiang et al., 2003), due to auto-activation or activation by other 
proteases in the medium. This sample (~150 ml) was then applied to a Ni-NTA column (1.5×14 
cm, Qiagen), and after washing with buffer (10-30 mM imidazole, 50 mM sodium phosphate, 
300 mM NaCl, pH 8.0), PAP3 was eluted with the same buffer supplemented with 250 mM 
imidazole. The fractions containing PAP3 were dialyzed against 5 L of 20 mM Tris-HCl, 20 mM 
NaCl, pH 8.0 three times and then concentrated to 3.5 ml by centrifugal ultrafiltration (Amicon 
30K MWCO, Millipore). PAP3 was further purified by anion exchange chromatography on a 
UnoQ1 column (7×35 mm, Bio-Rad) using a linear gradient elution of 20-500 mM NaCl in 20 
mM Tris-HCl, pH8.0. Fractions containing PAP3 were pooled, quantified, and stored at -80°C. 
 Expression and purification of recombinant serpin-3∆N 
Recombinant plasmid pET28a containing serpin-3 sequence encoding residues 31-435 
was used to transfect E. coli strain BL21(DE3). Serpin-3ΔN expression in 1 L E. coli culture was 
induced at mid-log stage by 1 mM IPTG at 37°C for 6 h. Bacteria were then pelleted by 
centrifugation and lysed by sonication in cold 300 mM NaCl, 10 mM imidazole, 50 mM sodium 
phosphate, pH 8.0 at 4°C. After centrifugation, the pellet and supernatant were subjected to SDS-
PAGE, which showed that the majority of serpin-3ΔN was insoluble, but also was present in 
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lower amounts in the soluble fraction. The supernatant (36 ml) was applied to a NiNTA (Qiagen) 
column (1×7 cm), and after washing with buffer (10-30 mM imidazole, 50 mM sodium 
phosphate, 300 mM NaCl, pH8.0), serpin-3ΔN was eluted with the same buffer supplemented 
with 250 mM imidazole. Fractions containing serpin-3ΔN were dialyzed against 4 L of 20 mM 
Tris-HCl, 20 mM NaCl, pH 8.0 three times at 4°C. Serpin-3ΔN was further purified by 
chromatography on a UnoQ1 column (7×35 mm, Bio-Rad) using a linear gradient of 20-500 mM 
NaCl in 20 mM Tris-HCl, pH 8.0. Fractions containing serpin-3ΔN were pooled, quantified, and 
stored at -80°C.   
 Expression and purification of recombinant serpin-1B 
The plasmid pQE-60 containing full-length mature serpin-1B was used to transfect E. 
coli strain BL21 (Kanost et al., 1989). Serpin-1B expression in 1 L YT medium was induced at 
mid-log stage by 1 mM IPTG at 37°C for 3.5 h. Bacteria were then pelleted by centrifugation 
and lysed by sonication in cold 300 mM NaCl, 10 mM imidazole, 50 mM sodium phosphate, pH 
8.0 at 4°C. After centrifugation, the supernatant (~20 ml) was incubated with 2 ml NiNTA beads 
at 4°C for 1.5 h, the mixture was then applied to column (1×7 cm), and after washing with buffer 
(10-30 mM imidazole, 50 mM sodium phosphate, 300 mM NaCl, pH8.0), serpin-1B was eluted 
with the same buffer supplemented with 250 mM imidazole. Fractions containing serpin-1B 
were dialyzed against 4 L of 20 mM Tris-HCl, 20 mM NaCl, pH 8.0 three times at 4°C. Serpin-
1B was further purified by chromatography on a UnoQ1 column (7×35 mm, Bio-Rad) using a 
linear gradient of 20-500 mM NaCl in 20 mM Tris-HCl, pH 8.0. Fractions containing serpin-1B 
were pooled, quantified, and stored at -80°C. 
 Plasma preparation from naïve larvae 
Hemolymph was collected from day 2 fifth instar larvae of M. sexta. Hemocytes were 
removed by centrifugation at 12,000  g for 20 min at 4°C. Plasma samples from each larva were 
screened as follows: 2 µl of plasma was added to 97 µl of 50 mM sodium phosphate, pH 6.5, 
followed by addition of 1 µl of 1 mg/ml Micrococcus luteus to activate the proPO protease 
cascade or 1 µl filter-sterilized 0.85% NaCl as a control. These mixtures were incubated at room 
temperature for 10 min, and then PO activity was measured by adding 100 μl of 4 mM dopamine 
as substrate in 50 mM sodium phosphate, pH 6.5. PO activity was measured by detecting an 
increase in absorbance at 470 nm. One unit of PO activity was defined as 1000×∆A470/min. 
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Those plasma samples with low basal PO activity but significantly induced activity in response 
to M. luteus induction were stored at -80°C for future use.     
 SDS-PAGE and immunoblotting 
Protein samples analyzed by SDS polyacrylamide gel electrophoresis were mixed with 
2× or 6×SDS loading buffer (supplemented with -mercaptoethanol) followed by heating at 
95°C for 5 min. Samples were loaded into wells of 4-12% Bis-Tris NuPAGE gels and separated 
by electrophoresis using MES or MOPS buffer. The gels were stained using Instant Blue 
(Expedeon) or transferred to nitrocellulose in a semi-dry transfer cell (Bio-Rad). The presence of 
PAP3, serpin-3ΔN or serpin-1 on the membrane was detected using rabbit antisera to PAP3 
(Wang et al., 2001), serpin-3 (Zhu et al., 2003) or serpin-1 (Kanost et al., 1989), followed by 
goat anti rabbit IgG conjugated to alkaline phosphatase (BioRad) and colorimetric detection of 
immobilized alkaline phosphatase activity. 
 Protein and peptide concentration assay 
Protein concentration was measured using Coomassie Plus Protein Assay Reagent 
(Thermo Scientific), with bovine serum albumin as a standard. Concentration of RCL-derived 
peptides was determined spectrophotometrically at 257 nm using a molar extinction coefficient 
of phenylalanine, 195 M-1  cm-1 (Mach et al., 1995). 
 Inhibitory activity of recombinant serpin-3∆N against PAP3 
Purified recombinant PAP3 (40 ng) was incubated with 0, 18, 36, 54, 72, 90, or 180 ng of 
recombinant serpin-3∆N (molar ratio from 0 to 4.0) in 100 mM Tris, pH 8.0, supplemented with 
5.8 μg bovine serum albumin (BSA) in a 96-well plate for 10 min at room temperature. The 
PAP3 substrate N-acetyl-Ile-Glu-Ala-Arg-p-nitroanilide (IEAR-pNA) at 50 μM in 0.1 M Tris, 
0.1 M NaCl, 5 mM CaCl2, pH 8.0 was then added, and residual PAP3 activity was measured by 
the change of absorbance at 405 nm over 20 min at room temperature. 
Purified recombinant PAP3 (72 ng) was incubated with 81 ng or 40.5 ng purified 
recombinant serpin-3ΔN in 100 mM Tris, pH 8.0 at room temperature for 10 min, followed by 
analysis by SDS-PAGE and immunoblotting as described above. 
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 Inhibition of PAP3 by serpin-3∆N in the presence of RCL-derived peptides 
Peptides (25 nmol) in TFE or TFE alone as a control were applied to wells of a 96-well 
plate and allowed to dry (>1 h).  Serpin-3ΔN (135 ng) was then added to the wells and incubated 
at 37°C for 2 h. PAP3 (108 ng) supplemented with 18 μg BSA was then added to the wells and 
incubated for 10 min at room temperature. Substrate IEAR-pNA at 50 μM in 0.1 M Tris, 0.1 M 
NaCl, 5 mM CaCl2, pH 8.0 was then added, and residual PAP3 activity was measured by the 
change of absorbance at 405 nm over 20 min at room temperature. Percentage of IEARase 
activity was defined as IEARase activity divided by IEARase activity of PAP3 in the absence of 
serpin. Data were analyzed by one-way ANOVA with Tukey’s multiple comparison as post test 
using GraphPad Prism. Samples for analysis by reducing SDS-PAGE and immunoblotting were 
prepared in a similar way. Peptides or TFE alone were dried in 1.5 mL microcentrifuge tubes and 
incubated with 7.5 µl serpin-3ΔN (135 ng) at 37°C for 2 h, followed by addition of 46.5 µl PAP3 
(108 ng) supplemented with 18 μg BSA and further incubated for 10 min at room temperature. 
Samples were then analyzed by reducing SDS-PAGE and immunoblotting as described above. 
To examine the time course of peptide interaction with serpin-3ΔN, pre-dried Ac-SVAFS-NH2 
(400 nmol), Ac-SVAFS-COO- (400 nmol) and TFE alone as a control were incubated with 40 μl 
purified serpin-3ΔN (720 ng) supplemented with 40 μl BSA (80 μg) at 37°C for 1 h. At 0, 10, 20, 
40 and 60 min, 12 μl aliquots were withdrawn and immediately incubated with 72 ng of PAP3 at 
room temperature for 10 min, followed by measuring residual PAP3 activity with 50 mM IEAR-
pNA in 0.1 M Tris, 0.1 M NaCl, 5 mM CaCl2, pH 8.0. 
 Inhibition of trypsin/elastase by M. sexta serpin-1A and 1B in the presence of Ac-
SVAFS-COO- 
Recombinant serpin-1A was obtained from Dr. Chunju An and recombinant serpin-1B 
was purified in this work. Recombinant serpin-1A or 1B (2 μM) was incubated with pre-dried 
Ac-SVAFS-COO- (0.4 μmol) or pre-dried TFE at 37°C for 2 h. Serpin-1A (1 μl, 2 μM) treated 
with or without Ac-SVAFS-COO- was then incubated with 2 μl bovine trypsin (0.2 μM; Sigma) 
supplemented with 12 μg BSA in 20 m Tris, pH 8.0 for 10 min at room temperature. Serpin-1B 
(8 μl, 2 μM) treated with or without Ac-SVAFS-COO- was then incubated with 2 μl porcine 
pancreatic elastase (4 μM; Sigma) supplemented with 12 μg BSA in 20 m Tris, pH 8.0 for 10 
min at room temperature. Substrate IEAR-pNA (for trypsin) or AAA-pNA (elastase) at 50 μM in 
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0.1 M Tris, 0.1 M NaCl, 5 mM CaCl2, pH 8.0 was then added, and residual amidase activity was 
measured by the change of absorbance at 405 nm over 20 min at room temperature. The same 
samples were analyzed by reducing SDS-PAGE and immunoblotting as described above. 
 Inhibition of PAP3 by A. gambiae SRPN2 in the presence of two pentapeptides 
Ac-SVAFS-NH2 or Ac-SVAFS-COO
- (25 nmol) in TFE or TFE alone as a control were 
applied to wells of a 96-well plate and allowed to dry (>1 h). Recombinant A. gambiae SRPN2 
purified by Dr. David Meekins (80 ng) was then added to the wells and incubated at 37°C for 2 
h. PAP3 (108 ng) supplemented with 18 μg BSA was then added to the wells and incubated for 
10 min at room temperature. Substrate IEAR-pNA at 50 μM in 0.1 M Tris, 0.1 M NaCl, 5 mM 
CaCl2, pH 8.0 was then added, and residual PAP3 activity was measured by the change of 
absorbance at 405 nm over 20 min at room temperature. Percentage of IEARase activity was 
defined as IEARase activity divided by IEARase activity of PAP3 in the absence of serpin. 
 Effects of RCL-derived peptides on pro-PO activation in plasma 
Hemolymph was collected from day 2 fifth instar larvae and centrifuged at 12,000 rpm 
for 25 min at 4°C to remove hemocytes, to prepare plasma samples containing the proPO 
activation system. To examine the effect of pre-incubation of peptide with serpin before 
exposure to plasma, Ac-SVAFS-COO- (10 nmol in TFE) or TFE alone were dried in wells of a 
96-well plate and then incubated with 4 µl serpin-3ΔN (0.1 μg) at 37°C for 2 h, followed by 
incubation with 2 μl plasma at room temperature for 10 min. Then the proPO cascade was 
stimulated by addition of 1 μg Micrococcus luteus (Sigma) or filter-sterilized 0.85% NaCl as a 
control. These mixtures were incubated at room temperature for 10 min, and then PO activity 
was measured by adding 100 μl of 4 mM dopamine as substrate in 50 mM sodium phosphate, pH 
6.5. PO activity was measured by detecting increase in absorbance at 470 nm. One unit of PO 
activity was defined as 1000×∆A470/min. Three replicates with four different larval plasma 
samples were examined. Paired one-way ANOVA with Tukey’s multiple comparison as post test 
was performed in GraphPad Prism. 
To test the effects of peptide mixed directly to plasma samples, pre-dried Ac-SVAFS-
NH2 (25 nmol) or TFE in wells of a 96-well plate were incubated with 5 μl plasma for 1 h at 
room temperature, followed by addition of 95 μl of 50 mM sodium phosphate buffer, pH 6.5 
supplemented with or without 2 μg of M. luteus (Sigma). After incubation for 10 min at room 
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temperature, PO activity was measured as described above. Three replicates with four different 
larval plasma samples were examined. Statistical analysis was done as described above.  
 Circular dichroism analysis 
To examine effects of RCL-derived peptides on serpin-3ΔN secondary structure, 600 µl 
serpin-3ΔN (150 μg) and 1.8 ml Ac-SVAFS-COO- (25 μmol) were mixed and incubated at 37°C 
for 2 h to allow formation of a serpin-peptide binary complex. Then the mixture was subjected to 
gel permeation chromatography using Superdex 200 10/300 GL (Bio-Rad) in 20 mM Tris-HCl, 
150 mM NaCl, pH 8.0 to separate binary complex from free peptide. The fractions containing 
serpin-3ΔN, presumed to be in complex with peptide, were pooled and quantified. Ellipticity of 
serpin-3ΔN (0.18 mg/ml) or purified binary complex (0.12 mg/ml) in 20 mM Tris, 10 mM NaCl, 
pH 8.0 was measured in a 0.02 cm cuvette from 190 nm to 260 nm at 20°C. The temperature was 
then increased in 10°C increments, and the spectra were measured at each temperature from 
20°C to 90°C. The ellipticity of the buffer was also recorded and subtracted from that of serpin-
3ΔN and binary complex. The data were smoothed by the method of Savitzky-Golay with value 
of 1533. Molar ellipticity was calculated as (ellipticity × molecular weight)/(10 × 0.02 cm × 
concentration). 
 Results 
 Expression and purification of PAP3, serpin-3∆N and serpin-1B 
PAP3 is present as a zymogen (proPAP3) in M. sexta plasma, and can be activated by 
hemolymph protease HP21 in response to microbial infection. M. sexta proPAP3 is composed of 
N-terminal dual clip domains (19 kDa) and a C-terminal protease domain (37 kDa) (Jiang et al., 
2003). Cleavage of proPAP3 by HP21 between clip domains and protease domain generates 
active PAP3, while a disulfide bridge connects both parts after activation (Gorman et al., 2007). 
It was also reported that purified recombinant PAP3 can activate proPAP3 (Wang et al., 2014). I 
found that proPAP3 expressed in Sf9 cells became cleaved during ammonium sulfate 
precipitation or dialysis, observed as two bands that match the size of the dual clip domain and 
protease domain on reducing SDS-PAGE (Fig. 3-1). These bands are consistent with the sizes of 
the two products after activation of proPAP3 by HP21 (Gorman et al., 2007). Possibly the highly 
dense protein environment favored the activation of proPAP3 by a small amount of active PAP3 
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or other unknown PAP3-activating enzymes present in cell culture medium. The overall yield of 
PAP3 from 1.0 L of Sf9 cell culture was ~0.05 mg. Another way of activating proPAP3 was 
using proHP21[LK], which is a constitutively active variant with the leucine P1 at the 
activation site replaced by lysine (Gorman et al., 2007). I found that proHP21[LK] could 
activate proPAP3 at 1:10 molar ratio at 37°C after 18 h (data not shown). But this approach 
should be further optimized to avoid over-proteolysis of PAP3. 
A majority of serpin-3∆N (with deletion of a 30-residue amino-terminal extension to 
improve recombinant expression) expressed in E. coli remained insoluble, and lowering the 
temperature during expression (17, 23, 30°C rather than 37°C) did not lead to improvement of 
solubility (data not shown). Therefore, only the soluble portion of serpin-3∆N expressed at 37°C 
was subjected to purification. From 2.0 L of bacterial culture, ~4.2 mg of recombinant serpin-
3∆N was obtained after purification (Fig. 3-1). Yield of recombinant serpin-1B was ~3.75 mg 
from 500 ml bacterial culture after purification (Fig. 3-1). 
 Serpin-blocking activities of four serpin-3 RCL-derived peptides 
I sought to test whether short peptides derived from the serpin-3 RCL would block the 
inhibitory activity of serpin-3. Based on previous studies of mammalian serpins (Schulze et al., 
1990; Carrell et al., 1991; Björk et al., 1992; Mast et al., 1992; Eitzman et al., 1995; Jankova et 
al., 2001; D'Amico et al., 2012; Mahadeva et al., 2002), I designed four peptides that began at 
the P14 residue of the serpin-3 RCL, with sizes of 5-8 amino acid residues (Fig. 3-2). These were 
initially synthesized with blocking groups at each end (acetyl block at the amino-terminus and 
amide block at the carboxyl-terminus) to avoid charged groups at the ends of the peptides. The 
effect of RCL-derived peptides on serpin-3∆N was tested by treating the serpin with peptides and 
then measuring serpin-3∆N inhibition of M. sexta PAP3, one of the main target serine proteases 
of serpin-3 in regulating M. sexta immune responses (Zhu et al., 2003; Christen et al., 2012). 
Serpin-3∆N was an efficient inhibitor of PAP3, with ~100% inhibition of PAP3 activity at 
1.6:1.0 molar ratio (serpin-3∆N:PAP3) (Fig. 3-3A). The inhibitory complex formed by serpin-
3∆N and PAP3 was observed by immunoblotting (Fig. 3-3B). Incubation of RCL-derived 
peptides with serpin-3∆N led to decreased inhibitory activity of serpin-3∆N (Fig. 3-4A). The 
treatment of serpin-3∆N with the pentapeptide, Ac-SVAFS-NH2 (peptide 1, Fig. 3-1B), 
completely blocked its PAP3 inhibitory activity, whereas longer peptides had less effect, in a 
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size-dependent manner. The octapeptide, Ac-SVAFSATQ-NH2 (peptide 4, Fig. 3-1B) showed 
about 50% blockage of serpin-3∆N inhibition of PAP3. The peptides in the absence of serpin had 
no effect on PAP activity (data not shown). 
To further examine molecular effects caused by the RCL-derived peptides, we analyzed 
samples of serpin-3∆N after reaction with PAP3 in the presence or absence of the four RCL-
derived peptides by SDS-PAGE and immunoblotting, using serpin-3 antiserum (Fig. 3-4B). In 
the absence of peptides, a major band of intact serpin-3∆N at ~42 kDa was present, and a 
covalent inhibitory complex of serpin-3∆N with PAP3 was detected at ~75 kDa (Fig. 3-3B and 
Fig. 3-4B) as previously observed (Zhu et al., 2003). A minor band at ~38 kDa was also present, 
consistent with some serpin-3∆N undergoing cleavage in the RCL as a substrate rather than 
acting as an inhibitor. In contrast, the incubation of RCL-derived peptides with serpin-3∆N 
resulted in an enhanced conversion of serpin-3∆N from inhibitor to substrate, indicated by 
increased intensity of the 38 kDa cleaved serpin band, and decreased formation of the 75 kDa 
inhibitory complex (Fig. 3-4B). Consistent with effects on PAP3 amidase activity assay, Ac-
SVAFS-NH2, the shortest RCL-derived peptide, was the most efficient of the four RCL-derived 
peptides in inducing substrate-like property, with an intense band for the 38 kDa cleaved form, 
and absence of the ~75kDa complex. Therefore, this pentapeptide was used for further 
experiments.  
 Comparison of effects of Ac-SVAFS-COO- and Ac-SVAFS-NH2 on serpin-3 
Peptide 1, Ac-SVAFS-NH2, with amino-terminal and carboxyl-terminal blocking groups, 
had very low aqueous solubility. We synthesized a peptide with the same sequence but only an 
amino-terminal blocking group and a free carboxyl end, Ac-SVAFS-COO-, which has a negative 
charge at neutral pH, for improved solubility. Ac-SVAFS-NH2 and Ac-SVAFS-COO
- were 
evaluated for their effect on serpin-3∆N as an inhibitor of PAP3 (Fig. 3-5).  Inactivation of 
serpin-3∆N began to occur by 10 min after incubating the serpin with either of the pentapeptides 
and increased to ~100% suppression of serpin-3∆N inhibitory activity by 40 min. This result 
suggests that the difference in the solubility of these two peptides did not limit their effects on 
serpin function in this experiment, and that the peptides interact with serpin to cause its 
inactivation on the scale of minutes.  
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 Specificity of serpin-3 RCL-derived peptides  
A peptide based on the serpin-3 RCL was also tested with M. sexta serpin-1A and 1B, 
which are inhibitory serpins with a different hinge and RCL sequences (Fig. 3-6A). Amidase 
activity of trypsin was completely inhibited by serpin-1A at 1:4 molar ratio. Incubation of serpin-
1A with Ac-SVAFS-COO- completely blocked the inhibitory activity of serpin-1A (Fig. 3-6B). 
Serpin-1B showed 100% inhibition against elastase at 2:1 molar ratio, but 74% of elastase 
activity remained after incubation with Ac-SVAFS-COO- treated serpin-1B (Fig. 3-6C). 
Immunoblotting results are consistent with the amidase activity assay. Incubation of Ac-SVAFS-
COO- with serpin-1A or 1B promoted the substrate-behavior of the serpins and abolished or 
attenuated the complex formation (Fig. 3-6D and E).  
Specificity of serpin-3 based RCL peptides was also tested with A. gambiae SRPN2, 
which is orthologous to M. sexta serpin-3 (Fig. 3-7A) (Michel et al., 2005). Ac-SVAFS-NH2 was 
able to block ~40% of the inhibitory activity of SRPN2, while Ac-SVAFS-COO- did not show 
any inhibition of SRPN2 (Fig. 3-7B and C). Immunoblotting displayed a slight enhancement of 
the cleaved SRPN2 band and a less intense complex band when PAP3 was incubated with Ac-
SVAFS-NH2 treated SRPN2 (Fig. 3-7E). However, bands for Ac-SVAFS-COO
- treated SRPN2 
did not appear different from those in the absence of the peptide (Fig. 3-7F).  
 Serpin-3 RCL-derived peptide promotes increased PO activation in plasma 
Detection of microbes in hemolymph stimulates the initiation of a protease cascade that 
results in the activation of proPO by PAPs, leading to oxidation of catechols in hemolymph and 
subsequent reactions that produce melanin (Kanost et al., 2004). Serpin-3 in hemolymph 
regulates proPO activation by inhibiting PAPs (Zhu et al., 2003). To investigate whether the 
inactivation of serpin-3 by RCL-derived peptides can have an effect in hemolymph, Ac-SVAFS-
COO- was pre-incubated with serpin-3∆N to allow formation of peptide-serpin complex, 
followed by the addition of plasma and stimulation of the protease cascade by M. luteus (Fig. 3-
8A). M. luteus treatment stimulated activation of PO in plasma, which was suppressed by 
addition of free serpin-3∆N. However, addition of serpin-3∆N treated with Ac-SVAFS-COO- to 
plasma did not significantly attenuate PO activation. This result is consistent with lack of 
inhibition of PAP activity by serpin-3∆N complexed with the peptide. 
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To further confirm the inactivation of naturally occurring serpin-3 by the RCL-derived 
peptide in the complex protein mixture in hemolymph, plasma was incubated with Ac-SVAFS-
NH2 for 1 h to allow the association of RCL-derived peptides with endogenous serpin-3, 
followed by triggering the proPO cascade by addition of M. luteus (Fig. 3-8B). Addition of the 
bacteria to plasma led to increased PO activity, as expected, but in the presence of Ac-SVAFS-
NH2, PO activity was significantly greater after addition of bacteria than in control plasma (Fig. 
3-8B), consistent with the hypothesis that the peptide blocked inhibition of PAPs by serpin-3.    
 Ac-SVAFS-COO- alters conformation and increases thermal stability of serpin-3∆N 
The incorporation of RCL-derived peptides into β-sheet A was confirmed to mimic the 
relaxed state of human antithrombin, with increased thermodynamic stability (Björk et al., 1992). 
To compare the thermostability of serpin-3∆N with that of the complex formed by serpin-3∆N 
and RCL-derived peptide, I incubated serpin-3∆N with Ac-SVAFS-COO- and then separated the 
complex from free peptide by gel permeation chromatography. Analysis of serpin-3∆N and the 
serpin-3∆N•Ac-SVAFS-COO- complex by circular dichroism spectroscopy (Fig. 3-9A) revealed 
a deeper trough at around 220 nm in the complex compared with the free serpin, indicating a 
slight change in secondary structure in the presence of Ac-SVAFS-COO-. The effect of 
interaction of Ac-SVAFS-COO- on the thermal stability of serpin-3∆N was tested by measuring 
circular dichroism spectra at increasing temperatures. The spectrum of serpin-3∆N changed 
significantly at temperatures of 60°C and above, whereas the serpin-3∆N in complex with Ac-
SVAFS-COO- maintained its secondary structure, with little change in CD spectrum up to 90°C 
(Fig. 3-9B and C). Molar ellipticity of both native serpin-3∆N and serpin-peptide complex at 215 
nm was plotted as a function of temperature (Fig. 3-9D). The obvious conformational transition 
of native serpin-3∆N occurred between 50°C and 70°C. In contrast, there was only small and 
gradual elevation of molar ellipticity of the serpin-3∆N complexed with Ac-SVAFS-COO- at 
higher temperatures, suggesting that the association of serpin with the RCL-derived peptide 
significantly increased the stability of the serpin molecule. 
 Discussion 
M. sexta serpin-3 regulates proPO activation in response to bacteria by inhibiting PAP-1 
and PAP-3 in hemolymph (Zhu et al., 2003). Complexes formed by serpin-3 with plasma 
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proteases, including PAP-1, PAP-2, PAP-3 and HP8, were previously identified in plasma by 
mass spectrometry, confirming the role serpin-3 plays in regulating immune protease cascades in 
vivo (Christen et al., 2012). RNA interference to decrease the expression of a mosquito ortholog 
of M. sexta serpin-3 (SRPN2 in A. gambiae) resulted in enhanced melanin deposition on 
implanted Sephadex beads and the appearance of melanotic pseudotumors on the abdominal 
wall, indicating that this serpin has a critical role in regulating proPO activation (Michel et al., 
2006, An et al., 2011a). RNA interference has not been successfully used to decrease expression 
of plasma proteins in M. sexta (Terenius et al., 2011) and therefore it has not been possible to 
determine the effect of lowered serpin-3 concentrations in vivo. However, we hypothesized that 
blocking the inhibitory activity of serpin-3 would result in misregulated proPO activation. 
Modulation of mammalian serpin function by RCL-derived peptides has been studied through 
biochemical approaches and showed potential feasibility for application in a mouse model 
(Ambadapadi et al., 2016). In this study, experiments were carried out to use regulation of the 
melanization response by serpin-3 as a model system to investigate the potential for using RCL-
derived peptides to probe the functions of insect serpins.  
The proximal hinge region in the RCL of serpins tends to have small, hydrophobic 
residues, allowing this flexible sequence to drive the incorporation of the N-terminal RCL into -
sheet A during protease inhibition, whereas the distal region of the RCL has much more 
sequence variability in different serpins (Irving et al., 2000). Synthetic peptides with sequences 
spanning P15 or P14 to P1 of the RCL were the first to be described as a counterpart of 
incorporated strand A4, converting human serpins from an inhibitor to a substrate (Mast et al., 
1992; Schulze et al., 1990; Björk et al., 1992; Eitzman et al., 1995; Jankova et al., 2001). 
Furthermore, research with human α1-antitrypsin revealed that peptides representing the 
proximal RCL (P14-P4 and P14-P8) are sufficient to substantially inhibit antitrypsin activity, 
while those peptides representing the distal part of the RCL (P10-P1, P9-P1 and P8-P1) were 
much less efficient in blocking α1-antitrypsin (Schulze et al., 1992). Therefore, we designed and 
synthesized peptides based on the RCL proximal hinge of serpin-3, with length of 5-8 residues 
(P14-P10, P14-P9, P14-P8 and P14-P7). These peptides did block serpin-3’s ability to inhibit 
proteolytic activity of PAP3. We found that increasing the length of peptides decreased their 
efficiency in blocking serpin-3∆N function, with the 5-residue peptide (P14-P10) having the 
greatest effect (Fig. 3-4A). This shorter peptide may have easier access for inserting into the 
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space between strand 3A and strand 5A (Fig. 3-1A). Such a difference was not observed between 
11-residue (P14-P4) and 7-residue peptides (P14-P8) derived from the human α1-antitrypsin RCL 
in blocking α1-antitrypsin function (Schulze et al., 1992), perhaps because the longer incubation 
time they used may permit entry of longer peptides into -sheet A.  
In the natural RCL sequence of serpin-3, the amino acid residues from P14 to P2 are not 
charged, since they are participating in peptide bonds and lack ionizable side chains. In order to 
mimic the endogenous proximal RCL sequences, we synthesized peptides with ends blocked by 
N-terminal acetylation and C-terminal amidation, so that they would not contain charged groups 
at the ends. These peptides functioned in blocking serpin-3∆N function, but they had low 
solubility due to the hydrophobic nature of this segment of the serpin sequence. For this reason, 
the five-residue peptide SVAFS was synthesized with only an N-terminal acetylated group and 
lacking the C-terminal amidation. This peptide with one negative charge was much more soluble 
and functioned equally as well as the uncharged peptide (Fig. 3-5). Therefore, it appears that 
negative charge at the C-terminus did not impede insertion of the peptide into -sheet A of 
serpin-3∆N.   
The incorporation of an endogenous RCL into β-sheet A during a protease inhibition 
reaction is a complex process that requires opening of an existing -sheet and insertion of a new 
strand (Björk et al., 1992). This involves coordinated movements of the RCL and regions of the 
serpin called the breach, the shutter, and the gate (Pearce et al., 2007). Long incubation times 
(15-48 h) at 37-48°C are necessary in many cases for inactivation of the human serpins α1-
antitrypsin, antithrombin, PAI-1 and PAI-2 by corresponding RCL-derived peptides, conditions 
which probably favor partial unfolding to promote accessibility of the peptides to insert into -
sheet A (Mast et al., 1992; Chang et al., 1996; Schulze et al., 1990; Björk et al., 1992; Skinner et 
al., 1998; Jankova et al., 2001). However, we found that the SVAFS peptide can block serpin-
3∆N function within 40 min at 37°C.  The relatively small size of this peptide, compared to those 
investigated in studies of human serpins may contribute to more efficient insertion into -sheet 
A. Furthermore, the three-dimensional structure of a mosquito ortholog of serpin-3, A. gambiae 
SRPN2 has the RCL hinge in a “partially inserted” conformation (An et al., 2011b; Zhang et al., 
2015), which might contribute to more efficient insertion of the peptide as a new -strand in 
these related insect serpins.  
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After serpin-3∆N was incubated with the RCL peptides to allow formation of the 
complex, it lost activity as an inhibitor of PAP, and instead behaved as a substrate for the 
protease (Fig. 3-4B). This is consistent with observations of human serpins after insertion of 
RCL-derived peptides into -sheet A, with increased vulnerability to cleavage in the RCL and 
lack of inhibitory reactions (Skinner et al., 1998; Xue et al., 1998; Jankova et al., 2001; Zhou et 
al., 2004; Eitzman et al., 1995; D'Amico et al., 2012).   
At least 8 different serpins are present in the circulating plasma of M. sexta, including 
serpin-1, -3, -4, -5, -6, -9, -11 and -12 (He et al., 2016). It may be possible that some of these 
serpins would be unspecific targets of peptides based on the RCL of serpin-3. I tested the 
interaction of M. sexta serpin-1A and 1B with Ac-SVAFS-COO- derived from serpin-3 RCL. 
Ac-SVAFS-COO- was able to block >74% of the inhibitory activity of serpin-1A and 1B (Fig. 3-
6B and C), indicating nonspecific interaction of this peptide with two isoforms of serpin-1. A 
few cases of unspecificity of RCL-derived peptides have been reported. P15-P1 peptide derived 
from α1-antitrypsin had off-target effect on antichymotrypsin and antithrombin (Mast et al., 
1992). P14-P3 peptide from antithrombin was able to inactivate α1-antitrypsin (Chang et al., 
1996). It seems that lack of specificity may result from a sequence rich in small hydrophobic 
residues in the hinge region of inhibitory serpins (Irving et al., 2000), without requirement of a 
specific sequence. This may impede the application of RCL-derived peptides in therapies for 
serpin related diseases. Ac-SVAFS-NH2 displayed partial inhibition of a serpin-3 ortholog A. 
gambiae SRPN2, while Ac-SVAFS-COO- did not have an effect on SRPN2 (Fig. 3-7). The 
charge on Ac-SVAFS-COO- may have impeded the insertion into -sheet A of A. gambiae 
SRPN2.  
The CD spectrum of serpin-3∆N complexed with Ac-SVAFS-COO- differed slightly 
from that of serpin-3∆N alone, with lower ellipticity at 220 nm, similar to observations of human 
α1-antitrypsin and antithrombin in complex with their RCL-derived peptides (Schulze et al., 
1990; Schulze et al., 1992; Carrell et al., 1991; Björk et al., 1992). The insertion of an RCL or 
RCL-derived peptide as a new strand (strand A4) in -sheet A changes the configuration of that 
region of the -sheet. Strands 3A and 5A are parallel in the native serpin before insertion of the 
RCL as strand A4, in a new antiparallel relationship with strands A3 and A5, which increases the 
stability of overall structure (Gettins and Olson, 2016). Native serpins are relatively unstable, 
with average melting temperature of around 58°C, while the forms that contain strand 4A have a 
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much higher melting temperature, such as cleaved serpins with >110°C melting temperature 
(Pearce et al., 2007). Similarly, we found that native serpin-3∆N started to denature at ~60°C, 
whereas serpin-3∆N in complex with Ac-SVAFS-COO- showed little change in CD spectrum up 
to the highest temperature (90°C) tested (Fig. 3-9B and C). This result is quite similar to an 
experiment with human antithrombin, with change in CD at 220 nm revealing a melting 
temperature of 58°C for native antithrombin, but no elliptical change of an antithrombin•P14-P1 
complex up to 85°C (Björk et al., 1992). These results support the hypothesis that the RCL 
peptides are functioning in M. sexta serpin-3 in a manner similar that that shown by previous 
structural and biochemical studies of human serpins.   
Because serpin-3 is a negative modulator of the proPO cascade by inhibiting PAPs in 
hemolymph (Zhu et al., 2003), we hypothesized that interfering with serpin-3 activity would lead 
to a higher level of proPO activation in response to a microbial challenge. The results 
demonstrated that addition of recombinant serpin-3∆N to plasma samples stimulated by M. 
luteus caused a significant reduction in PO activity, likely due to inhibition of PAPs. In contrast, 
when serpin-3∆N treated with Ac-SVAFS-COO- was added to the same plasma, PO activity was 
as high as in the absence of added serpin, indicating that the Ac-SVAFS-COO- peptide blocked 
the inhibition of PAPs by serpin-3∆N, resulting in unregulated proPO activation (Fig. 3-8A). 
Similar results were observed when the RCL peptide was mixed with plasma, to allow it to 
interact with endogenous serpin-3 in the complex mixture of hemolymph proteins.  
 Future Directions 
The work presented in this chapter explored the potential use of RCL-derived peptides as 
serpin inhibitors in M. sexta. A foundation was laid for future study involving serpin regulation 
by RCL mimicking peptides and potentially the physiological functions of M. sexta serpins. 
Some questions arose from the current data:  
(1) Is the pentapeptide derived from M. sexta serpin-3 able to block the inhibitory activity 
of other serpins besides serpin-1A, serpin-1B and A. gambiae SRPN2 in vitro by being 
incorporated into -sheet A? 
(2) Ac-SVAFS-NH2 and Ac-SVAFS-COO
- behaved differently in blocking A. gambiae 
SRPN2 (Fig. 3-7), which indicates that one negative charge on the C-terminus is sufficient to 
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alter the efficiency of serpin blocking. The mechanism underlining this difference remains to be 
revealed. 
(3) The addition of Ac-SVAFS-NH2 to M. sexta plasma caused misregulation of PO 
activation (Fig. 3-8B), but this effect was not seen when Ac-SVAFS-COO- was added to plasma. 
Current data and literature could not give a good explanation, and I generally believe the 
complicated environment in plasma likely reduced the accessibility of Ac-SVAFS-COO- to 
serpin-3. But more study should be done to solve this puzzle.  
(4) Molecular Dynamics or crystal structure of RCL-derived peptide and serpin-3 
complex could be performed or solved to have a look at the binding interaction at the angstrom 
level. 
(5) RCL peptides have been shown to decrease serpin function in regulating mammalian 
blood clotting. RCL peptides from plasminogen activator inhibitor-1 (PAI-1) suppress activity of 
this serpin and result in decreased blood clot lysis in vitro (Eitzman et al., 1995; D'Amico et al., 
2012; Van De Craen et al., 2012). A series of RCL-derived peptides from mammalian 
neuroserpin and a myxomavirus serpin displayed anti-inflammatory, anti-atherogenic and pro-
thrombotic functions in mice (Ambadapadi et al., 2016), indicating that RCL peptides can have 
biological activity in vivo. Another application of RCL-derived peptides is to depolymerize or 
deaccelerate aberrant polymerization of serpin monomers, as a potential treatment for human 
serpinopathies (Fitton et al., 1997; Chang et al., 1997). Modulating activity of arthropod serpins 
by RCL-derived peptides may be a useful tool for investigating the biological roles of serpins 
with unknown functions. Therefore, injection of Ac-SVAFS-NH2 or Ac-SVAFS-COO
- into the 
hemocoel of larvae was carried out, but no effect of PO activation was observed (data not 
shown), possibly due to the high variability of tested larvae. Determinants of efficient in vivo 
application of serpin RCL-derived peptides in insects require further investigation.     
(6) Another application of RCL-derived peptides is to depolymerize or deaccelerate 
aberrant polymerization of serpin monomers, as a potential treatment for human serpinopathies 
(Fitton et al., 1997; Chang et al., 1997). Whether serpin-3 RCL derived peptides are able to play 
a role in depolymerization may be worth studying.  
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 Figures 
 
 
 
Figure 3-1. Purification results of PAP3, serpin-3∆N and serpin-1B. 
Purified recombinant PAP3, serpin-3ΔN, or serpin-1B with reducing SDS loading buffer was 
subjected to 4-12% Bis-Tris NuPAGE gel. Instant blue staining and immunoblotting using 
diluted antiserum against PAP3, serpin-3 or serpin-1 as the primary antibody were performed for 
each protein.  
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Figure 3-2. RCL derived peptide design. 
(A) Homology model of serpin-3. P1 and P1’ side chains are indicated as stick drawings and 
P14-P7 residues are in orange. (B) Sequences of RCL derived peptides aligned with P14-P1’ of 
the serpin-3 RCL.  
A
B
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Figure 3-3. Inhibition of PAP3 by serpin-3∆N. 
(A) Purified recombinant PAP3 (40 ng) was incubated with 0, 18, 36, 54, 72, 90, or 180 ng of 
recombinant serpin-3∆N (molar ratio: 0, 0.4, 0.8, 1.2, 1.6,  2.0 and 4.0) in 100 mM Tris, pH 8.0 
at room temperature for 10 min, followed by residual amidase activity determination of PAP3 by 
using 50 μM IEAR-pNA as substrate. (B) Purified recombinant PAP3 was incubated with serpin-
3ΔN at 0:1, 1:1 and 2:1 molar ratio in 100 mM Tris, pH 8.0 at room temperature for 10 min, 
followed by analyzing with reducing 4-12% Bis-Tris NuPAGE gel and immunoblotting using 
diluted antiserum against PAP3 (left) or serpin-3 (right) as the primary antibody.  
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Figure 3-4. Effects of RCL peptides on inhibitory activity of serpin-3∆N. 
Pre-dried peptides (25 nmol) or dried TFE as a control were incubated with purified serpin-3∆N 
(135 ng) at 37°C for 2 h, followed by addition of PAP3 (108 ng) and further incubation for 10 
min at room temperature. (A) Residual amidase activitiy of PAP3 was determined by using 
IEAR-pNA (50 µM) as the substrate. Data are means ± standard deviation (n=3). Results of 
statistical analysis (one-way ANOVA followed by Tukey’s multiple comparison test, P<0.05) 
are indicated. Means with the same letter are not significantly different. (B) Samples prepared as 
described above were analyzed by reducing SDS-PAGE followed by immunoblotting using 
diluted antiserum against serpin-3 as the primary antibody.  
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Figure 3-5. Inactivation of serpin-3∆N by Ac-SVAFS-NH2 and Ac-SVAFS-COO- over the 
time. 
Pre-dried Ac-SVAFS-NH2, Ac-SVAFS-COO
- (400 nmol) and TFE alone as control were 
incubated with purified serpin-3∆N (720 ng) at 37°C for 2 h. A portion of sample was withdrawn 
at the indicated time intervals and added PAP3 to react at room temperature for 10 min, followed 
by IEARase activity measurement in 0.1 M Tris, 0.1 M NaCl, 5 mM CaCl2, pH 8.0. Percentage 
of IEARase activity is defined as individual IEARase activity over gross PAP3 activity.  
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Figure 3-6. Effects of Ac-SVAFS-COO- on inhibitory activity of serpin-1A and 1B. 
(A) N-terminal RCL sequence alignment of serpin-3, serpin-1A and 1B. P1 and P1’ residues 
flanking the scissile bond are indicated. (B) serpin-1A (1 μl, 2 μM) treated with or without Ac-
SVAFS-COO- was incubated with 2 μl trypsin (0.2 μM) for 10 min at room temperature, 
followed by residual amidase activitiy determination of trypsin by using IEAR-pNA (50 µM) as 
the substrate. Data are means ± standard deviation (n=3). (C) serpin-1B (8 μl, 2 μM) treated with 
or without Ac-SVAFS-COO- was incubated with 2 μl elastase (4 μM) for 10 min at room 
temperature, followed by residual amidase activity determination of elastase using AAA-pNA 
(50 µM) as the substrate. Data are means ± standard deviation (n=3). (D) and (E) Samples 
prepared as described above were analyzed by reducing SDS-PAGE followed by 
immunoblotting using diluted antiserum against serpin-1 as the primary antibody.
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Figure 3-7. Effects of Ac-SVAFS-NH2 and Ac-SVAFS-COO- on inhibitory activity of A. 
gambiae SRPN2. 
(A) N-terminal RCL sequence alignment of serpin-3 and A. gambiae SRPN2. P1 and P1’ 
residues flanking the scissile bond are indicated. (B) and (C) Recombinant serpin-3ΔN (108 ng) 
or SRPN2 (80 ng) treated by pre-dried Ac-SVAFS-NH2 or Ac-SVAFS-COO
-
 was incubated with 
PAP3 (108 ng) at room temperature for 10 min, followed by residual amidase activitiy 
determination by using IEAR-pNA (50 µM) as the substrate. Data are means ± standard 
deviation (n=3). (D), (E) and (F) Immunoblotting was performed using indicated antisera as the 
primary antibody. 
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Figure 3-8. Interference of proPO activation in M. sexta plasma by RCL-derived peptides. 
(A) Ac-SVAFS-COO- treated serpin-3∆N (0.1 µg) or untreated serpin-3∆N (0.1 µg) was 
incubated with 2 µl plasma at room temperature for 10 min, followed by addition of 2 µg M. 
luteus or sterile saline and further incubation for 10 min at room temperature. PO activities were 
measured by adding 2 mM dopamine. (B) 1 µl plasma was incubated with pre-dried Ac-SVAFS-
NH2 (5 nmol) or TFE in 50 mM sodium phosphate, pH 6.5 at room temperature for 1 h, followed 
by addition of 2 µg M. luteus or sterile saline and further incubation for 10 min at room 
temperature. PO activities were measured after adding 2 mM dopamine. The graphs represent 
results using plasma from four different larvae. One unit of PO activity is defined as 0.001 
change of OD470 per minute. Data are means ± standard deviation (n=4). Results of statistical 
analysis (paired one-way ANOVA followed by Tukey’s multiple comparison test, P<0.05) are 
indicated with different letters. 
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Figure 3-9. Circular dichroism of serpin-3∆N and binary complex formed by serpin-3∆N 
and Ac-SVAFS-COO-. 
CD spectra were measured with serpin-3∆N and binary complex formed by serpin-3∆N and Ac-
SVAFS-COO- in 20 mM Tris, 10 mM NaCl, pH 8.0 at different temperatures. (A) CD spectra of 
serpin-3∆N and binary complex at 20°C. (B) CD spectrum of serpin-3∆N at different 
temperatures. (C) CD spectrum of binary complex formed by serpin-3∆N and Ac-SVAFS-COO- 
at different temperatures. (D) Molar ellipticity of serpin-3∆N and binary complex at 215 nm at 
different temperatures
A
B
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Chapter 4 - Characterization of Diapausin, an Antifungal Peptide 
from Manduca sexta 
 Introduction 
Production of antimicrobial peptides (AMPs) is an essential strategy for multicellular 
organisms, including insects, to combat infectious bacteria, fungi and parasites (Zasloff, 2002). 
AMPs found in insects are typically synthesized in fat body in response to foreign microbes and 
secreted into hemolymph (Kanost et al., 2004). They are diverse in size and molecular structure, 
but a majority of them cause damage to pathogens by disrupting the cell membrane and 
subsequent leakage of cell contents (Rautenbach et al., 2016). Because of this mode of action, 
some AMPs are active against both bacteria and fungi, such as defensins from mammalians 
(Ganz, 2003), plants (Thomma et al., 2002) and insects (Yi et al., 2014), histatins from primates 
(Kavanagh and Dowd, 2004), LL-37 from mammals (Dürr et al., 2006), cecropins from insects 
(Yi et al., 2014). 
Antifungal peptides refer to those AMPs with fungistatic or fungicidal activity. The 
fungal cell wall can be a target for some antifungal peptides, such as rabbit defensin NP-1 
targeting chitin (Levitz et al., 1986), tobacco defensin NaD1 binding to mannoproteins on the 
cell wall (van der Weerden et al., 2010), and human histatin-5 binding to Candida albicans cell 
wall protein Ssa1/2 (Li et al., 2003). Cell wall synthesis-related enzymes localized at the 
membrane can be the targets as well, such as -1,3 glucan synthase targeted by a family of cyclic 
lipopeptides, echinocandins (Cappelletty and Eiselstein-McKitrick, 2007). Glycerophospholipids 
in the cell membrane interact with a group of antifungal peptides with single linear -helical 
structure, such as LL-37 from mammals (den Hertog et al., 2005) and cecropins from 
Hyalophora cecropia (De Lucca et al., 1998a). Specific lipids on the cell membrane are 
preferred for some antifungal peptides to bind, such as phosphatidylinositol(4,5)-bisphosphate 
(PIP2) targeted by NaD1 from tobacco and TPP3 from tomato (Payne et al., 2016; Baxter et al., 
2015). 
Several antifungal peptides have been isolated from insects and their properties were 
characterized. The only  described fungi-specific peptides from insects, lacking antibacterial 
activity, are drosomycin from Drosophila melanogaster (Landon et al., 1997), heliomicin from 
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Heliothis virescens (Lamberty et al., 1999), gallerimycin from Galleria mellonella (Schuhmann 
et al., 2003), defensin from G. mellonella (Lee et al., 2004), defensin-like peptide (Btdef) from 
Bemisia tabaci (Wang et al., 2013), and diapausin-1 from Manduca sexta. Drosomycin is 
composed of an -helix and three -strands, stabilized by four pairs of disulfide bonds (Landon 
et al., 1997) and has potent antifungal activity, with IC50 0.9-12 M against various fungi (Tian 
et al., 2008). Diapausin was first discovered in Gastrophysa atrocyanea (leaf beetle) hemolymph 
as diapause-specific peptide (DSP), composed of 2 -helices and 3 -strands stabilized by 3 
pairs of disulfide bonds (Kouno et al., 2007). DSP was observed to inhibit the growth of a 
dermatophytic fungus Trichophyton rubrum and an entomopathogenic fungus Beauveria 
bassiana (Tanaka et al., 2003). It was proposed that DSP might be a Ca2+ channel blocker based 
on experimental and structural evidence. DSP reduced Ca2+ influx into bovine adrenal 
chromaffin cells in a dose-dependent manner (Tanaka et al., 2003). NMR structure of DSP 
revealed a similar surface residue distribution with -conotoxins, which inhibit N-type voltage-
dependent calcium channels (Kouno et al., 2007).  
Diapausin-1 was isolated from M. sexta hemolymph, demonstrating antifungal activity 
against Saccharomyces cerevisiae, Magnaporthe oryzae, Fusarium culmorum and Fusarium 
graminearum, with no antibacterial activity (Al Souhail et al., 2016). Germination tubes of M. 
oryzae became curled and cockscrew-like in the presence of 15 M diapausin-1. Hyphal growth 
of Fusarium was reduced and morphologically altered. Diapausin-1 mRNA levels significantly 
increased (>100-fold) after larvae were injected with S. cerevisiae, suggesting its protective role 
during fungal infection (Al Souhail et al., 2016). Genome analysis of M. sexta annotated 14 
diapausin genes with 65-100% amino acid sequence identity (He et al., 2015). 
To further investigate the diapausin family in M. sexta, regarding antifungal activity and 
modes of action, we expressed and purified recombinant diapausin-1 and diapausin-2. They were 
tested against S. cerevisiae, Candida, a genus of yeast that causes human fungal infections, as 
well as an entomopathogenic fungus, B. bassiana. Diapausin-1 was shown to bind to -1,3-
glucan on the yeast cell wall and to interrupt cell separation after cell division, leading to cell 
clusters.   
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 Materials and Methods 
 I-TASSER models of diapausin-1 and diapausin-2 
Full sequences of diapausin-
1(INNWVRVPPCDQVCSRSNPEKDECCRAHGHAFHAHCNGGMNCYRR) and diapausin-2 
(VRVPPCDEVCNRIPRERDECCRAHGHSGYSSCSGGMYCY) were uploaded to I-TASSER 
server (https://zhanglab.ccmb.med.umich.edu/I-TASSER/) with default settings for structure 
prediction (Yang and Zhang, 2015).  
 Expression and purification of recombinant diapausin-1 and diapausin-2 
The plasmid pHis-GB1 containing full-length mature diapausin-1 or diapausin-2 was kindly 
provided by Dr. Bindiya Sachdev and used to transfect Escherichia coli strain Rosetta-gami 
(Novagen). Expression of fusion proteins 6His-GB1-diapausin-1 and 6His-GB1-diapausin-2 was 
induced in 1 L LB medium at mid-log stage by 0.4 mM IPTG at 37°C for 4 h. Bacteria were then 
pelleted by centrifugation and lysed by sonication in 20 ml cold 300 mM NaCl, 10mM 
imidazole, 50 mM sodium phosphate, pH 8.0 at 4°C. After centrifugation, 17 ml supernatant 
containing fusion 6His-GB1-diapausin-1 was incubated with 4.25 ml NiNTA beads and 12 ml 
supernatant containing fusion 6His-GB1-diapausin-2 was incubated with 3 ml NiNTA beads at 
4°C for 1 h. The mixture was then applied to a column (17 cm), and after washing with buffer 
(300 mM NaCl, 20mM imidazole, 50 mM sodium phosphate, pH 8.0), 6His-GB1-diapausin-1 or 
6His-GB1-diapausin-2 were eluted with the same buffer supplemented with 250 mM imidazole. 
Fractions containing 6His-GB1-diapausin-1 or 6His-GB1-diapausin-2 were dialyzed against 4 L 
of 20 mM Tris-HCl, 20 mM NaCl, pH 8.0 three times at 4°C. The amino-terminal 6His-GB1 tag 
was removed by incubating the fusion proteins with Tobacco Etch Virus (TEV) protease (from 
Dr. Brian Geisbrecht) at 800:1 (fusion protein:TEV) mass ratio for 2 or 7 days at 30°C. To 
separate the 6His-GB1 tag from the mature diapausin-1 or diapausin-2, the sample was applied 
to an UnoQ1 column (735 mm, Bio-Rad) and eluted with a linear gradient of 20-1000 mM 
NaCl in 20mM Tris, pH 8.0. Fractions containing mature diapausin-1 or diapausin-2 were 
pooled, concentrated using Pall Corp Microsep Advance device 1K, and quantified. MALDI-
TOF was also used for confirmation of the correct masses of diapausin-1 and diapausin-2 on a 
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Bruker Ultraflex II instrument (Billerica, MA). Recombinant diapausins used for antifungal 
assays were sterilized using SPIN-X centrifuge tube filters (0.22 m). 
 SDS-PAGE and protein concentration assay 
Protein samples analyzed by SDS polyacrylamide gel electrophoresis were mixed with 
2× or 6×SDS loading buffer (supplemented with -mercaptoethanol) followed by heating at 
95°C for 5 min. Samples were loaded into wells of 4-12% Bis-Tris NuPAGE gels and separated 
by electrophoresis using MES buffer. The gels were stained using Instant Blue (Expedeon). 
Protein concentration was measured using Coomassie Plus Protein Assay Reagent (Thermo 
Scientific), with bovine serum albumin (BSA) as a standard. 
 Antifungal assay of diapausin-1 and diapausin-2 against Saccharomyces cerevisiae 
A single colony of S. cerevisiae wild type diploid strain BY4743 was inoculated into 3 ml 
YPD medium and cultured overnight with shaking at 200 rpm at 30°C. Then the overnight 
culture was diluted with YPD medium to OD600=0.1. Sterile recombinant diapausin-1 (9.4 l/6.3 
l, 1.27 mM) or diapausin-2 (2.8 l/1.9 l, 4.23 mM) was added to 200 l of yeast sample to a 
final concentration of 60 M or 40 M in a sterile 96-well plate, followed by 2-fold serial 
dilution, resulting in 60, 40, 30, 20, 15, 10, 7.5, 5, 2.5 M final concentration of diapausin-1/2. 
The plate was covered by Breathe-Easy sealing membrane (Sigma) and cultured at 30°C for 8 h, 
followed by measurement of OD600 using an Epoch2 microplate reader (BioTek). 
 Spot assay of diapausin-1 against S. cerevisiae 
An overnight culture of S. cerevisiae wildtype BY4743 cells was diluted to OD600=0.1 in 
YPD medium, followed by incubation with 0, 40, 80, 120, 160, or 200 M of sterile diapausin-1 
at 30°C. After 2, 4, 6, 8, 10 and 20 h, a 5 l of sample was collected from each treatment and 
serially diluted 5-fold. Then 2 l from each dilution was spotted onto a YPD agar plate, followed 
by incubation at 30°C for 2 days. 
 Time course microscopic observations of S. cerevisiae treated by diapausin-1 
An overnight culture of S. cerevisiae wild type BY4743 cells was diluted to OD600=1.0 in 
YPD medium, followed by mixing with 19 l of cell suspension with 1 l sterile diapausin-1 
(1.67 mM) or 1 l sterile deionized water, and incubation at 30°C. After 0, 1, 2, 3 and 4 h, a 2 l 
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sample from treatment and control was collected and applied to a 12-well glass slide. Then the 
cells were examined using a differential interference contrast microscope (ZEISS 30 B) and 
imaged by camera (AxioCam MRc5). Cells were categorized into four groups: single (a cell 
without a bud), double (a mother cell with a bud), triple (a mother cell with probably two buds) 
and cluster (with four or more cells stuck to each other). The number of cells in each group was 
counted (n>60). 
 Antifungal assay of diapausin-1 against Beauveria bassiana 
B. bassiana conidia were kindly provided by Patil Tawidian and Dr. Kristin Michel from 
the Division of Biology, KSU. Conidia were suspended in sterile medium (2% yeast extract, 2% 
sucrose) to 3.5  104/ml. Then 24 l of conidia suspension was mixed with 16 l of 5 mM sterile 
diapausin-1 in a 96-well plate, followed by 2-fold serial dilution, resulting in 400, 200, 100, 50, 
25, and 12.5 M final concentration of diapausin-1 and included a control with no diapausin-1. 
The plate was covered by Breathe-Easy sealing membrane (Sigma) and cultured at 30°C for 8 h, 
followed by examination and imaging using an inverted phase contrast microscope. Lengths of 
the germination tubes were measured by using Image J (Abràmoff et al., 2004). A conidium with 
a germination tube more than two times longer than the conidial diameter was defined as 
germinated, otherwise as non-germinated.  
 Antifungal assay of diapausin-1 and diapausin-2 against Candida 
C. albicans and C. krusei were cultured overnight in YPD medium at 30°C, followed by 
dilution to 1 106 cells/ml in YPD medium. Sterile diapausin-1 (40 l, 1.44 mM) or diapausin-2 
(40 l, 2.52 mM) were added to 200 l cell suspension in a 96-well plate to a final concentration 
of 240 M and 420 M respectively, followed by 2-fold serial dilution. The plate was incubated 
at 30°C for 8 h, and OD600 was measured using an Epoch2 microplate reader (BioTek).      
 Staining and visualization of C. albicans treated by diapausin-1 
C. albicans was cultured overnight in YPD medium at 30°C, followed by dilution to 1 
106/ml in YPD medium. In a 96-well plate, sterile diapausin-1 (2.2 l, 5.45 mM) was added to 
100 l cell suspension to a final concentration of 120 M. Sterile deionized water (2.2 l) was 
added as control, followed by incubation at 30°C. After 8 h, the cells were transferred to 1.5 ml 
centrifuge tubes and fixed in 3.7 % formaldehyde for 30 min with agitation at room temperature, 
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followed by centrifugation at 4,000 rpm for 5 min and washing twice in 600 l PBS. Then the 
cells were stained in 0.1 mg/ml Alexa Fluor® 594 conjugate of Concanavalin A (Invitrogen) for 
15 min at room temperature in the dark, followed by washing twice in 600 l PBS. The pellet 
was resuspended in 400 l PBS, and 2 l cell suspension was mounted on one well in a 12-well 
glass slide with fluoromount-G (Southern Biotech). Examination of fluorescence was performed 
using an LSM airyscan 880 microscope.     
 Labeling of diapausin-1 with FITC 
Recombinant diapausin-1 (500 l, 11 mg/ml) or BSA (500 l, 11 mg/ml) were incubated 
with 100 l of 10 mg/ml fluorescein isothiocyanate (FITC, Sigma) in 0.1 M sodium bicarbonate, 
pH 9.0 for 1 h at room temperature in the dark. SephadexTM G-25 (Amersham Bioscience AB) 
was swelled in water and packed in an Econo column (17 cm). The protein-FITC was applied 
to the column and 1 ml fractions were collected. The fractions were analyzed by measuring 
OD280 and OD494. The concentration of the labeled protein and degree of labeling were 
calculated according to the manufacturer’s manual. 
 Staining and visualization of S. cerevisiae by ConA-Alexa Fluor 594, calcofluor 
white M2R, and FITC-diapausin-1 
This experiment was based on the protocol from Okada and Ohya (Okada and Ohya, 
2016) with modifications. An overnight culture of S. cerevisiae wildtype BY4743 cells was 
diluted to OD600=1.0 in YPD medium. The cell suspension (38 l) was incubated with 2 l 
sterile deionized water/FITC-BSA (11mg/ml)/FITC-diapausin-1 (11mg/ml) at 30°C. After 2 h, 
the cells were collected by centrifugation and washed twice in sterile deionized water. The cells 
were resuspended and incubated with sterile 2.5 mg/ml fluorescent brightener 28 (synonym: 
calcofluor white M2R; Sigma) at room temperature for 10 min in the dark. The cells were 
collected by centrifugation, washed twice in sterile PBS and incubated with sterile 0.1 mg/ml 
Alexa Fluor® 594 conjugate of Concanavalin A (Invitrogen) for 10 min at room temperature in 
the dark, followed by washing twice in sterile PBS. Cells were resuspended in 40 l sterile PBS 
and examined in 35 mm dishes (MatTek) using an LSM airyscan 880 microscope.    
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 Cell wall components pull-down assay 
Curdlan (from Alcaligenes faecalis; Sigma), zymosan (from Saccharomyces cerevisiae; 
Sigma), chitin (from shrimp shell; Sigma), starch (from wheat; MGP, Midsol 50), and 
peptidoglycan (from Micrococcus luteus; Sigma) were each suspended in 10 mM sodium 
phosphate, pH 7.4 to a final concentration of 5 mg/ml. Each polysaccharide (20 l) was 
incubated with 0.5 g/ml recombinant diapausin-1 or diapausin-2 at room temperature for 10 
min, followed by centrifugation at 14,000 rpm for 5 min and collection of supernatant as 
unbound fraction. Pellets were washed with 50 l buffer (10 mM sodium phosphate, pH 7.4), 
followed by centrifugation at 14,000 rpm for 5 min and collection of supernatant. Each pellet 
was mixed with 20 l 2SDS loading buffer supplemented with -mercaptoethanol and heated at 
95°C for 5 min, followed by centrifugation at 14,000 rpm for 5 min and collection of supernatant 
as elution fraction. Unbound (20 l), wash (20 l) and elution fractions (20 l) were analyzed 
with SDS-PAGE as described above.  
 Morphological changes of S. cerevisiae induced by diapausin-1 
This experiment was based on the protocol from Okada and Ohya (Okada and Ohya, 
2016) with modifications. An overnight culture of S. cerevisiae wildtype BY4741 cells was 
diluted to OD600=1.0 in YPD medium. Cell suspension (19 l) was incubated with 1 l sterile 
recombinant diapausin-1 (1.67 mM) or 1 l sterile deionized water at 30°C for 2 h, followed by 
fixation in 3.7% formaldehyde at room temperature for 30 min. The cells were collected by 
centrifugation and washed twice in sterile PBS. Then the pellet was resuspended and incubated 
with 0.1 mg/ml Alexa Fluor® 594 conjugate of Concanavalin A (Invitrogen) for 10 min at room 
temperature in the dark, followed by washing twice in sterile PBS. Cells were resuspended in 40 
l sterile PBS, and 2 l cell suspension was mounted in one well in a 12-well glass slide with 
fluoromount-G (Southern Biotech). Examination of fluorescence was performed by using an 
LSM airyscan 880 microscope. Pictures (696520 pixel size) were processed to grayscale (256 
gradation) and 8- bit depth using Zen and Photoshop. CalMorph 2.0 was used to quantify the 
parameters relevant to cell shape (Ohya et al., 2005). Triplicates were performed with more than 
490 cells being analyzed in each replicate. Wilcoxon rank-sum test (synonym: Mann–Whitney U 
test) (Nachar 2008) was performed to test whether there was a significant difference between 
control and diapausin-1-treated yeast cells regarding each parameter given by CalMorph. Violin 
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plots, which display the kernel density along the vertical axis, were made by jjplot for those 
parameters which had significant differences (p<0.05) between control and diapausin-1 
treatment. 
 Search of single gene deletion mutants with “clover” phenotype 
Diapausin-1disrupted the S. cerevisiae daughter cell separation after cell division, 
resulting in cell clusters after a few cell cycles. This “clover” phenotype was observed frequently 
after 2 h (1-2 cell cycles) treatment with diapausin-1, so we were seeking to find yeast mutants 
with similar “clover” phenotype. Saccharomyces Cerevisiae Morphological Database 
(https://scmd.gi.k.u-tokyo.ac.jp/datamine/) provides photos from 4782 haploid MATa strains 
with single non-essential gene deletions. Photos of S. cerevisiae mutants with deleted genes that 
are required for cell wall polymer synthesis/remodeling and in cell wall relevant Gene Ontology 
(GO) terms (GO:0006075, (1->3)-beta-D-glucan biosynthetic process; GO: 0005199, structural 
constituent of cell wall; GO: 0042546, cell wall biogenesis; GO: 0097271, protein localization to 
bud neck; GO: 0070880, fungal-type cell wall beta-glucan biosynthetic process; GO: 0009986, 
cell surface; GO: 0009272, fungal-type cell wall biogenesis; GO: 0031505, fungal-type cell wall 
organization) were screened visually for a high proportion of “clover” cell clusters.  
 Results 
 Diapausin-1 and diapausin-2 homology models 
To examine a predicted three-dimensional structure of M. sexta diapausins, we produced 
homology models for diapausin-1 and diapausin-2. The top threading templates used by I-
TASSER to model diapausin-1 and diapausin-2 was diapausin-specific peptide (DSP) (PDB ID: 
2E2F) from Gastrophysa atrocyanea, which also belongs to diapausin family of antimicrobial 
peptides (Kouno et al., 2007; Tanaka et al., 2003). The homology models of diapausin-1 and 
diapausin-2 have three disulfide bonds to stabilize the compact structure comprised of two -
helices and two -strands (Fig. 4-1A). The arrangement of the disulfide bonds is consistent with 
that in GaDSP (Kouno et al., 2007), but different from defensins or drosomycin (Yi et al., 2014; 
Landon et al., 1997). Diapausin-1 has four more neutral amino acid residues at the amino-
terminus and two more arginines at the carboxyl-terminus compared to diapausin-2 (Fig. 4-1B). 
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 Expression and purification of diapausin-1 and diapausin-2 
Recombinant diapausin-1 and diapausin-2 were expressed with an amino-terminal 6His-
GB1 tag, which was removed by TEV protease after NiNTA chromatography. The trials in small 
batches (20 l) of TEV processing took 1-2 days to show complete cleavage between the 6His-
GB1 tag and diapausin. However, complete processing of 6His-GB1-diapausin-2 with TEV in 
large batches (1 ml) required 7 days. Mass spectrometry indicated the actual cleavage site on 
6His-GB1-diapausin-2 during TEV processing was 3 residues away from expected site (Fig. 4-
2A, Fig. C-1). This unexpected cleavage shift might be caused by contaminating proteases which 
were not successfully removed during NiNTA column and the long reaction time. The fusion 
6His-GB1-diapausin-1 was properly processed by TEV according to MS data (Fig 4-2A, Fig. C-
1). I used NiNTA chromatography attempting to retain the 6His-GB1 tag and collect diapausins 
after TEV processing, but the tag did not bind to column. Unexpected protease processing might 
have occurred to 6His-GB1 tag by removing 6His, resulting in reduced affinity to the NiNTA 
column. Therefore, a UnoQ1 ion exchange column was utilized for separating the tag from 
diapausins (Fig 4-2B). The yield of recombinant diapausin-1 was 4.5 mg, and diapausin-2 was 
0.37 mg from 1 L bacterial culture. 
 Antifungal activities of diapausins against S. cerevisiae, B. bassiana and Candida 
Recombinant diapausin-1 and diapausin-2 exhibited antifungal activity against a S. 
cerevisiae wildtype strain in a dose dependent manner, with IC50 of 30 M and 60 M, 
respectively based on optical density measurement (Fig. 4-3A). A colony spot assay was 
performed with S. cerevisiae after 2, 4, 6, 8, 10 and 20 h treatment with recombinant diapausin-1 
at various concentrations, as well as 0 h at 0 M diapausin-1 as control (Fig. 4-3B). All treatment 
samples demonstrated a comparable or higher colony densities on the plate compared to control 
(0 h at 0 M diapausin-1). The treatment of S. cerevisiae with diapausin-1 apparently caused the 
inhibition of cell growth, rather than cell death.  
It was previously reported that diapausin-1 did not have antifungal activity against B. 
bassiana, an entomopathogenic fungus (Al Souhail et al., 2016). But this result may have been 
due to the limitation of the assay using measurement by optical density. Therefore, I used 
measurement of the germination tube length for anti-B. bassiana assay (Fig. 4-4). 82% of conidia 
germinated in the absence of diapausin-1 after 8 h, but germination was reduced in a dose-
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dependent manner in the presence of diapausin-1 (Fig. 4-4). Only 32% conidia were germinated 
in the medium supplemented with 200 M diapausin-1 after 8 h. The growth of germination 
tubes was impaired by diapausin-1 as well. The median length of germination tubes reduced 
from 16 m to 7 m when concentration of diapasuin-1 increased from 0 M to 200 M (Fig. 4-
4).  
 Antifungal activity of diapausins was also determined against C. albicans and C. krusei, 
which are human pathogenic fungi. In YPD medium, the growth of C. albicans and C. krusei 
was inhibited by recombinant diapausin-1 with IC50 of 60 M and 20 M respectively (Fig. 4-5). 
Inhibitory activity of recombinant diapausin-2 against C. albicans and C. krusei was less potent 
than that of diapausin-1, with IC50 of 240 M and >600 M respectively (Fig. 4-5). 
 Diapausin-1 binds to the S. cerevisiae cell surface, likely to -1,3-glucan 
Recombinant diapausin-1was labeled with FITC and incubated with S. cerevisiae. 
Calcofluor white M2R and Alexa Fluor® 594 conjugate of Con-A were used to stain chitin and 
mannoproteins, respectively on the cell wall (Fig. 4-6). FITC-diapausin-1 only appeared at the 
surface of the yeast cells, with an even appearance similar to mannoprotein labeling. In contrast, 
chitin appeared mostly at bud necks of dividing yeast. FITC-BSA as a control did not label the 
yeast (Fig. 4-6). This result indicates that diapausin-1 likely binds to a component on the surface 
of yeast cells and does not enter the cells. 
To further investigate the potential molecule on the cell wall that might bind to diapausin, 
a pull-down assay was performed to test binding of diapausin to different fungal cell wall 
components, bacterial peptidoglycan, and starch as a polysaccharide control (Fig. 4-7, Fig. C-2). 
Recombinant diapausin-1 was present predominantly in the unbound fraction from chitin (-1,4-
N-acetylglucosamine), starch (α-1,4-glucose with α-1,6 branches), and peptidoglycan 
(alternating N-acetylglucosamine and N-acetylmuramic acid with peptide chain crosslinking), 
indicating little affinity of diapausin-1 to those polysaccharides or peptidoglycan (Fig. 4-7). In 
contrast, curdlan (-1,3-glucan) from Alcaligenes faecalis and zymosan (-1,3-glucan) from S. 
cerevisiae retained diapausin-1 until elution with SDS (Fig. 4-7). Recombinant diapausin-2 
exhibited the same results (Fig. C-2). These results suggest that diapausins bind specifically to -
1,3-glucans in fungal cell walls. We also intended to test -1,3-glucan as the target of diapausin-
1 by using mutants of FKS1, a gene encoding -1,3-glucan synthase catalytic subunit (Nogami 
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and Ohya, 2009). However, the growth of both homozygous fks1/fks1 and heterozygous 
FKS1/fks1 yeast was still inhibited by 80 M diapausin-1 after 24 h (Fig. C-3), probably due to 
the presence of -1,3-glucan synthesized by redundant homologous genes FKS2 and FKS3.  
 Failure of cell separation after cell division caused by diapausin-1 
S. cerevisiae yeast cells were incubated with recombinant diapausin-1 and examined 
using differential interference contrast (DIC) microscopy every hour. Control yeast cells in YPD 
medium are rich in double-cell form with a mother cell and a bud (>60%), which is consistent 
with proportions of double-cell appearance in the active cell cycle (Hartwell 1974). In contrast, 
after 1 h incubation with diapausin-1, a triple-cell form was frequently seen, and after 2 h cell 
clusters started to dominate (Fig. 4-8). After incubation with 80 M diapausin-1 for 4 h, nearly 
90% of yeast cells were in cell clusters. In contrast, yeast cells did not display prevalent 
abnormal triple-cell form or clumps when treated by diapausin-1 in YP medium, which limits the 
cell growth due to lack of carbon source (Fig. C-4). Recombinant diapausin-1 was also incubated 
with S. cerevisiae strain GFY-42 with mCherry-labeled Cdc10p, which is one of the septins 
mediating cytokinesis and cell septation (Finnigan et al., 2015). The control in absence of 
diapausin-1 had typical dividing cells, with mCherry-Cdc10p localized at the bud neck between a 
mother cell and a budding daughter cell (Fig. C-5). However, diapausin-1 treatment caused a 
frequent triple-cell form with a single mCherry-Cdc10p labeled septum between two of the cells 
(Fig. C-5), implying no concurrence of the cell cycle in the triple-cell form. These observations 
verified that the appearance of the triple-cell form and cell clusters was the consequence of failed 
cell separation after completion of cytokinesis. Cell clusters were also observed in C. albicans 
treated with diapausin-1, as well as abnormal cell swelling (Fig. 4-9), which is often seen with 
drugs affecting the cell wall (Okada et al., 2014).  
 Morphological changes of S. cerevisiae caused by diapausin-1  
Phenotypic analysis was carried out on control and diapausin-1-treated S. cerevisiae 
(BY4741) cells by utilizing CalMorph, a software package for quantification of yeast cell 
morphology (Fig. 4-10) (Ohya et al., 2005). Parameters describing mother cell, daughter cell and 
the overall cell shape were output for every individual cell (Table 4-1, Fig. C-6). Cells in control 
and diapausin-1 treatment had significant differences regarding 20/24 parameters. In mother 
cells, diapausin-1 treatment caused a longer long axis, shorter short axis and less elliptical shape 
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(Fig. 4-11A). In daughter cells, the long axis was shorter, short axis was longer and overall size 
was smaller in the presence of diapausin-1 (Fig. 4-11B). The ratio of daughter cell size to mother 
cell size was decreased, and the neck was wider in diapausin treatment compared with control 
(Fig. 4-11C). Overall, the morphometric analysis revealed that diapausin-1 caused appearance of 
an elongated mother cell with a flattened bud and wider neck, as well as less elliptical shape 
(Fig. 4-11D). 
We performed morphological comparison of diapausin-1-treated S. cerevisiae with single 
gene deletion mutants in the Saccharomyces Cerevisiae Morphological Database (SCMD), 
aiming to find mutants with similar morphology, which might provide hints of diapausin-1 mode 
of action. However, not much valuable information resulted from this method (data not shown). 
This strategy was originally developed to screen target genes of antifungal drugs with no 
evidence of modes of action, based on correlation between morphological phenotypes and gene 
functions (Ohya et al., 2005). Since we were aware that diapausin-1 interacts with the cell 
surface without penetrating into the cell cytosol, the genes which are involved in cell wall 
biogenesis and maintenance are of interest in the study of the mode of action of diapausin-1. 
Considering the observation of cell clusters caused by diapausin-1, I screened by visual 
inspection of available micrographs the mutants deficient in cell-wall associated genes for those 
exhibiting triple-cell forms (“clover-like”) (Table 4-2). Additionally, Pearson’s chi-square test 
indicated SWA2, SWI4 and GUP1 with the similar bud size distribution in diapasuin-1-treated 
yeast cells (Table 4-3). Of note, these three mutants also display frequent triple-cell forms.  
 Discussion 
In response to invading bacteria, fungi, and parasites in the hemolymph, insects transduce 
the message to nuclei and trigger the synthesis of AMPs as effectors to eliminate foreign 
microbes (Yi et al., 2014). Most insect AMPs were characterized with antibacterial activity, 
while some of them also have antifungal activity (Faruck et al., 2016). Only a few AMPs were 
previously reported to have fungi-specific activity (Landon et al., 1997; Lamberty et al., 1999; 
Schuhmann et al., 2003; Lee et al., 2004; Al Souhail et al., 2016; Wang et al., 2013). These 
antifungal specific peptides all have cysteine-stabilized alpha beta structure (CSαβ). Galleria 
defensin, gallerimycin, heliomycin and Btdef have a conserved defensin structure composed of 
one -helix and an antiparallel -sheet, with six cysteines forming three disulfide bridges as 
122 
follows: Cys (1)-Cys (4), Cys (2)-Cys (5) and Cys (3)-Cys (6) (Lamberty et al., 1999; 
Schuhmann et al., 2003; Lee et al., 2004). Drosomycin contains eight cysteines with four 
disulfide bonds, Cys (1)-Cys (8), Cys (5)-Cys (5), Cys (3)-Cys (6), and Cys (4)-Cys (7) (Landon 
et al., 1997). Based on GaDSP structure (Kouno et al., 2007), M. sexta diapausins were predicted 
to have a disulfide array as following: Cys (1)-Cys (3), Cys (2)-Cys (5) and Cys (4)-Cys (6), a 
topology different from the CSαβ structures mentioned above (Fig. 4-1).   
Antifungal activity of recombinant diapausins against S. cerevisiae and Candida species 
was measured in YPD growth medium and expressed as IC50. Recombinant diapausin-1 was 
more potent than diapausin-2 against Saccharomycetes with IC50 of 20-60 M (Fig. 4-3, 4-5), a 
higher concentration than some anti-Saccharomycetes peptides. Heliomicin has minimun 
inhibitory concentration (MIC) of 2.5-5 M against C. albicans and C. neoformans (Lamberty et 
al., 1999), drosomycins have IC50 of 1.5-12 M against S. cerevisiae and Geotrichum candidum 
(Fehlbaum et al., 1994; Tian et al., 2008), Galleria defensin has MIC of 1.6-50 M against C. 
albicans, G. candidum and C. neoformans (Lee et al., 2004). Btdef has MIC of 1.9-7.6 M 
against C. albicans and Pichia pastoris (Wang et al., 2013). Heliomicin and gallerimycin did not 
show any inhibitory activity against S. cerevisiae up to 50 M (Lamberty et al., 1999; Lee et al., 
2004).  
Previously it was thought that diapausin-1 did not have activity against B. bassiana, an 
entomopathogenic fungus (Al Souhail et al., 2016). But this was probably due to the limitation of 
measurement by optical density as an assay. Therefore, I measured germination ratio and length 
of germination tubes of B. bassiana and found that recombinant diapausin-1 inhibited the 
germination and growth of germination tubes (Fig. 4-4). Btdef showed strong activity against B. 
bassiana with IC50 of 0.48 M and germination rate was 0% after 24 h incubation with 0.96 M 
Btdef (Wang et al., 2013). In contrast, diapausin-1 demonstrated less potency against B. bassiana 
with 31% germination rate caused by 200 M diapausin-1 (Fig. 4-4).  
Diapausin-1 showed activity against fungi tested in this work, but did not show evidence 
of fungi killing (Fig. 4-3). Viability of blastospores from the entomopathogenic fungi 
Metarhizium anistropliae was 55% after the treatment of 50 M Btdef (Schuhmann et al., 2003). 
But viability data is lacking for other fungi-specific AMPs. Those peptides with both 
antibacterial and antifungal activity likely cause cell death by interrupting the integrity of the cell 
membrane and subsequent cell leakage (Faruck et al., 2016). The observation of cell growth 
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inhibition without causing significant cell death suggests that diapausin-1 does not disrupt the 
cell membrane integrity. 
Distortion of S. cerevisiae cell shape occurred upon diapausin-1 treatment (Table. 4-1), 
probably due to binding of diapausin-1 to -1,3-glucan on the cell wall. The median neck width 
in diapausin-1 treated yeast cells is 1.68 m, significantly greater than 1.51 m in control cells 
(Table 4-1). Of note, wider neck was reported as a common phenotype induced by wall-
associated drugs, such as echinocandin B, tunicamycin, and nikkomycin Z (Okada et al., 2014).  
Recombinant diapausins showed affinity to -1,3 glucan, which is the major component 
for ascomycete cell walls (Fig. 4-7). Poacic acid, a diferulate found primarily in grasses 
(Poaceae), also showed binding to -1,3 glucan and inhibited the incorporation of -1,3 glucan 
into cell wall (Piotrowski et al., 2015). Other targets might be involved in poacic acid activity, 
considering the observation of rapid cell leakage caused by poacic acid (Piotrowski et al., 2015). 
Binding to cell wall components occurs with some non-insect antifungal peptides and is always 
associated with further actions. Histatin-5 discovered in humans specifically binds to cell wall 
proteins Ssa1/2, followed by cell membrane permeabilization and subsequent intracellular 
actions leading to mitochondrial depletion and induction of reactive oxygen species (Li et al., 
2003; Vylkova et al., 2006; Helmerhorst et al., 2001). NaD1 from tobacco anchors to 
mannoproteins on the cell wall, which is necessary for further interaction with PIP2 on the cell 
membrane and subsequent cell lysis (van der Weerden et al., 2010; Payne et al., 2016). Rather 
than cell permeabilization, blocking the cell separation after cell division was observed as the 
direct effect triggered by M. sexta diapausin (Fig. 4-8, 4-9). By looking through the morphology 
of 214 mutants of cell wall biogenesis and maintenance-related genes in SCMD, I found a few 
genes whose absence leads to a “clover”-like phenotype, suggesting the inefficient cell 
separation (Table 4-2). Additionally, the mutants that showed similar bud size distribution with 
diapausin-1-treated cells, exhibit “clover”-like phenotype as well (Table 4-3). By taking 
advantage of the correlation between phenotype and gene function, diapausin-1 mode of action 
might be relevant to these gene products, whose gene deletion manifests “clover”-like cell cluster 
morphology.  
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 Future Directions 
Characterization of M. sexta antifungal peptide, diapausin, regarding activity and 
morphology leads to some open questions for the future study: 
(1) Antifungal activity of recombinant diapausin-2 was not potent, which was probably 
caused by incorrect TEV cleavage or wrong disulfide bonds formed in E. coli. Future 
purification could include the verification of the correct disulfide bond pattern. If the inefficiency 
did not come from incorrect disulfide bonds, it would be interesting to look at the different 
amino acid residues between diapausin-1 and diapausin-2, especially the longer N- and C-
terminal parts in diapausin-1.  
(2) The abundance of -1,3-glucan varies among different fungal Divisions. For example, 
zygomycota and chytridiomycota cell wall is rich in chitin and chitosan (Faruck et al., 2016). 
Testing antifungal activity of diapausins against non-ascomycete fungi is another direction that 
should be pursued.  
(3) Binding of diapausin-1 to -1,3-glucan is worth further study. The N-terminal binding 
domain of Plodia interpunctella and M. sexta GRP interacts with laminarihexaoses through 
side chains of Agr29, D49, Y78 and R87 on the -sheet (Kanagawa et al., 2011; Takahashi et al., 
2014). A glycoside hydrolase family 149 protein Pro_7066 was revealed to form hydrogen bonds 
with laminarihexaoses through side chains of K831, E838, E990, E994 E982, and R1062 
(Kuhaudomlarp et al., 2019). Electrostatic interactions in glucan binding was believed to be 
critical (Takahashi et al., 2014). Therefore, several charged resides in diapausins, especially a 
two-arginine C-terminal tail in diapausin-1, might be responsible for glucan binding. 
(4) Synergistic effects can be test by using diapausin-1 with other antifungal peptides. 
(5) Information of deleted genes in the mutants with “clover”-like phenotype was 
collected from Saccharomyces Genome Database and I notice three genes (DSE2, EGT2 and 
SCW3) encode glucanase/glucanase-like proteins, which might participate in septum degradation 
(Lesage and Bussey, 2006; Mouassite et al., 2000). Two of them (OCH1, ANP1 and MNN10) 
encode enzymes critical for N-mannosylation (Nakanishi-Shindo et al., 1993; Nakayama et al., 
1992). SWI4 and SWI5 are transcription factors associated with cell cycle regulation (Harrington 
and Andrews 1996; Cosma et al., 1999). GAS1 encodes a GPI-anchored β-1,3-glucan elongase 
(Tomishige et al., 2003). It is interesting to test whether diapausin-1 interferes with glucan 
degradation during cell septation. 
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Figure 4-1. Structural models of M. sexta diapausins. 
(A) I-TASSER homology models of diapausin-1 and diapausin-2 were made using DSP from 
Gastrophysa atrocyanea (PDB ID: 2E2F) as template. Three disulfide bonds formed by six 
cysteins are indicated in each model. (B) Sequence alignment of diapausin-1 and diapausin-2 
with identical amino acid residues highlighted. Secondary structures are marked above 
corresponding sequence: loop (green line), α-helix (red curled line), and β-strand (yellow arrow). 
Disulfide bridges are indicated by blue brackets, and cystines forming disulfide bonds are in 
blue.  
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Figure 4-2. Purification of recombinant diapausin-1 and diapausin-2. 
(A) Sequences of fusion 6His-GB1-diapausin-1 and 6His-GB1-diapausin-2 are shown with 
diapausin-1 and diapausin-2 sequences underlined. The sizes of 6His-GB1 tag and diapausins are 
illustrated by cartoon. The TEV protease recognition site is highlighted in green, TEV theoretical 
cleavage site is indicated with red arrow and actual cleavage site in indicated with purple arrow. 
(B) Fusion 6His-GB1-diapausins were processed by TEV protease and further purified by ion 
exchange chromatography. Samples with reducing SDS loading buffer were subjected to 4-12% 
Bis-Tris NuPAGE gel, followed by Instant Blue staining.  
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Figure 4-3. Antifungal activity of diapausins against S. cerevisiae. 
(A) OD600 was measured after 8 h of incubation of recombinant diapausin-1/2 with yeast cells at 
different diapausin concentrations. IC50 values of recombinant diapausin-1 and diapausin-2 
against S. cerevisiae are 30 M and 60 M, respectively. (B) Spot assay was performed with 5-
fold serial dilutions after 2, 4, 6, 8, 10, and 20 h treatment of yeast cells with various 
concentrations of recombinant diapausin-1 prior to spotting on the plate. Control (0 M) was 
spotted at 0 h. Pictures of plates were scanned after 2 days of incubation at 30°C.
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Figure 4-4. Inhibition of germination and hyphal growth of B. bassiana by diapausin-1. 
B. bassiana conidia (3.5  104/ml) were incubated with recombinant diapausin-1 at different 
concentrations at 30°C for 8 h. (A) The percentage of conidia germinated was calculated and 
marked above the figure. Median and interquartile range of lengths of germination tubes are 
indicated in red (n=131, 110, 97, 77, 55, 51). Results of statistical analysis (Kruskal-Wallis test 
followed by Dunns multiple comparison test, p<0.05) are indicated with different letters. (B) 
Representative pictures show the conidial status in the presence of diapausin-1 at different 
concentrations.  
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Figure 4-5. Antifungal activity of diapausins against Candida species.  
Recombinant diapausin-1 or diapausin-2 at different concentrations were incubated with C. 
albicans and C. krusei at 30°C for 8 h in YPD medium, followed by measurement of OD600. The 
growth of C. albicans and C. krusei was inhibited by recombinant diapausin-1 with IC50 of 60 
M and 20 M respectively, and by diapausin-2 with IC50 of 240 M and >600 M respectively.  
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Figure 4-6. FITC-diapausin-1 binds to yeast cell surface.  
Wildtype S. cerevisiae cells were incubated with 80 M FITC-diapausin-1 and FITC-BSA at 30°C for 2 h, respectively, followed by 
staining with Alexa Fluor 594-ConA to label mannoproteins and calcofluor white M2R to mark chitin on the cell wall. Pictures were 
obtained using an LSM airyscan 880 microscope. 
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Figure 4-7. Binding of recombinant diapausin-1 to -1,3-glucan. 
Recombinant diapausin-1 (10 ng) was incubated with 100 g polysaccharides (curdlan, zymosan, 
chitin, starch and peptidoglycan) at room temperature for 10 min in 1.5 ml centrifuge tubes. 
Supernatant was collected as unbound (UB) fraction by centrifugation. The polysaccharides were 
washed with 10 mM sodium phosphate, pH 7.4 and subjected to centrifugation for collecting 
supernatant as wash (W) fraction. Bound diapausin-1 was eluted by heating the polysaccharides 
in 2SDS loading buffer supplemented with -mercaptoethanol at 95°C for 5 min and collecting 
the supernatant as elution (E) fraction after centrifugation. Each fraction with reducing SDS 
loading buffer was subjected to 4-12% Bis-Tris NuPAGE gel, followed by Instant Blue staining. 
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Figure 4-8. Time course microscopic observations of S. cerevisiae treated by diapausin-1. 
Wildtype S. cerevisiae cells were incubated with recombinant diapausin-1 (80 M) or sterile water as a control at 30°C. Cells were 
observed after 0, 1, 2, 3 and 4 h of incubation using a DIC microscope and captured by camera. The number of single (a cell without a 
bud), double (a mother cell with a bud), triple (a mother cell with probably two buds) and cluster (with four or more cells sticking to 
each other) was counted in each sample (n>74) and reflected by percentage in bar graph. 
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Figure 4-9. Microscopic observations of C. albicans caused by diapausin-1. 
C. albicans cells were incubated in YPD medium with recombinant diapausin-1 (80 M) or 
sterile water as a control at 30°C for 8 h, followed by fixation in 3.7% formaldehyde and staining 
with Alexa Fluor 594-ConA. Pictures were obtained using an LSM airyscan 880 microscope. 
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Figure 4-10. Demonstration of morphological analysis of S. cerevisiae caused by 
diapausin-1. 
S. cerevisiae wildtype BY4741 cells were incubated with 80 M diapausin-1 or sterile water as a 
control at 30°C for 2 h, followed by fixation in 3.7% formaldehyde and staining with Alexa 
Fluor 594-ConA. Pictures were obtained using an LSM airyscan 880 microscope, followed by 
morphological quantification of yeast cells using CalMorph (n>490). Difference between control 
and diapausin-1-treated yeast cells regarding each parameter was tested by Wilcoxon rank-sum 
test. An example picture of morphological quantification by CalMorph was shown.
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Figure 4-11. Morphological changes of S. cerevisiae caused by diapausin-1. 
Morphological parameters in mother cell (A), bud (B) and other (C), which have significant difference (p<0.05) between control 
(sterile H2O treatment) and diapausin-1 treatment are shown using violin plots. (D) A sketch of general morphological differences of 
control and diapausin-1-treated yeast cells. 
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 Tables 
Table 4-1. Morphological analysis of S. cerevisiae cells treated with diapausin-1. 
Morphology of control (sterile H2O treatment) and diapausin-1-treated cells was quantified by CalMorph by measuring parameters 
listed below. Parameters which have significant difference (p<0.05; Wilcoxon rank-sum test) between control and diapausin-1 
treatment are in red. 
parameter control diapausin-1 p value definition of parameter 
median interquartile median interquartile 
C11-1 14.465 4.127 14.490 3.566 0.05219243 mother cell size (m2) 
C11-2 7.264 6.382 7.220 4.574 0.0015091 bud cell size (m2) 
C12-1 12.893 1.981 12.614 1.813 1.24E-05 mother cell circumference (m) 
C12-2 8.397 4.616 8.172 3.141 2.52E-07 bud cell circumference (m) 
C13 6.103E-05 4.656E-05 6.855E-05 6.006E-05 5.03E-10 order of the elliptical approximation of mother cell 
C101 18.850 9.778 20.399 7.976 5.69E-07 whole cell size (m2) 
C102 18.738 8.032 19.992 5.636 1.89E-05 whole cell outline length (m) 
C103 4.718 0.736 4.841 0.643 4.09E-16 long axis length in mother cell (m) 
C104 3.733 0.570 3.653 0.511 2.37E-05 short axis length in mother cell (m) 
C105 28.794 24.020 28.926 21.693 0.2667755 neck position (°) 
C106 43.141 32.632 40.903 30.928 0.00070258 bud direction (°) 
C107 3.094 1.674 2.843 1.007 3.37E-16 long axis length in bud (m) 
C108 2.985 1.110 3.138 0.950 1.62E-05 short axis length in bud (m) 
C109 1.511 0.299 1.685 0.235 8.09E-96 neck width (m) 
C110 2.873 2.231 2.683 1.686 1.57E-05 distance between bud tip and mother long axis extension (m) 
C111 3.648 1.977 3.834 1.787 0.42192479 distance between bud tip and mother short axis extension (m) 
C112 2.160 0.336 2.160 0.303 0.86131183 distance between middle point of neck and mother center (m) 
C113 4.540 1.845 4.386 1.331 5.17E-05 distance between bud tip and mother long axis through middle point of neck (m) 
C114 1.026 0.174 0.914 0.125 1.51E-106 bud axis ratio 
C115 1.244 0.150 1.303 0.160 4.00E-42 mother axis ratio 
C116 0.821 0.174 0.701 0.123 3.66E-114 axis ratio ratio 
C117 0.674 0.325 0.632 0.222 1.23E-05 cell outline ratio 
C118 0.498 0.377 0.453 0.265 0.00088629 cell size ratio 
C128 4.450 0.625 4.492 0.555 0.002436651 distance between middle point of neck and mother hip (m) 
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Table 4-2. Mutants with “clover” phenotype. 
systematic name gene name description of the gene product (from Saccharomyces Genome Database) 
YDR245w  MNN10 Subunit of a Golgi mannosyltransferase complex; complex mediates elongation of the polysaccharide mannan 
backbone; membrane protein of the mannosyltransferase family; other members of the complex are Anp1p, 
Mnn9p, Mnn11p, and Hoc1p 
YEL036c ANP1 Subunit of the alpha-1,6 mannosyltransferase complex; type II membrane protein; has a role in retention of 
glycosyltransferases in the Golgi; involved in osmotic sensitivity and resistance to aminonitrophenyl 
propanediol 
YHR143w  DSE2 Daughter cell-specific secreted protein with similarity to glucanases; degrades cell wall from the daughter side 
causing daughter to separate from mother; expression is repressed by cAMP; encodes a putative GPI-
anchored cell surface protein 
YMR307w  GAS1 Beta-1,3-glucanosyltransferase; required for cell wall assembly and also has a role in transcriptional silencing; 
localizes to cell surface via a glycosylphosphatidylinositol (GPI) anchor; also found at nuclear periphery; 
genetic interactions with histone H3 lysine acetyltransferases GCN5 and SAS3 indicate previously unsuspected 
functions for Gas1 in DNA damage response and cell cycle regulation. 
YNL327w  EGT2 Glycosylphosphatidylinositol (GPI)-anchored cell wall endoglucanase; required for proper cell separation after 
cytokinesis; expression is activated by Swi5p and tightly regulated in a cell cycle-dependent manner 
YNL066w SCW3 Cell wall protein related to glucanases; possibly involved in cell wall septation; member of the SUN family; 
SUN4 has a paralog, SIM1, that arose from the whole genome duplication 
YDR146c  SWI5 Transcription factor that recruits Mediator and Swi/Snf complexes; activates transcription of genes expressed 
at the M/G1 phase boundary and in G1 phase; required for expression of the HO gene controlling mating type 
switching; localization to nucleus occurs during G1 and appears to be regulated by phosphorylation by Cdc28p 
kinase; SWI5 has a paralog, ACE2, that arose from the whole genome duplication 
YLR038c  OCH1 Och1, α-1,6-manno-syltransferase catalyzes the transfer of a mannose residue to the Man8GlcNAc2 structure. 
Glycoproteins produced by a null och1 mutant lack α-1,6-polymannose, indicating that the addition of this 
initial mannose residue is critical for other reactions to take place and/or that Och1 is involved in the catalysis 
of subsequent α-1,6 linkages 
YNL233w BNI4 Targeting subunit for Glc7p protein phosphatase; localized to the bud neck, required for localization of chitin 
synthase III to the bud neck via interaction with the chitin synthase III regulatory subunit Skt5p; 
phosphorylation by Slt2p and Kss1p involved in regulating Bni4p in septum assembly 
YPL158c  AIM44/GPS1 Protein that regulates Cdc42p and Rho1p; functions in the late steps of cytokinesis and cell separation; 
sustains Rho1p at the cell division site after actomyosin ring contraction; inhibits the activation of Cdc42-Cla4 
at the cell division site to prevent budding inside the old bud neck; transcription is regulated by Swi5p; null 
mutant displays elevated frequency of mitochondrial genome loss; relocalizes from bud neck to cytoplasm 
upon DNA replication stress 
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Table 4-3. Mutants with similar bud size distributions in diapausin-1-treated cells. 
Cells were categorized to “no bud” (a single cell without bud), “small bud” (0<bud size/mother cell size<0.5), “medium bud” 
(0.5bud size/mother cell size<0.7), “large bud” (0.7bud size/mother cell size), and “complex” (too complicated to be analyzed by 
CalMorph). Pearson’s chi-square test was performed between diapausin-1 treatment and mutants provided by SCMD regarding bud 
size distribution. Listed three mutants don’t have significant difference with diapausin-1 treatment (p<0.05). 
 no bud small bud medium bud large bud complex 
diapausin-1-treated 14.20% 17.62%  31.55%  36.62%  28.6%  
YDR320c (SWA2) 15.79% 12.75% 23.89% 23.48% 24.09% 
YER111c (SWI4) 13.18% 15.19% 13.47% 32.66% 25.50% 
YGL084c (GUP1) 13.91% 11.26% 13.91% 31.12% 29.80% 
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Figure B-1. Complete sequence alignment of M. sexta serpin proteins.  
Conserved amino acid residues in regions that are critical for the inhibition mechanism (Irving et 
al., 2000) are highlighted. Residues conserved in the shutter region are in blue, residues 
conserved in the breach region are in yellow, residues conserved in the hinge region are in green, 
residues conserved in the gate region are in magenta and other conserved residues are in grey. 
Predicted secondary structures, α-helix and β-strand, and reactive center loop (RCL) marked 
above the sequences are based on crystal structures of human α1-antitrypsin and M. sexta serpin-
1K (Irving et al., 2000; Li et al., 1999).
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Table B-1. Annotation of serpin gene clusters on scaffold. 
Locations of serpin genes were obtained from M. sexta JBrowse/Apollo (Poelchau et al., 2015). 
scaffold number serpin gene Location on scaffold length (bp) 
00101 serpin-2 488980..496460 (- strand) 7481 
  serpin-17 503779..514944 (- strand) 11166 
00559 serpin-12 44567..50075 (- strand) 5509 
  serpin-10 69198..85271 (- strand) 16074 
  serpin-11 93634..104693 (- strand) 11060 
  serpin-3a 108941..117428 (- strand) 8488 
00170 serpin-6 212220..222394 (+ strand) 10175 
  serpin-15 504696..517545 (+ strand) 12850 
00024 serpin-23 119237..125940 (+ strand) 6704 
  serpin-24 126242..129331 (- strand) 3090 
  serpin-8 128602..131566 (+ strand) 2965 
00304 serpin-14 135952..137163 (- strand) 1212 
  serpin-9 167191..168399 (+ strand) 1209 
00258 serpin-16 113210..117691 (- strand) 4482 
  serpin-29 131185..134857 (- strand) 3673 
00379 serpin-28 117090..122676 (+ strand) 5587 
  serpin-19 135525..138905 (+ strand) 3381 
  serpin-18 140554..149737 (- strand) 9184 
  serpin-26 159939..167504 (- strand) 7566 
  serpin-31 175404..182306 (- strand) 6932 
  serpin-30 183177..190063 (- strand) 6887 
  serpin-27 200810..208208 (- strand) 7399 
  serpin-25 210586..216389 (- strand) 5804 
00125 serpin-32 67811..70348 (+ strand) 2538 
  serpin-20 72329..74807 (+ strand) 2479 
a incomplete sequence with only N-terminal fragment 
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Table B-2. Gene structure annotation of alternative splicing variants.  
Information of serpin-15 and serpin-28 exons and CDS were obtained from M. sexta JBrowse/Apollo (Poelchau et al., 2015). 
 exon length (bp) position on scaffold 00170 position in gene serpin-15A_CDS serpin-15B_CDS  
serpin-15 1 46 212210-212255(+) 1-46 none none  
2 98 212363-212460(+) 154-251 195-251 195-251  
3 135 214445-214579(+) 2236-2370 2236-2370 2236-2370  
4 207 215126-215332(+) 2917-3123 2917-3123 2917-3123  
5 99 215413-215511(+) 3204-3302 3204-3302 3204-3302  
6 141 215601-215741(+) 3392-3532 3392-3532 3392-3532  
7 210 217130-217339(+) 4921-5130 4921-5130 4921-5130  
8 145 217602-217746(+) 5393-5537 5393-5537 5393-5537  
9A 147 219513-219659(+) 7304-7450 7304-7431 N/A  
9B 1518 220877-222394(+) 8668-10185 N/A 8668-8807  
 
 exon length (bp) position on scaffold 00379 position in gene serpin-28A_CDS serpin-28B_CDS serpin-28C_CDS 
serpin-28 1 144 117090-117233(+) 1-144 1-144 1-144 1-144 
2 204 117857-118060(+) 768-971 768-971 768-971 768-971 
3 99 118466-118564(+) 1377-1475 1377-1475 1377-1475 1377-1475 
4 141 118708-118848(+) 1619-1759 1619-1759 1619-1759 1619-1759 
5 210 119458-119667(+) 2369-2578 2369-2578 2369-2578 2369-2578 
6 145 120199-120343(+) 3110-3254 3110-3254 3110-3254 3110-3254 
7A 132 121258-121389(+) 4169-4300 4169-4299 N/A N/A 
7B 139 121633-121771(+) 4544-4682 N/A 4544-4674 N/A 
7C 135 122164-122298(+) 5075-5209 N/A N/A 5075-5208 
8 73 122604-122676(+) 5515-5587 none none none 
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Table B-3. Changes of M. sexta serpin transcript abundance in response to immune challenge. 
The data was retrieved from previous work (Zhang et al., 2011). nCF, nCH, nIF and nIH are normalized read numbers. When nIF or 
IH is zero, nIF/nCF=nIF×825/1618, nIH/nCH=nIH×3980/3352 (Zhang et al., 2011).  
  contig# CF CH IF IH nCF nCH nIF nIH nIF/nCF nIH/nCH 
Serpin-1 07639 651 0 1237 14 7713.36 0.00 7473.22 40.83 0.97 16.62 
Serpin-2 05255 6 102 24 159 71.09 250.52 144.99 463.67 2.04 1.85 
  05821 1 37 6 198 11.85 90.87 36.25 577.40 3.06 6.35 
  14248 0 6 0 196 0.00 14.74 0.00 571.57 0.00 38.79 
  14456 0 0 1 52 0.00 0.00 6.04 151.64 3.08 180.05 
  15111 1 48 8 800 11.85 117.89 48.33 2332.94 4.08 19.79 
  15910 1 31 4 472 11.85 76.14 24.17 1376.43 2.04 18.08 
  16917 0 40 2 519 0.00 98.24 12.08 1513.49 6.16 15.41 
  17048 0 1 0 95 0.00 2.46 0.00 277.04 0.00 112.80 
  17058 0 32 4 545 0.00 78.59 24.17 1589.31 12.32 20.22 
  17751 0 24 1 269 0.00 58.94 6.04 784.45 3.08 13.31 
  18441 0 1 0 65 0.00 2.46 0.00 189.55 0.00 77.18 
  sum 9 322 50 3370 106.64 790.84 302.07 9827.49 2.83 12.43 
Serpin-3 02693 21 7 310 19 248.82 17.19 1872.84 55.41 7.53 3.22 
Serpin-4 04422 47 136 370 211 556.88 334.02 2235.32 615.31 4.01 1.84 
  01873 51 141 355 160 604.27 346.30 2144.70 466.59 3.55 1.35 
  sum 98 277 725 371 1161.15 680.32 4380.02 1081.90 3.77 1.59 
Serpin-5 05831 3 8 97 25 35.55 19.65 586.02 72.90 16.49 3.71 
  13453 5 4 58 7 59.24 9.82 350.40 20.41 5.91 2.08 
  13454 0 1 17 10 0.00 2.46 102.70 29.16 52.37 11.87 
  sum 8 13 172 42 94.79 31.93 1039.12 122.48 10.96 3.84 
Serpin-6 01706 7 34 27 81 82.94 83.51 163.12 236.21 1.97 2.83 
Serpin-7 08071 14 2 75 2 165.88 4.91 453.11 5.83 2.73 1.19 
  08076 18 1 53 1 213.27 2.46 320.19 2.92 1.50 1.19 
  sum 32 3 128 3 379.15 7.37 773.30 8.75 2.04 1.19 
Serpin-9 08071 14 2 75 2 165.88 4.91 453.11 5.83 2.73 1.19 
  08076 18 1 53 1 213.27 2.46 320.19 2.92 1.50 1.19 
  10218 12 2 34 2 142.18 4.91 205.41 5.83 1.44 1.19 
  14528 29 2 62 1 343.61 4.91 374.57 2.92 1.09 0.59 
  sum 73 7 224 6 864.94 17.19 1353.28 17.50 1.56 1.02 
Serpin-11 06359 0 2 6 11 0.00 4.91 36.25 32.08 18.48 6.53 
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Serpin-12 03776 109 5 579 31 1291.48 12.28 3497.98 90.40 2.71 7.36 
  06215 29 1 108 8 343.61 2.46 652.47 23.33 1.90 9.50 
  06531 45 2 199 11 533.18 4.91 1202.24 32.08 2.25 6.53 
  17814 21 0 74 1 248.82 0.00 447.06 2.92 1.80 3.46 
  sum 204 8 960 51 2417.09 19.65 5799.75 148.72 2.40 7.57 
Serpin-13 02184 53 2 111 1 627.97 4.91 670.60 2.92 1.07 0.59 
Serpin-14 09363 0 5 2 4 0.00 12.28 12.08 11.66 6.16 0.95 
Serpin-15 05255 6 102 24 159 71.09 250.52 144.99 463.67 2.04 1.85 
  05821 1 37 6 198 11.85 90.87 36.25 577.40 3.06 6.35 
A 09533 3 26 5 37 35.55 63.86 30.21 107.90 0.85 1.69 
B 17895 0 9 4 13 0.00 22.10 24.17 37.91 12.32 1.72 
  sum 10 174 39 407 118.48 427.35 235.61 1186.88 1.99 2.78 
Serpin-17 05821 1 37 6 198 11.85 90.87 36.25 577.40 3.06 6.35 
  16684 0 22 0 100 0.00 54.03 0.00 291.62 0.00 5.40 
  05255 6 102 24 159 71.09 250.52 144.99 463.67 2.04 1.85 
  14456 0 0 1 52 0.00 0.00 6.04 151.64 3.08 180.05 
  15111 1 48 8 800 11.85 117.89 48.33 2332.94 4.08 19.79 
  18549 0 0 0 8 0.00 0.00 0.00 23.33 0.00 27.70 
  sum 8 209 39 1317 94.79 513.31 235.61 3840.60 2.49 7.48 
Serpin-18 03224 98 0 477 0 1161.15 0.00 2881.75 0.00 2.48 0.00 
Serpin-19 09511 11 0 1 0 130.33 0.00 6.04 0.00 0.05 0.00 
Serpin-22 03224 98 0 477 0 1161.20 0.00 2881.80 0.00 2.48 0.00 
CF, control fat body; CH, control hemocyte; IF, induced fat body; IH, induced hemocyte. 
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Figure C-1. Mass Spectrometry of purified recombinant diapausin-1 and diapausin-2. 
MALDI-TOF was also used for confirmation of the correct mass of diapausin-1 (above) and 
diapausin-2 (below).  
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Figure C-2. Binding of recombinant diapausin-2 to -1,3-glucan. 
Recombinant diapausin-2 (10 ng) or deionized water as a control was incubated with 100 g 
polysaccharides (curdlan, zymosan, chitin, starch and peptidoglycan) at room temperature for 10 
min in 1.5 ml centrifuge tubes. Supernatant was collected as unbound (UB) fraction by 
centrifugation. The polysaccharides were washed by 10 mM sodium phosphate, pH 7.4 and 
subjected to centrifugation for collecting supernatant as wash (W) fraction. Bound diapausin-2 
was eluted by heating the polysaccharides in 2SDS loading buffer supplemented with -
mercaptoethanol at 95°C for 5 min and colleting supernatant as elution (E) fraction after 
centrifugation. Each fraction with reducing SDS loading buffer was subjected to 4-12% Bis-Tris 
NuPAGE gel, followed by Instant Blue staining.  
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Figure C-3. Antifungal assay of diapausin-1 against FKS1 mutants. 
Antifungal assay was performed by using WT (BY4743), FKS1/fks1 (hom dip; MATa/MATα; 
YLR342w::kanMX4/YLR342w::kanMX4), and fks1/fks1 (BY4743; MATa/MATα; 
YLR342w/YLR342w::kanMX4). OD600 was measured after 8 h and 24 h of incubation of 
recombinant diapausin-1 at 0, 20 and 80 M with three yeast strains. 
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Figure C-4. Microscopic observation of S. cerevisiae treated by diapausin-1 in YP medium. 
Yeast cells were incubated at 30°C in YP medium, which restrains the cell growth due to lack of 
carbon source, supplemented with or without 80 M recombinant diapausin-1. Samples were 
examined and imaged by DIC microscope at 0 h and after 3 h of incubation. The number of 
single (a cell without a bud), double (a mother cell with a bud), triple (a mother cell with 
probably two buds) and cluster (with four or more cells sticking to each other) was counted in 
each sample (n>60) and reflected by percentage in bar graph.  
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Figure C-5. Microscopic observations of GFY-42 treated by diapausin-1. 
S. cerevisiae strain GFY-42 (BY4741; cdc10::CDC10::mCherry::SpHIS5) (Finnigan et al., 
2015) was cultured overnight and diluted to OD600=1.0, followed by incubation with 80 M 
recombinant diapausin-1 or sterile water as a control at 30°C for 2 h. Then the cells were 
examined and imaged using an LSM airy scan 880 microscope. 
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Figure C-6. Morphological changes of S. cerevisiae treated by diapausin-1 (complete). 
Morphological parameters which have a significant difference (p<0.05) between control (sterile 
H2O treatment) and diapausin-1 treatment were shown using violin plots. 
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